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The potential involvement of intracellular pH and adaptor proteins in GLUT4 
trafficking has been investigated in insulin-sensitive tissues. To this end, a 
cardiomyocyte isolation protocol was established and characterised. Glucose transport 
in cardiomyocytes prepared by a modified isolation procedure was increased 4-15-fold 
depending on cell batch. Photoaffinity labelling of cardiomyocytes using both ATB- 
[3H]-BMPA and Bio-lc-ATB-BMPA revealed that insulin increased the level of GLUT4 
at the plasma membrane by 3.5 to 5.2-fold, whereas GLUT1 was increased by 
approximately 2-fold. Immunocytochemical analysis of GLUT4 in these cells 
demonstrated that under basal conditions, GLUT4 is predominantly intracellular and 
particularly abundant just under the cell surface and in the perinuclear region. Upon 
insulin stimulation GLUT4 was translocated to the sarcolemma, as expected.
Intracellular pH was perturbed by the addition of the sodium-proton inhibitor HOE-642 
prior to insulin stimulation. Under these conditions insulin-stimulated hexose transport 
into adipocytes and cardiomyocytes was partially inhibited. Furthermore the level of 
fully functional GLUT4 at the plasma membrane was reduced by approximately 35% as 
judged by photoaffinity labelling with Bio-lc-ATB-BMPA. However confocal analysis 
of GLUT4 in cardiomyocytes and subfractionation and Western blotting of GLUT4 in 
adipocytes showed no change in the cell surface content of GLUM. Similar results 
were obtained when v-ATPases were inhibited by the addition of bafilomycin A \t 
however the inhibition of insulin stimulated glucose transport was more potent, being 
approximately 60%. These results demonstrate that glucose transport and GLUT4 
translocation can be partly dissociated from one another and may imply that glucose 
transporters at the plasma membrane exist in occluded or fusion incompetent states. 
The exact mode of action of pH in regulating protein trafficking is unknown but may be 
as a result of modulating interactions between receptor tails containing targeting motifs 
and adaptor proteins.
Using Nycodenz and glycerol gradients the association of adaptor complexes with 
GLUT4 vesicles was examined. Both API and AP3 co-migrate with GLUT4 on 
Nycodenz gradients. On addition of GTPyS, GLUT4 fractionates as a heavier 
population of vesicles. Under these conditions there is an increase in the co­
sedimentation of GLUT4 with API, but not with AP3. On glycerol gradients only AP3
migrates with the GLUT4 fraction. However upon addition of GTPyS API is also 
found in fractions containing GLUT4, whereas the levels of AP3 are unchanged.
Western blotting of proteins associated with immunoadsorbed GLUT4 vesicles from 
adipocytes shows the presence of high levels of API and AP3 but not AP2. Cell free, in 
vitro, association of API is increased approximately 4-fold by the addition of GTPyS 
and an ATP regenerating system. Following GTPyS treatment ARF is also recruited to 
isolated GLUT4 vesicles. Both API and ARF exhibit temperature dependent GTPyS- 
stimulated recruitment. API and ARF association with GLUT4 vesicles is inhibited by 
incubation with brefeldin A. These data demonstrate that the coating of GLUT4 
vesicles can be studied in isolated cell-free fractions. Furthermore at least two distinct 
adaptor complexes are recruited to GLUT4 vesicles, where they are likely to be 
responsible for directing the trafficking of GLUT4 through the labyrinth of intracellular 
compartments.
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Glucose is the major metabolic substrate utilised by eukaryotic cells. Its catabolism via 
glycolysis, the citric acid cycle and oxidative phosphorylation provides cellular energy 
in the form of ATP. Polymerisation of glucose to form the readily mobilised storage 
molecule glycogen is used by higher organisms to protect against times of fuel shortage. 
Glucose homeostasis is maintained, despite the varied metabolic demands of the animal, 
by the relative concentrations of two hormones, insulin and glucagon, in the blood. 
Insulin stimulates glucose uptake by gluconeogenesis; while glucagon promotes glucose 
release via the glycogenolysis pathway. The major organ involved in the maintenance 
of blood glucose levels is the liver, however a number of other cell types are concerned 
with post-prandial, insulin-responsive glucose disposal.
Under normal physiological conditions uptake of glucose is the rate-limiting step in 
glucose utilisation. Since glucose is a polar molecule and therefore cannot cross the 
lipid membrane, specific carriers are required to mediate its transport into cells. These 
glucose transporters allow passive facilitated diffusion, an energy independent process 
in which the creation of a glucose concentration gradient across the membrane provides 
the driving force for glucose to enter or exit the cell (reviewed in Gould and Holman, 
1993). Cloning and sequencing of the first glucose transporter was reported in 1985, 
(Mueckler et a l, 1985). Since then a number of glucose transporter (GLUTs) isoforms 
have been identified (Gould and Holman, 1993). These transporters are variably 
expressed in tissues (Bell et al., 1993), enabling them to perform a variety of distinct 
functions to maintain cellular homeostasis.
1.1.1 GLUT1
GLUT1 is a ubiquitous glucose transporter. It is present at high concentrations in 
erythrocytes, comprising 3-5% of the membrane protein. In the late 1970s, GLUT1 was 
purified from erythrocyte membranes (Baldwin et al., 1979). The kinetics were then 
studied in defined lipid vesicles and this led to the production of anti-sera against the 
transporter. These antibodies enabled Mueckler and co-workers to screen a cDNA 
library prepared from the HepG2 cell line, and to clone the cDNA for GLUT1
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(Mueckler et al., 1985). The open reading frame of the GLUT1 cDNA is 1476 bases 
and codes for a 492-residue polypeptide with a predicted molecular weight of 54,117 
daltons. Hydropathy plots in conjunction with chemical and proteolytic digestion 
experiments predict 1 2 -membrane spanning domains, comprising of a-helical segments 
each containing around 21 amino acids. These amphipathic helices are arranged so that 
both the N- and C- termini of the protein, along with a large hydrophilic loop situated 
between putative transmembrane helices 6  and 7, are cytoplasmic.
Tissues which respond to insulin have a unique glucose transport system. This transport 
system is capable of increasing glucose uptake 20 to 40-fold in a timescale of minutes. 
Although GLUT1 is expressed in insulin-responsive cells, namely adipocytes and 
muscle (Flier et a l, 1987), it is unlikely to mediate this massive change in glucose 
transport in response to insulin, for a number of reasons. Firstly immunocytochemical 
evidence has shown that GLUT1 is particularly abundant in cells which comprise the 
blood-brain barrier and is only expressed at low levels in fat and muscle (Flier et al., 
1987). Secondly under basal conditions a large proportion of GLUT1 is localised to the 
plasma membrane in insulin-sensitive cells. Therefore following insulin treatment there 
is only a relatively small increase in GLUT1 at the cell surface (2 to 3-fold). Thus the 
concentration of GLUT1 in fat and muscle, the amount of transporter in the plasma 
membrane under basal conditions and the low level of stimulation (2-3 fold) cannot 
account for the large change in glucose transport observed upon insulin stimulation.
GLUT1 has been extensively characterised with respect to its kinetic properties. The 
transporter is unusual in that it exhibits asymmetrical transport of sugar. This 
mechanistic feature of GLUT1 was demonstrated in intact human erythrocytes by the 
measurement of the net flux of D-[14C]-glucose into or out of a sugar-free compartment 
using a quenched-flow apparatus and automated syringe, (Lowe and Walmsley, 1986). 
Transport data from these experiments revealed that the Km for the efflux of glucose 
was far greater that that for its influx. The asymmetrical nature of GLUT1 kinetics has 
led to the suggestion (Gould and Holman, 1993) that it may operate under conditions of 
glucose starvation, where it could effectively function in a predominantly influx mode.
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1.1.2 GLUT4
Immunoblotting with a monoclonal antibody against the fat cell glucose transporter 
resulted in the identification of GLUT4 in 1988 (James et al., 1988). One year later, 
five independent laboratories isolated cDNA clones for GLUT4 from a variety of 
tissues and cell lines (James et al., 1989; Bimbaum, 1989; Fukumoto et a l, 1989; 
Charron et al., 1989; Kaestner et al., 1989). The polypeptide sequence of GLUT4 is 
509 amino acids long in rats and humans (James et a l, 1989; Bimbaum, 1989; Charron 
et al., 1989), and 510 amino acids long in mice (Kaestner et a l, 1989). The human and 
rat GLUT4 proteins share 65% sequence identity with GLUT1 isoforms from the same 
species, mainly differing in the N- and C-termini and in the hydrophilic intracellular 
loop (Figure 1.1).
The kinetic properties of GLUT4 differ substantially from GLUT1, appearing to 
function as a simple, symmetrical carrier. In order to identify whether the differences in 
the kinetic properties of GLUT1 and GLUT4 were due to their expression in distinct 
environments or due to inherent properties of the respective transporters, GLUT1 and 
GLUT4 mRNAs were injected into Xenopus oocytes. Transport assays using the 
Xenopus oocyte expression system revealed that the half saturation constants (KmS) for 
3-0-methyl-D-glucose transport under equilibrium exchange conditions were 21 mM 
for GLUT1 and 1.8 mM for GLUT4 (Keller et a l, 1989). The Km values obtained in 
Xenopus oocytes agree well with values obtained in erythrocytes for GLUT1 and 
adipocytes for GLUT4 (reviewed in Baldwin, 1993) and suggest that the differences in 
the kinetic properties are intrinsic to each transporter. The relatively low Km for 
GLUT4 ensures that the transporter operates close to its Vmax over the normal range of 
blood glucose concentrations.
In fat and muscle, the massive insulin-induced increase in glucose transport is attributed 
to GLUT4. This effect is mediated by an increase in the Vmax of the transporter with 
very little change in Km (Taylor and Holman, 1981). In 1980, two groups independently 
demonstrated, by cytochalasin B binding and subcellular fractionation, that insulin 
increases the Vmax of transport by mobilising a population of transporters, now known to 
be GLUT4, from an intracellular compartment to the plasma membrane (Suzuki and 
Kono, 1980; Cushman and Wardzala, 1980). Thus in the absence of insulin, GLUT4 is 
localised primarily to an internal compartment. Upon insulin stimulation, GLUT4 is
Figure 1.1 Hypothetical Model of GLUT4. The protein is predicted to contain 12 transmembrane helices with both the N- and C-termini situated intracellularly. 
Ligand binding and labelling studies have shown separation of the external and internal glucose binding sites, with putative helices 7-9 making up the exofacial site and 10-11 

















quickly translocated from this compartment to the plasma membrane, where its presence 
results in a substantial increase in glucose transport. When the stimulus is removed, 
GLUT4 re-enters the cells and returns to the storage compartment. This major property 
of GLUT4 distinguishes it from all other glucose transporters and makes it crucial in the 
hormonal regulation of glucose homeostasis. Since patients with pathophysiological 
disorders such as morbid obesity and type 2  diabetes have unaltered levels of total 
GLUT4 in their muscle (Kahn, 1992), defects in the signalling to GLUT4 and/or the 
translocation of GLUT4 from the intracellular storage site to the plasma membrane have 
been implicated in these diseases.
1.2 The Insulin Signalling Pathway
Insulin stimulation of glucose transport into muscle and adipose cells is a multi-step 
process. In order to fully understand the processes of GLUT4 trafficking and 
translocation, a knowledge of the mechanisms by which receipt of a hormone signal is 
translated in to movement of vesicles from a storage pool to the plasma membrane, is 
required. Thus a brief overview of the insulin-signalling cascade has been included here 
(Figure 1.2).
1.2.1 The Insulin Receptor
The insulin receptor (IR) is a heteromeric protein consisting of two a  and two p 
subunits ((X2P2). Binding of insulin to its receptor results in autophosphorylation of 
tyrosine residues in the P-subunits which in turn leads to the association and 
phosphorylation of downstream proteins. The intrinsic kinase activity of the insulin 
receptor is an important step in the signal-transduction process since tyrosine kinase 
deficient receptors transfected into rat adipocytes are incapable of transmitting the 
signal for increased hexose uptake (Roth et a l, 1994). Target proteins for the insulin 
receptor include a family of multi-functional docking proteins known as insulin- 
receptor substrates (IRS). Four members of the IRS family have been described so far: 
IRS-1, (Sun et a l, 1991), -2, (Sun et a l, 1995), -3 (Lavan et a l, 1997a) and -4 (Lavan 
et a l, 1997b). Phosphorylation of IRS proteins triggers the activation of a number of 
signalling cascades, one of which includes activation of phosphatidylinositol 3-kinase 
(PI 3-kinase) and protein kinase B (PKB). This signal transduction pathway ultimately
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results in the exocytic translocation of GLUT4 vesicles from an intracellular pool to the 
plasma membrane.
1.2.2 Insulin Receptor Substrates
IRS-1 and IRS-2 are ubiquitously expressed while IRS-3 is found in adipocytes, 
fibroblast and liver cells, and IRS-4 has only been detected in embryonic kidney cells in 
culture (reviewed in Shepherd et al., 1998). All the IRS proteins display remarkably 
similar architecture, sharing homologous N-terminal pleckstrin homology domains (PH 
domains) and phosphotyrosine binding domains (PTB domain). The PTB domain binds 
directly to the insulin receptor at an NPEY motif (He et al., 1995), whereas the PH 
domain (although also implicated in receptor binding) seems to interact with 
phosphoinositides, and may play a modulatory role in IRS function (Rameh et al,
1997). IRS molecules also contain many potential sites for tyrosine phosphorylation, 
the majority of which resemble the YMXM or YXXM motifs (Shoelson et al., 1992). 
Phosphorylation of specific tyrosine residues within IRS-1 allows the protein to recruit 
a number of signalling molecules through interactions with their src-homology 
domains. These include Grb2, the small adaptor protein, Nek and PI 3-kinase (reviewed 
in Shepherd et a l, 1996).
One of the difficulties in studying the role of the IRS proteins in signalling cascades is 
their ability to compensate for one another. This was demonstrated in studies using 
IRS-1 knockout mice (Araki et a l, 1994). In the skeletal muscle of these mice, where 
the concentration of IRS-2 is low, insulin-stimulated PI 3-kinase activity was 
diminished. However in hepatocytes, where the levels of IRS-2 are comparable with 
IRS-1, PI 3-kinase activity was near normal. Furthermore, in adipocytes, it was IRS-3 
and not IRS-2 which compensated for the loss of IRS-1, although IRS-3 was unable to 
completely activate PI 3-kinase (Smith-Hall et al., 1997). Thus there appears to be 
some partial redundancy between the IRS proteins.
The relationship between PI 3-kinase and the IRS proteins has been most extensively 
studied for IRS-1. During insulin stimulation, IRS-1 becomes hyper-phosphorylated on 
tyrosine residues and this enables it to bind to the src homology 2 domains (SH2 
domains) on the p85 regulatory subunit of PI 3-kinase (reviewed in Shepherd et al.,
1998). This binding results in the activation of the pi 10 catalytic subunit of PI 3-
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kinase, and the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3) from 
phosphatidylinositol 4,5 bisphosphate (PI 4,5-P2).
1.2.3 PI 3-Kinase
PI 3-kinase was originally identified as the protein responsible for the phosphorylation 
of the D-3 position of the inositol head group of phosphoinositides (Stephens et al, 
1993). It is now known to play a pivotal role in many cellular processes. These include 
cell growth and differentiation (Toker and Cantley, 1997), synthesis and degradation of 
carbohydrates, lipids and proteins (Holman and Kasuga, 1997), cytoskeletal 
rearrangement (Toker and Cantley, 1997) and membrane trafficking (Holman and 
Kasuga, 1997).
PI 3-kinases form a large family of enzymes, with some homology both to PI 4-kinases 
and even to enzymes with no identifiable lipid kinase activity (Vanhaesebroeck et a l,
1997). The PI 3-kinase superfamily can be sub-divided into 3 classes based on their 
substrate specificity. Class 1 PI 3-kinases can be further subdivided into Class 1A and 
IB. Activation of the insulin-receptor tyrosine kinase results in the immediate targeting 
of class 1A PI 3-kinase into signalling complexes. As well as class 1A, class 2 PI 3- 
kinases are also stimulated by insulin (Shepherd et a l, 1998). Class 2 PI 3-kinases are, 
however, unlikely to play an important role in insulin signalling to GLUT4 for two 
reasons. Firstly they are unable to produce PIP3 as a product (thought to be an 
important intermediate in the insulin pathway), (Domin et a l, 1996; Virbasius et a l, 
1996; Rameh and Cantley, 1999), and secondly they are not susceptible to certain cell- 
permeable inhibitors (Domin et a l, 1996; Virbasius et a l, 1996), to which many 
insulin-induced events are intimately sensitive. Such inhibitors include the fungal 
metabolite wortmannin and the structurally independent LY29002 compound, both of 
which have been widely used to inhibit GLUT4 translocation (Clarke et a l, 1994). 
Although wortmannin acts to varying degrees on all classes of PI 3-kinases, class 1A is 
most sensitive exhibiting an IC50 in the low nanomolar range. In addition, dominant 
negative forms of class 1A PI 3-kinase (Hara et a l, 1994), and experiments using 
antisense RNA to p85 (Yin et a l, 1998), have shown the absolute requirement for this 
class of lipid kinase in the insulin signalling cascade.
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Stimulation of PI 3-kinase by insulin results in the translocation of GLUT4 from an 
intracellular compartment to the plasma membrane. This insulin-stimulated recruitment 
of GLUT4 is completely abolished by incubation with nanomolar concentrations of 
wortmannin. Conversely insulin recruits PI 3-kinase to the internal pool, where it 
interacts with tyrosyl-phosphorylated IRS-1. Analysis of microsomal membranes by 
sucrose gradient centrifugation (Clark et al., 1998), has shown that GLUT4 sediments at 
30/50% sucrose while cytoskeletal markers, PI 3-kinase and IRS-1 are resolved in a 
separate fraction (at 60% sucrose). This differential localisation suggests that GLUT4 
and PI 3-kinase/IRS-1 are derived from different vesicles, the latter being strongly 
tethered to the actin cytoskeleton, (although there is one report of a direct recruitment of 
PI 3-kinase to GLUT4 vesicles (Heller-Harrison et al., 1996)).
How does PI 3-kinase activity lead to downstream activation? Mounting evidence 
suggests that PIP3, the major product of PI 3-kinase, acts as a second messenger, 
relaying information concerning agonist stimulation, to other components of the 
signalling pathway(s). Firstly, the rise in PIP3 concentration occurs rapidly after insulin 
binding, and is thought to precede the activation of signalling molecules downstream of 
PI 3-kinase (Shepherd et a l, 1998). Secondly, increases in PIP3 concentration are 
transient, being precisely regulated both at the level of synthesis and at the level of 
degradation (Stephens et a l, 1991; Cross et a l, 1997). Finally, experiments using 
membrane permeant forms of PIP3 have shown that this lipid is capable of directly 
modulating downstream events (Jiang et a l, 1998). The mode of action of PIP3 is 
unclear but two mechanisms have been proposed. The first is that PIP3 could insert into 
membranes, transiently altering their composition and resulting in membrane curvature, 
which may facilitate vesicle budding, (Schu et a l, 1993). The second is that PIP3 
specifically interacts with proteins downstream in the trafficking pathway, perhaps 
acting as an allosteric modulator, or inducing a change in the conformation of the target 
protein such that it is now capable of interacting with other downstream molecules 
(Shepherd et a l, 1997). Indeed a number of proteins have been shown to bind PIP3 in 
vitro. These include protein kinase B (PKB) {Section 1.2.4), PI 3-kinase dependent 
protein 1 (PDK-1) {Section 1.2.4), the atypical protein kinase C-C (PKC-Q {Section 
1.2.4), the G-protein Dynamin {Section 1.5.2), the ARF-GEFs GRP1 and cytohesin-1 
(Section 1.5.5), the ARF-GAP, centaurin-a (Section 1.5.6) and the adaptor protein 
complexes, API-4 (Section 1.6.6).
1.2.4 Downstream Targets of PI 3-kinase
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The involvement of a serine/threonine kinase downstream of PI 3-kinase in the 
signalling cascade has been suggested by the finding that stimulation of GLUT4 
translocation by serine phosphatase inhibitors is not blocked by PI 3-kinase inhibitors 
(Kanai et al., 1993a). The exact serine/threonine kinase is not known but may include 
PKBp, which has been shown to be targeted to GLUT4 vesicles (Calera et a l , 1998) or 
PKCA,, which can cause GLUT4 translocation in response to insulin (Kotani et a l, 
1998).
1.2.4.1 Protein Kinase B
Protein kinase B is a serine/threonine kinase (Coffer and Woodgett, 1991). Three 
isoforms of PKB have been identified to date, namely PKBa (Coffer and Woodgett, 
1991), PKBP (Cheng et a l, 1992) and PKBy (Konishi et a l, 1993). All three are 
activated by insulin to varying degrees in a cell specific manner. An absolute 
requirement for PI 3-kinase in the activation of PKB has been demonstrated both by the 
use of inhibitors of PI 3-kinase, such as wortmannin (Franke et a l, 1995), and by the 
expression of dominant negative forms of p85, the PI 3-kinase adaptor subunit 
(Burgering and Coffer, 1995). PKB contains one pleckstrin homology (PH) domain, 
which is capable of binding PIP3, and it was initially thought that this in some way 
attenuated PKB activation (Burgering and Coffer, 1995). However, activation of PKB 
results from phosphorylation by a serine/threonine kinase (on Thr308 and Ser73). So 
where is the requirement for a lipid? In fact the kinase which phosphorylates PKB has 
now been characterised and cloned, and named PDK-1 (PI 3-kinase dependent protein 
1) (Walker et a l, 1998). This protein binds PIP3 avidly, however this does not increase 
the intrinsic activity of the enzyme (Alessi et a l, 1998). Thus it is proposed that 
binding of PIP3 to PKB, somehow results in a conformational change, which places 
Thr308 and possibly Ser73 into more accessible positions for phosphorylation by PDK-1 
(Shepherd et a l, 1998). Since both PKB and PDK-1 are capable of binding PIP3, this 
may constitute a mechanism by which the two proteins are brought into close proximity 
with one another (for review see Shepherd et a l, 1998).
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F ig u re  1.2 T h e  In su lin  S ig n a llin g  P a th w a y . Binding of insulin to its receptor in the plasma 
membrane leads to autophosphorylation of the P-subunits. This in turn leads to the association of the 
receptor with insulin receptor substrates (for example IRS1), which also become phosphorylated. PI 3- 
kinase interacts with tyrosyl phosphorylated IRS1 via the p85 regulatory subunit. Activation of PI 3- 
kinase leads to the generation of PIP3, which ultimately signals to GLUT4 possibly via Protein Kinase B 











Doubts are raised over the involvement of PKB, by a recent study, (Kitamura et al., 
1998), in which the expression of a dominant negative form of PKB in 3T3-L1 
adipocytes resulted in the inhibition of protein synthesis but had no effect on glucose 
transport. In contrast to this, a study of PKB activity in L6  myotubes showed that 
transfection of a constitutively active haemoglutinin tagged PKB into these cells, results 
in an increase in cell surface GLUT4 (Wang et al., 1999). Furthermore this GLUT4 
translocation could be reduced by co-transfecting the haemoglutinin tagged PKB with a 
kinase inactive, phosphorylation deficient PKB mutant. Thus the use of dominant 
negative PKB constructs has provided mixed results as to the importance of PKB in 
GLUT4 translocation. Specific inhibitors could more definitively ascribe a role for 
PKB, but as yet none have been described.
1.2.4.2 Protein Kinase C
A role for PI 3-kinase in the stimulation of protein kinase C (PKC) activity has recently 
been established by the observation that introduction of constitutively active PI 3- 
kinases into cells, results in the activation of atypical PKC isoforms (PKC-£ and - 
A,)(Standaert et al., 1997; Kotani et al., 1998). Although these proteins do not contain 
PH domains, they do seem to bind PIP3 with reasonable affinity, (Palmer et a l, 1995). 
Thus it is possible that PIP3 acts on atypical PKC isoforms in an analogous manner to 
its action on PKB; altering the conformation of the protein to expose serine/threonine 
residues for phosphorylation, and attenuating the co-localisation of PKC with its 
serine/threonine kinase (possibly PDK-1).
Thus a complex signalling pathway exists between the insulin receptor and the glucose 
transporter. Evidence to date conclusively demonstrates a role for the insulin receptor 
substrates and for PI 3-kinase. However more data is required to decisively place PKB 
or PKC in this signal transduction cascade.
1.3 Insulin-stimulated Translocation of Glucose Transporters
1.3.1 Kinetics of GLUT4 Trafficking
In order to examine the movement of GLUT4 (and GLUT1) between the plasma 
membrane and the intracellular storage site(s), a method for accurately quantitating cell
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surface glucose carriers is required. Initially a subfractionation and Western blotting 
protocol was employed to address this issue. Adipocytes were fractionated into 4 
fractions: the plasma membrane (PM), the low density microsomes (LDM), containing 
endosomes, Golgi and TGN membranes, the high density microsomes (HDM), 
containing endoplasmic reticulum, and the cytosolic pool. The amount of GLUT4 in 
each of these fractions was then analysed by immunoblotting. Results obtained using 
this method revealed a translocation of GLUT4 from the LDM fraction to the plasma 
membrane. However the relatively small insulin-induced increase in GLUT4 
concentration at the plasma membrane did not correlate well with the impressive 
augmentation of hexose transport activity observed (Gould and Holman, 1993).
Originally it was thought that the discrepancy between transporter number and glucose 
uptake was due to an insulin-induced increase in the ‘intrinsic activity’ of the 
transporter (Czech et al., 1992). However it soon became clear that part of the 
inconsistency was due to contamination of the plasma membrane fraction with 
microsomal membranes (LDM), a substantial problem, which needed to be 
circumvented. To this end, the bis-mannose photolabel ATB-BMPA (Clark and 
Holman, 1990) and its biotinylated derivative Bio-lc-ATB-BMPA (Koumanov et al.,
1998) were developed. Due to their bulky hydrophilic nature, these compounds are 
membrane impermeable, allowing only those transporters exposed at the cell surface to 
be tagged. Upon UV irradiation, the diazirine group on the label produces a carbene, 
which can directly insert into the target protein. Using this approach in rat adipose 
cells, researchers (Holman et al., 1990) have shown that cell surface levels of GLUT4 
increase markedly (15-20 fold) upon insulin stimulation, while the levels of cell surface 
GLUT1 increase only moderately (3-5 fold). The photolabelling technique can also be 
used to monitor the distribution of glucose transporters among subcellular pools. Since 
only plasma membrane proteins are labelled, a pulse-chase approach can be utilised, i.e. 
transporters can be labelled with ATB-BMPA and the time-course of cell surface tagged 
GLUT4 equilibration with internal microsomes analysed. ATB-BMPA tagged 
transporters monitored in cells from both basal and insulin-stimulated states show that 
the rate constant for the internalisation of transporters is unaffected (or slightly 
decreased) by the presence of insulin. Conversely the rate of exocytosis is markedly 
stimulated by insulin (Satoh et al., 1993). Studies with ATB-BMPA have also shown 
that, even under basal conditions, a small proportion of the glucose transporters
continually recycle between the plasma membrane and the internal microsomes (Yang 
and Holman, 1993).
Stimulation of glucose transport in rat adipose tissue is rapid, occurring with a half-time 
of approximately 3 min at 37°C (Clark et al., 1991). However Western blotting of 
subcellular fractions and photolabelling have demonstrated that the appearance of 
GLUT1 and GLUT4 at the cell surface pre-empts transport activity, occurring with a 
half-time of » 2 min (Clark et al., 1991). The lag period between precipitation of 
transporters at the cell surface and the increase in carrier activity may be due to a 
population of glucose transporters in occluded precursor/fusion-incompetent states or 
bound to regulatory proteins which prevent the full exposure of the transporter to the 
extracellular environment (Holman and Cushman, 1994). This lag phenomenon has 
been observed in both rat adipocytes (Clark et al., 1991) and 3T3-L1 adipocytes (Yang 
etal., 1992).
The kinetic data obtained from photolabelling experiments of GLUT4 (Clark et a l, 
1991; Yang et al., 1992) has enabled a mathematical analysis of its trafficking 
behaviour (Figure 1.3). Mathematically, insulin can increase the number of transporters 
on the cell surface either by increasing the rate of exocytosis, decreasing the rate of 
endocytosis, or both. The “2-pool model” (Holman et a l, 1994) consists of an 
intracellular pool (the endosomes) and the plasma membrane, which are governed by 
two rate constants, one for endocytosis ( k e n )  and one for exocytosis ( k e X) .  Under basal 
conditions the number of transporters at the plasma membrane is small. Thus following 
insulin stimulation a marked decrease in the rate of endocytosis of GLUT4 would be 
required in order to allow for the necessary increase in steady-state glucose transporters 
(Holman et a l, 1994). In addition, the rate of appearance of GLUT4 at the cell surface 
and its endocytosis should be the same as both are dependent on the same values for keX 
and ken- Neither of these criteria are mathematically feasible, nor does the biochemical 
evidence support them. For example, in rat adipose tissue, the half-times {t\n = In2/k) 
for exocytosis and endocytosis of GLUT4 are 2.7 min and 10.6 min respectively (Satoh 
etal., 1993).
In the “3-pool model” (Holman et a l, 1994), a second intracellular pool, the 
tubulovesicular pool is predicted. The involvement of the tubulovesicular pool allows 
insulin to stimulate a rapid initial translocation of GLUT4 from this pool without a
Figure 1.3 GLUT4 Recycling Models. In the ‘two-pool’ model the functional GLUT4 at the plasma membrane (Tp) is in equilibrium with one intracellular early 
endosomal pool (Tee). In the ‘three pool’ model a second distinct intracellular pool, the tubulovesicular pool (Ttv) is evoked. Figure adapted from Holman et al., 1994.
3-Pool Model2-Pool Model
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significant effect on the rate of endocytosis (ken). Thus the tubulovesicular pool acts as 
a reservoir responsible for the initial translocation of GLUT4 to the plasma membrane, 
which may later re-fill via the endosomal system. In this model, in addition to the 
GLUT4 in the tubulovesicular pool, GLUT4 present in the endosomal system can also 
translocate to the plasma membrane by constitutive recycling. The biochemical data for 
GLUT4 trafficking is more consistent with the “3-pool model” than with the “2-pool 
model”. GLUT4 trafficking data can also be fitted to more complex 4- and 5- pool 
models in which the formation of occluded populations of vesicles at the plasma 
membrane are considered (Holman et al., 1994).
1.3.2 GLUT4 Vesicles
GLUT4 vesicles comprise 2-3% of the light microsomes (James et a l, 1987; Kandror et 
al., 1995). These vesicles are homogeneous, round-shaped, 50-70 nm particles with a 
sedimentation co-efficient of »120 S  in sucrose (Kandror and Pilch, 1996). Upon 
insulin stimulation the sedimentation co-efficient of the vesicles increases by 20 S  and 
consequently the buoyant density decreases, although no major changes in their protein 
composition are observed (Kandror and Pilch, 1998). One important question to 
address is whether GLUT4 vesicles obtained by subcellular fractionation are a true 
representation of the storage compartment in vivo, or an artefact of the homogenisation 
procedure. A plethora of observations suggest that GLUT4 vesicles isolated in vitro are 
not damaged by the subfractionation procedure. Firstly, vesicles isolated by a number 
of differing protocols from both fat and muscle are essentially the same (Kandror et al.,
1995). Secondly, if the vesicles were fragments of the intracellular membranes then 
they would exhibit similar protein compositions, however this is not the case. Silver 
staining profiles of GLUT4 vesicles and LDM protein show that they are veiy different 
(Kandror and Pilch, 1996). Finally a change in the density of isolated GLUT4 vesicles 
can be evoked by the addition of insulin to intact cells, which cannot be mimicked in 
vitro (Kandror and Pilch, 1996).
Using subcellular fractionation in combination with a number of other approaches, a 
timpani of proteins have been found to reside on GLUT4 vesicles. One technique that 
has provided some interesting data is cell surface biotinylation. Using this method 
several proteins have been shown to translocate to the cell surface in response to insulin. 
These included the mannose-6 -phosphate receptor (M6 PR) and the TfR. However this
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procedure has flaws, since small proteins, and those with inaccessible domains such as 
GLUT4, have low specific biotinylation and may be overlooked (Kandror and Pilch,
1996).
At the time of writing, vpl65 (also known as gpl60 and IRAP) is the only protein that 
has been identified, which has a distribution and translocation pattern superimposable 
with that of GLUT4. Unlike GLUT1, the TfR, and the M6 PR, which show only a small 
2 to 3-fold insulin-dependent increase in cell surface levels, vpl65 is upregulated 10 to 
40-fold (comparable with GLUT4), with a half-time of » 2 min (Ross et al., 1997). 
Furthermore a small proportion of vpl65 continually recycles between the LDM and the 
plasma membrane in the basal state (Ross et al., 1997).
Vpl65 is a member of the family of zinc-dependent membrane aminopeptidases and has 
homology to aminopeptidase N. It also exhibits aminopeptidase activity in vitro 
(Kandror et a l, 1994). It consists of a large extracellular catalytic domain, a single 
transmembrane domain and a unique extended cytoplasmic region which contains 2  di­
leucine motifs {Section 1.3.5). Unlike aminopeptidase N, which is targeted to the 
plasma membrane with its catalytic domain exposed, vpl65 is sequestered 
intracellularly in the absence of insulin, with the catalytic domain buried within the 
vesicle. One interesting point to note is that a number of aminopeptidases have been 
identified in other secretory vesicles, for example on the secretory granules of mast cells 
and on water channel vesicles from renal epithelia, the latter of which exhibits hormone- 
induced translocation of vesicles from the microsomes to the plasma membrane (Serafin 
et a l, 1991; Harris et a l, 1994). This raises the possibility that vpl65 may act to 
regulate or organise the GLUT4 secretory machinery in an insulin-responsive manner, 
perhaps behaving as a hormone sensor. Conversely, insulin may act on GLUT4 and 
vpl65 independently but they share the same carrier vesicle. The tissue distribution of 
vpl65 is less restrictive than that of GLUT4, raising the prospect that vpl65 regulates 
distinct specialised secretory vesicles in other cell types independent of insulin action 
(Keller et a l, 1995).
Other proteins including sortilin (Lin et al., 1997), acyl CoA synthase (Sleeman et a l,
1998), VAMPs (Tamori et a l, 1996), SCAMPS (Laurie et al., 1993), small GTP- 
binding proteins (Cormont et al., 1993) and components of the insulin-signalling 
pathway, (Heller-Harrison et a l, 1996; Calera et al., 1998) {Section 1.2) have all been
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detected in the membrane of GLUT4 vesicles. However it is not known whether 
GLUT4 vesicles carry specific cargo in their lumen. One possible cargo protein is the 
secreted proteinase adipsin (Kitagawa et al., 1989). However in these studies, GLUT1 
was used to adsorb vesicles from 3T3-L1 adipocytes, which probably led to the 
isolation of a heterogeneous population of both GLUT1 and GLUT4 vesicles. Thus as 
yet no results have been obtained in insulin-responsive fat or muscle. One intriguing 
possibility is the recently discovered protein, leptin, the gene-product of the ob gene, 
thought to be involved in the control of appetite (MacDougald et a l, 1995).
1.3.3 Compartmentalisation of GLUT4
Established studies on endocytosis have characterised two fates for the endocytosed 
protein: degradation and/or re-exocytosis to the plasma membrane (Mellman, 1987). 
However, more recently it has become clear that many cells sequester proteins in 
specialised pools from which they can be mobilised upon receipt of a viable signal 
(Mellman, 1996). GLUT4 is a classic example of such a protein, as are the proteins of 
the small synaptic vesicles (SSVs) of neuroendocrine cells (Rothman and Warren,
1994).
Immunochemical studies (Slot et al., 1991a) have localised GLUT4 to many separate 
cellular locations, some of which demonstrate elements of the recycling pathway. In the 
basal state, a small proportion of GLUT4 is found associated with the plasma 
membrane, with clathrin-coated vesicles and the TGN, and with early endosomes. 
However a sizeable fraction of GLUT4 (w 60%) is found in a dynamic array of tubules 
and vesicles distributed throughout the peripheral and perinuclear region, which are 
thought to represent a specialised secretory compartment, and have been referred to as 
the GLUT4 storage compartment (GSVs) (James and Rea, 1997).
According to the evidence from electron microscopy, at any particular moment 
approximately 1% of GLUT4 at the plasma membrane is associated with clathrin coated 
pits (Slot et al., 1991a). Furthermore biochemical data from two groups suggest an 
interaction between GLUT4 and clathrin-coated vesicles at both the plasma membrane 
and the TGN (Robinson et a l, 1992; Chakrabarti et a l, 1994). Thus it is likely that at 
least some of the GLUT4 at the cell surface is internalised via a coated pit mechanism 
and enters an early endocytic pathway. From here GLUT4 may be sequestered into the
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tubular vesicular storage compartment (GSVs) where it remains in the basal state. 
Administration of insulin would therefore ‘release’ GLUT4 from this reservoir, 
enabling it to traverse the intracellular membranes and traffic to the plasma membrane 
(Slot e ta l, 1991a).
This basic representation of GLUT4 trafficking can be derived from a number of 
possible scenarios, which can be illustrated by four (or a combination of four) more 
sophisticated models (Figure 1.4). However a word of caution is necessary - a number 
of problems face the researcher when analysing data concerning the 
endocytosis/exocytosis of a target protein. Firstly, segregation between compartments 
is not easy to define due to their complex, 3-dimentional structure. Secondly, the choice 
of markers to delimit an internal compartment is not unequivocal -  most internalised 
markers do not move synchronously through the intracellular membrane maze. Lastly, 
the membrane compartments are highly dynamic, with continuously evolving 
morphology. All of these factors complicate the analysis of static morphological data. 
That said, a wealth of data has been collected concerning the GLUT4 trafficking 
itinerary, which can be interpreted as follows:
In the first model (Figure 1.4A) the GLUT4 storage compartment buds directly from the 
endosomes. This theory is supported by the observation that there is a partial overlap 
between some endosomal markers and GLUT4 (Martin et al., 1996a), and by electron 
micrographs which show GLUT4 in tubular structures adjacent to sorting endosomes, 
(Slot et a l, 1991a). However, in many cells the recycling endosomes are located in the 
peri-Golgi region, juxtaposed to the Golgi stack and to the TGN, making them difficult 
to distinguish. Nevertheless, immunoprecipitation of GLUT4 vesicles from skeletal 
muscle has revealed the existence of two populations of vesicles with differential 
responses to insulin (Sevilla et a l, 1997). One population of vesicles, the ‘insulin- 
insensitive’ pool is rich in GLUT4, secretory carrier membrane proteins (SCAMPs) and 
vesicle associated membrane proteins-2 and -3 (VAMPs 2 and 3); the other, the 
‘insulin-sensitive’ pool is populated by GLUT4 and VAMP2 alone. The precise nature 
of these GLUT4 populations is unknown, however the pattern of proteins in each pool 
suggests that the ‘insulin-insensitive’ pool is an inherent component of the endosomal 
locus, while the ‘insulin-sensitive’ pool is derived from it.
The second model (Figure 1.4B) suggests that GLUT4 is internalised via clathrin coated 
vesicles into an endosome which is distinct from other recycling proteins, such as the 
transferrin receptor (TfR). Data to support this model comes from experiments in PC- 
12 cells, following the reformation of synaptic vesicle-like membranes (Schmidt et a l,
1997). Since there are many parallels between mechanisms initially reported for 
synaptic vesicle exo- and endocytosis, and for GLUT4 translocation, it would not be 
impossible for the GLUT4 storage compartment to be reminiscent of the specialised 
synaptic endosomal sorting station that has been described (Schmidt et a l , 1997). 
Indeed one of the features of this specialised compartment is that traffic out of the 
compartment is blocked at low temperature. In rat adipocytes, prolonged incubation at 
18°C can inhibit insulin-stimulated GLUT4 translocation. In addition, experiments 
comparing the internalisation of GLUT4 and the TfR show that GLUT4 accumulates 
within peripheral compartments, which exclude the TfR, at both 15°C and 37°C. GSV 
formation is blocked at 15°C but reappears when cells are returned to 37°C (Wei et al.,
1998). Thus this study suggests that GLUT4 and the TfR are sorted primarily at the 
plasma membrane into distinct endosomes, (Wei et al., 1998). One problem with this 
model is that it fails to address the partial co-localisation of GLUT4 with endosomal 
markers described by a number of laboratories, (Martin et al., 1996a; Malide and 
Cushman, 1997) unless it is assumed that after its’ formation endosomal ‘mixing’ can 
occur. Possible evidence for this comes from electron microscopy studies of TfR 
recycling in polarised MDCK cells. In these studies TfR labelled with gold and 
internalised apically was shown to mix with TfR tracers endocytosed basolaterally in a 
common compartment (reviewed in Robinson et al., 1996). These experiments 
demonstrate that mixing of the contents of some endosomes does occur.
Another major obstacle with this model of GLUT4 trafficking is that in studies where 
GLUT4 has been expressed in the neuroendocrine cell line PC 12, it does not behave 
like the SSVs (on which the model is based). PC 12 cells are known to contain two 
populations of vesicles, SSVs and secretory granules. However glycerol gradient 
centrifugation of homogenates from PC 12 cells transfected with GLUT4, revealed that 
the transporter is targeted to neither population of known vesicles but rather forms 
another storage organelle that can sediment twice as rapidly, and that excludes 
endosomal markers such as the TfR and synaptobrevin, (Herman et al., 1994). This 
population of GLUT4 vesicles was also observed in transfected fibroblast cell lines and
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Figure 1.4 Models for GLUT4 Trafficking. A GSVs bud directly from the endosomes. B. 
GLUT4 is internalised into an endosome which is distinct from the recycling endosomes. C. The GSVs 
are an integral component of the TGN. D. GLUT4 traffics back to the TGN from the plasma 





























rat adipocytes. Excitingly, insulin provoked a redistribution of GLUT4 from this 
storage organelle to a population of even faster-sedimenting vesicles.
The third model (Figure 1.4C) anticipates that part of the TGN represents the 
specialised storage locus. This model is supported by EM studies which indicate that at 
least 13% of the total GLUT4 is enriched in the TGN (Slot et a l, 1991a), and by 
confocal microscopy which reveals partial co-localisation of GLUT4 with y-adaptin, a 
subunit of the TGN-specific adaptor complex, API (Malide et al., 1997). In addition an 
elegant microscopical analysis of GLUT4 in C2 skeletal myotubes has shown that in 
this tissue the transporter is predominantly located in the /ra«s-most cistemae of the 
Golgi complex and in vesicles just beyond (presumably representing the TGN) (Ralston 
and Ploug, 1996). GLUT4 in these membranes partially co-localises with the Golgi 
marker, Giantin. Treatment of these myotubes with brefeldin A results in the fusion of 
the GLUT4 containing compartment with neighbouring endosomes, and this in turn 
leads to a loss of co-localisation of GLUT4 with markers of the Golgi and an increase in 
its association with TfR containing compartments. The authors therefore conclude that 
GLUT4 is localised to the TGN, but has a ‘functional and dynamic connection’ with 
TfR containing endosomes. An uncertainty with this model is the observation that 
TGN38, a marker of the trans-Golgi reticulum, does not co-immunoprecipitate with the 
GSVs (Martin et al., 1994). One theory is that the TGN comprises of a number of 
microenvironments in which proteins may be segregated from one another (Millar et al.,
1997). Thus TGN38 may inhabit a sub-domain of the TGN which is distinct from that 
enriched in GLUT4.
The final model {Figure 1.4D) suggests (like model 3) that GLUT4 may traffic back to 
the TGN from the plasma membrane, but from here it buds to create the GSVs. This 
model is supported by studies which showed, using the selective action of the fungal 
metabolite, brefeldin A (Section 1.6.6.2), that GLUT4 interacts with clathrin-coated 
vesicles budding from the TGN (Chakrabarti et a l, 1994). Furthermore a recent study 
in atrial cardiomyocytes (Slot et a l, 1997) demonstrated that a large proportion of 
GLUT4 (50-60%) enters ANF-containing secretory granules, apparently at the level of 
the TGN. This GLUT4 does not appear to be newly synthesised since incubation with 
the protein synthesis inhibitor cycloheximide, does not block its localisation. This data 
suggests that a sizeable portion of GLUT4 must recycle via the TGN, (the principal 
sorting station in the secretory pathway of mammalian cells).
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Corroborating evidence for this model comes from studies using the technique of 
compartmental ‘ablation* (Millar et a l, 1997). This technique utilises the recycling 
properties of the TfR. Transferrin conjugated to horseradish peroxidase (HRP) is 
internalised by the TfR with normal kinetics, and enters the endosomal system. 
Addition of 3, 3*-diaminobenzidine (DAB) and H2O2 allows HRP to transfer electrons 
from DAB to H2O2, and leads to cross-linking of the conjugate within its sequestered 
compartment. This, in turn, results in the formation of a high-molecular-mass complex 
and the compartment is designated ‘ablated*. Using this approach it has been shown 
that while almost all of the TfR, GLUT1 and mannose-6 -phosphate receptor (M6 PR) is 
lost, only 40% of the total cellular GLUT4 is ablated (Livingstone et al., 1996). This 
indicates that the remaining GLUT4 must reside in a post-endosomal compartment.
1.3.4 The Role of the Endosomal GLUT4 Pool in Insulin-Stimulated Glucose 
Uptake
It clear both from immunocytochemical evidence (Slot et al., 1991a) and from 
biochemical approaches such as ablation (Livingstone et al., 1996) that GLUT4 and 
GLUT1 partially overlap, presumably within the endosome. Ablation experiments have 
also shown that if the endosomal compartment is made inaccessible by cross-linking, 
insulin is still able to initiate enhanced exocytosis of GLUT4, albeit with a lag period 
(Martin et a l, 1998). Two possible explanations for this observation have been 
surmised. The first is that GLUT4 recycles from the GSV via the endosome to the 
plasma membrane (Martin et a l, 1998). In this model the lag period can be explained 
as the time it takes to reconstruct the endosomal apparatus. The second hypothesis 
assumes that GLUT4 bypasses the endosomes moving directly from the GSVs to the 
plasma membrane (Martin et a l, 1998). If insulin recruits GLUT4 back to the 
endosomes more quickly than the movement of GLUT4 from the endosome to the 
GSVs then the lag would be due to the lost endosomal GLUT4. Either way, these 
models show the importance not only of the GSVs but also of the endosomal pool.
In addition to GLUT4, a host of other proteins including GLUT1, the TfR and the 
M6 PR are trafficked to the plasma membrane as a direct response to insulin (reviewed 
in Kandror and Pilch, 1996). The magnitude of the insulin effect on each of these 
proteins is far less than that observed on GLUT4. How can this be reconciled with the 
proposed existence of a specialised GLUT4 locus and with the observation that many of
these proteins can be immunoprecipitated with GLUT4 vesicles? One hypothesis is that 
insulin acts differentially on vesicles in the GSVs and the endosomes, both of which 
contain some GLUT4. It is conceivable that proteins within these compartments or 
within the insulin-stimulated signalling cascades to these compartments act as 
molecular modulators, regulating the action of vesicle populations in response to 
insulin. Indeed heterogeneity of signalling to the endosomal pool of glucose 
transporters has been observed. For example this pool of transporters is not only 
regulated by insulin but also by phorbol esters (Holman et al., 1990) and by the protein 
phosphatase inhibitor okadaic acid (Lawrence, Jr. et al., 1990). The effects of phorbol 
esters partially mimic those of insulia Stimulation of rat adipose cells with phorbol 12- 
myristate 13-acetate (PMA) causes the translocation of both GLUT1 and GLUT4 to the 
plasma membrane to similar extents (3-fold). However the translocation of GLUT4 in 
response to PMA is much lower than that induced by insulin (Gibbs et al., 1991). This 
observation has led to speculation that PMA acts discretely on the population of 
GLUT4/GLUT1 vesicles present in the endosome. Downregulation of protein kinase C 
(PKC) by phorbol 12,13-dibutyrate pre-treatment inhibits PMA-stimulated glucose 
transport, but has no effect on insulin-stimulated glucose transport (Todaka et a l,
1996). By contrast, inhibition of PI 3-kinase by wortmannin inhibits insulin-stimulated 
GLUT4 translocation, but is without effect on PMA action (Todaka et a l, 1996). Thus 
heterogeneity of signalling to glucose transport can be partially dissected.
Preliminary data from the laboratory of Tavare and colleagues (Biochemical Society 
meeting lecture) revealed that the GLUT4 storage pool is regulated by protein kinase B 
(Section 1.2.4) and is sensitive to botulinum toxins, while the endosomal pool is not. 
These researchers argue that inhibition of GLUT4 vesicle exocytosis from the GSV 
pool, results in shunting of GLUT4 vesicles to the endosomal pool, from where insulin 
can recruit them to the plasma membrane.
1.3.5 Sorting Signals in GLUT4
The identification of multiple intracellular compartments for GLUT4 has important 
implications in terms of GLUT4 trafficking. It insinuates that the transporter must be 
recognised by subcellular trafficking proteins in several sorting depots. For many 
proteins the major determinant in establishing their steady state distribution is the rate of 
internalisation. This is controlled by a particular amino acid motif (Collawn et al.,
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1990). Sorting signals can be divided essentially into three classes; the tyrosine based 
sequences generally YXX0, the leucine/di-leucine based sequences consisting of 
ZXXXL0, and the acidic-based clusters, (single amino acid code, where Z is negatively 
charged, 0  is hydrophobic and X is any amino acid). The tyrosine and di-leucine based 
sequences share structural similarities and usually form [3-turns.
GLUT1 and GLUT4 are very similar in terms of their primary sequence and their 
predicted secondary structure, however under basal conditions they are targeted to 
distinct subcellular locations, GLUT4 being predominantly intracellular whereas 
GLUT1 is present at high levels in the plasma membrane (Bimbaum, 1992). When 
expressed in non-insulin responsive cells such as HepG2 or 3T3 fibroblasts via DNA- 
mediated gene transfer, the unique pattern of targeting for GLUT1 and GLUT4 is 
recapitulated (Haney et a l, 1991). This suggests that the information to sequester 
GLUT4 in an intracellular compartment is contained within the protein itself (Haney et 
al, 1991). Small intrinsic differences between GLUT1 and GLUT4 must therefore be 
recognised by trafficking and/or protein sorting machinery.
1.3.5.1 The Amino Terminus o f GL UT4
In a search for targeting information, many laboratories have analysed small regions of 
sequence diversity, which exist between GLUT1 and GLUT4. In 1992, Piper and 
colleagues constructed chimeras of GLUT1 and GLUT4 which they transiently 
expressed in CHO cells (Piper et al., 1992). Using these chimeras they showed that the 
N-terminus of GLUT4 (and not the C-terminus) is required for intracellular 
sequestration in the absence of insulin. In addition they reported that the sequence 
which confers this segregation selectivity is contained within the first 19 amino acids at 
the cytoplasmic side of the membrane. In this region at position 5 is an aromatic amino 
acid (phenylalanine), which may take the place of tyrosine in the formation of a GLUT4 
‘tyrosine-like’ internalisation motif. The sequence FQQI bears some resemblance to 
internalisation motifs found in other proteins such as the TfR and the M6 PR (Collawn et 
al, 1990; Canfield et a l, 1991). These amino acids may enable GLUT4 to interact with 
clathrin coated pits via adaptor proteins causing efficient endocytosis (Section 1.6.5) 
(Pearse and Robinson, 1990). Other studies have shown that aromatic residues may 
have pleiotropic effects on protein targeting. For example, the tyrosine residue in the
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cytoplasmic tail of lgpl2 0 , is responsible not only for internalisation but also for 
directing the protein from the TGN to the lysosomes (Harter and Mellman, 1992).
Confirming their earlier work and expanding upon it, Piper and co-workers expressed 
GLUT4 constructs containing deletions or alanine substitutions in the N-terminus (Piper 
et al., 1993). Use of these engineered transporters revealed that the loss of the first 8  
amino acids or substitution of F for A at position +5, resulted in a marked accumulation 
of the transporter at the cell surface. Furthermore co-localisation of GLUT4 with 
clathrin lattices at the plasma membrane is abolished by deleting the first 13 amino 
acids or by the F5->A substitution. In order to test whether the N-terminus could act as 
an internalisation motif independent of the remainder of the glucose transporter the first 
23 amino acids of GLUT4 were grafted onto the HI subunit of the asialoglycoprotein 
receptor. This chimera exhibited an increase in its intracellular sequestration when 
compared with the wild-type HI protein, which clearly demonstrates that the N- 
terminus of GLUT4 can function as an autonomous sorting domain (Piper et a l , 1993). 
However, not only did the N-terminal domain increase the internalisation rate of the 
asialoglycoprotein but it also targeted the protein to the peri-nuclear region, a 
subcellular location normally inhabited by GLUT4 but not by the HI protein.
One interesting study addressed the importance of the N-terminus of GLUT4 as an 
internalisation signal using chimeras of GLUT4 and the TfR (Garippa et a l, 1994). The 
N-terminus of the TfR was substituted with the corresponding region of GLUT4 and the 
endocytic behaviour of the chimera was characterised in CHO cells, using radioactive 
transferrin as a tracer. The GLUT4-TfR chimera trafficked back to the plasma 
membrane at the same rate as the wild-type TfR, indicating that the N-terminus does not 
promote intracellular retention, however the internalisation of the chimera was reduced 
by « 50%. Substitution of F5 for A slowed the rate of endocytosis even further to a 
level approximately equivalent to the rate of bulk membrane flow. Conversely 
substitution of F5 for Y resulted in an increase in internalisation equivalent to the 
endogenous TfR. None of these substitutions affected the rate of recycling back to the 
cell surface (Garippa et al., 1994).
As already discussed the N-terminal GLUT4 motif FQQI fulfils the presumed 
requirements for a functional clathrin-coated pit internalisation motif i.e. an aromatic 
residue separated by 2 residues from a bulky hydrophobic amino acid (Collawn et al.,
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1990). In addition nuclear magnetic resonance has indicated that the N-terminus of 
GLUT4 folds into the predicted p-tum (of such motifs) in solution, and that this 
conformation is lost by the F5 -> A substitution. Thus an important question to ask is 
whether there is a physiological significance for the use of phenylalanine (an 
intermediate internalisation motif) over tyrosine (a strong internalisation motif) in 
GLUT4? One observation is that the presence of phenylalanine in the GLUT4 motif 
results in the transporter remaining at the cell surface approximately twice as long as 
tyrosine motif-containing proteins (Garippa et al., 1994). It is therefore possible that 
this may be of some benefit during times of insulin stimulation.
1.3.5.2 The Carboxyl Terminus o f GLUT4
In addition to the N-terminal sequence, GLUT4 also contains a potential sorting motif 
in the C-terminal cytoplasmic tail. This region was analysed in two studies using 
similar chimeras expressed in COS-7 cells (Czech et al., 1993) or NIH 3T3 and PC 12 
cells (Verhey et al., 1993). In both cases the GLUT1/GLUT4 transporters were epitope 
tagged in a region of the protein that would not interfere with targeting motifs, thus 
enabling the chimeras to be distinguished from endogenous GLUTs. The results from 
these groups were near identical and illustrated the importance of the last 30 amino 
acids at the C-terminus in the sequestration of GLUT4 and to a lesser extent the first 
«150 amino acids of the N-terminus. This was in contrast to Piper and colleagues who 
saw no effect of the C-terminus under their experimental conditions (Piper et al., 1992). 
Thus Czech et al. (Czech et a l, 1993) speculated that at physiological concentrations of 
transporter the major structural determinant for GLUT4 sequestration is at the C- 
terminus. However when transporters are expressed at high levels (as in the study by 
Piper et al., 1992) this determinant becomes saturated and the intracellular sequestration 
information is now switched to motifs in the N-terminus and intracellular loops.
When the C-terminal domain was analysed in more detail a sequence around amino 
acids 489-490 was identified, which is consistent with di-leucine based internalisation 
motifs described in other recycling proteins (Verhey and Bimbaum, 1994). Using 
GLUT1/GLUT4 chimeras in NIH 3T3 cells researchers demonstrated that L489 and L490 
are important residues for intracellular sequestration since mutating them to A489 and 
S490 causes the movement of the chimera from the perinuclear region to the cell 
periphery. Thus the di-leucine motif is likely to regulate endocytosis but may also play
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a role at the TGN to sort proteins away from a default pathway to the cell surface. The 
authors also suggest that upon removal of insulin both the phenylalanine and the di­
leucine motif are important in the return of GLUT4 from plasma membrane.
The results obtained in the studies described thus far have provided many clues as to the 
important targeting information contained within GLUT4. However some of the earlier 
reports were plagued with contradiction. A number of possible explanations can be 
surmised to explain the varied results. Firstly the choice of expression system used in 
the study is of importance since vectors which induce high levels of expression, 
surpassing endogenous protein concentrations, may saturate sorting machinery, as has 
been described for other systems (Reaves and Banting, 1994). Indeed in studies using 
transgenic mice overexpressing GLUT4, the basal level of the transporter at the plasma 
membrane is substantially increased, indicating either saturation of a cytoplasmic 
compartment or of the machinery responsible for endocytosis (Liu et a l , 1993). 
Secondly, it is possible that two or more regions of the transporter, although 
discontinuous in the primary structure, may be juxtaposed in the native transporter to 
form a single sorting motif. These motifs would be difficult to analyse using the 
chimera approach. Thirdly, there is a risk when using chimeras in which large domain 
are swapped, that they will not fold correctly. Fourthly chimeras may exhibit the 
phenomenon of “piggy-backing” where by virtue of their ability to oligomerise, 
engineered transporters may couple with and be targeted by endogenous protein. 
Finally, and of utmost importance, all of these studies have been performed in non­
insulin regulated systems. These cell lines may lack the unique insulin sensitive sorting 
machinery responsible for targeting GLUT4 in fat and muscle.
Some of these problems were addressed in a study analysing the targeting of GLUT4 in 
bona-fide insulin responsive cells (Marsh et a l, 1995). Three constructs were expressed 
in 3T3-L1 adipocytes: TAG, (epitope-tagged wild-type GLUT4), FAG (GLUT4 
containing an F5—»A mutation in the N-terminal FQQI motif) and LAG (GLUT4 in 
which L489L490 were mutated to AA in the C-terminal di-leucine motif). All three 
mutants were expressed to the same level and the TAG construct was targeted to the 
same compartment as endogenous transporters. FAG accumulated at the plasma 
membrane, whereas LAG was only trapped at the cell surface if it was expressed at 
levels four-fold greater than the endogenous transporter. Thus one can speculate that 
the F-based motif is important in plasma membrane to endosomal trafficking. Under
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these experimental conditions, both FAG and LAG were stimulated to the plasma 
membrane by insulin, suggesting that the N- and C-terminal targeting motifs are not 
important for insulin-regulated movement.
A more extensive characterisation of the motifs was performed in an ablation study 
using the same TAG, FAG and LAG GLUT4 mutants (Melvin et al., 1999). Analysing 
the intracellular locations of the mutants using the DAB/H2O2 technique showed that the 
internal pool of FAG transporters was substantially ablated. This pool of mutant 
GLUT4 (FAG) was therefore either confined to the recycling endosomes with TfRs or 
does not accumulate in the non-ablated compartment. Conversely the LAG mutant 
escaped ablation even more effectively than the wild-type transporter (TAG). While the 
authors could not show conclusively that the failure to ablate the LAG mutant was not 
due to inappropriate targeting, the observation that the LAG mutant co-ffactionates with 
vpl65 (Section 1.3.2) provides compelling circumstantial evidence that LAG is targeted 
to the same pool as the wild-type GLUT4. The authors suggest a model to explain their 
results in which GLUT4 is internalised into the recycling endosomal compartment and 
from here traffics to the TGN from which the GSVs bud. They also suggests that 
internalisation into the endosomal compartment requires both the FQQI and LL motifs 
and that transfer to the TGN may be dependent upon the FQQI motif, explaining the 
reduced levels of FAG in the non-ablated compartment. Similarly, the LL motif may be 
required for the translocation of GLUT4 from the TGN to the GSVs. Thus in the LAG 
mutant, GLUT4 accumulates in the TGN resulting in a bottle-neck in its constitutive 
recycling and hence a greater proportion of it is protected from ablation, compared with 
the wild-type transporter (Melvin et a l, 1999). One important observation is that the LL 
motif is adjacent to a site of phosphorylation on GLUT4 and as such it would be 
interesting to examine whether the AA mutation abrogates phosphorylation, and 
whether this effects trafficking. Indeed studies in other systems have suggested that 
post-translational modifications such as phosphorylation can modulate intracellular 
sorting (Trowbridge et al., 1993).
Recently a series of experiments have analysed the involvement of the C-terminus of 
GLUT4 in rat adipose cells (Lee and Jung, 1997). Rat epididymal adipocytes were 
fused with erythrocyte ghosts preloaded with GLUT4 C-terminal peptide via 
polyethylene glycol-induced cell-cell fusion. The C-terminal GLUT4 peptide caused an 
increase in glucose transport and GLUT4 translocation in basal cells but not in insulin
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treated cells. This implies that information contained within the C-terminus of GLUT4 
is important for retaining GLUT4 in an intracellular compartment or is involved in 
GLUT4 endocytosis at the plasma membrane. The authors suggest that auxiliary 
proteins interact with the C-terminus of GLUT4 under basal conditions, tethering it to 
an internal locus, and that these proteins are released by the actions of insulin. Addition 
of exogenous C-terminal GLUT4 peptide may therefore saturate the intracellular 
binding site for GLUT4, and enable endogenous transporter to be released and traffic to 
the plasma membrane. The C-terminal peptide used in this study was 43 amino acids 
long and contained the di-leucine motif. Whether it is the LL motif or another sequence 
contained within the C-terminal peptide which confers this ‘docking’ ability remains to 
be established.
Like GLUT4, the di-leucine motifs in the aminopeptidase vpl65 are also important for 
the control of its intracellular trafficking. Indeed use of chimeras of vpl65 and the TfR 
have shown that the di-leucine motifs within vpl65 are responsible for the maintenance 
of a slow endocytic recycling mechanism in response to insulin (Johnson et al.91998).
Many proteins exhibit complex recycling patterns, which must be governed by a 
number of intrinsic sorting sequences. For example, the M6 PR contains 2 motifs both 
in its cytoplasmic tail, which are involved in regulating its intracellular repertoire. One 
of these motifs is a tyrosine based sequence that is required for efficient internalisation, 
the other is a di-leucine based motif which is responsible for regulating the recycling 
between the Golgi and the late endosomes (Johnson and Komfeld, 1992). Identification 
of a number of potential targeting domains in GLUT4 is therefore not surprising, when 
considered in the context of the labyrinth of intracellular compartments in which it is 
known to reside. Clearly both components of the N- and C-termini are instrumental in 
defining the trafficking and the compartmentalisation of GLUT4 under basal conditions. 
Presumably the C-terminus and potential additional signals are also required to elicit or 
further regulate entry into the specialised GLUT4 compartment (Section 1.3.3). These 
targeting motifs may not be as well conserved as the di-leucine or tyrosine based signals 
but could include a short sequence found at the extreme C-terminus of GLUT4 which 
shows some homology to a sequence found in the cytoplasmic tail of vpl65 (Rea and 
James, 1997).
1.4 Exercise and Contraction Induced GLUT4 Pools
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As well as insulin, a host of other stimuli (e.g. catecholamines, hypoxia, and growth 
factors) can alter glucose transport, however the only other major regulator of transport 
is exercise/contraction. Contraction-induced changes in glucose uptake occur in the 
heart and in slow and fast twitch muscles (Hayashi et a l, 1997). Like insulin, 
contraction can increase glucose transport through an increase in the Vmax of the 
transporter with little change in Km (Holloszy and Narahara, 1967). Initial experiments 
using a motorised rodent treadmill to exercise rats and a subfractionation protocol to 
separate skeletal membrane fractions demonstrated that, like insulin, muscle contraction 
stimulates glucose transport by the translocation of glucose carriers from an internal 
storage site to the plasma membrane (Douen et a l, 1989). Subsequently, using a 
modified subfractionation procedure, exercise was shown to induce not only a 
substantial translocation of GLUT4 to the plasma membrane, but also to the transverse 
tubules (t-tubules) (Marette et a l, 1992). This exercise-induced redistribution of 
GLUT4 to the t-tubules may serve to deliver glucose to sites deep within the muscle 
(Hayashi et a l, 1997).
The combinatorial effect of insulin and contraction on glucose transport is greater than 
the individual actions of these stimuli (Wallberg-Henriksson and Holloszy, 1985). The 
‘additive’ nature of the contraction and insulin stimuli implies that they act 
independently. In support of this view, a recent study, using discontinuous sucrose 
gradients, demonstrated the existence of two pools of glucose transporters (Coderre et 
al, 1995). These pools, which were found to fractionate at 32 and 36% sucrose, 
responded independently to insulin and exercise. Stimulation with both insulin and 
contraction caused the depletion of GLUT4 from both pools. Furthermore, vpl65, an 
inherent component of GLUT4 vesicles was found to subffactionate with both pools 
(Coderre et a l, 1995). In a corroborating study using EM microscopy, GLUT4 was 
observed at the TGN in two compartments: large depots, and small tubulovesicular 
elements (Ploug et a l, 1998). The small pools could be further subdivided into TfR- 
positive and TfR-negative pools. Insulin increased the co-localisation of GLUT4 and 
TfR, while contraction/exercise reduced this association. Thus contraction and insulin 
may act upon different populations of GLUT4 vesicles in whole muscle fibres.
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Unlike insulin, exercise stimulated GLUT4 translocation in skeletal muscle does not 
result in autophosphorylation of the insulin receptor nor is it mediated by PI 3-kinase, as 
indicated by the lack of effect of the PI 3-kinase inhibitor, wortmannin (Lund et al.,
1995). A caveat to this is that wortmannin does inhibit contraction stimulated glucose 
transport in cardiac myocytes (Till et al., 1997). Protein kinase B shown to be a down 
stream target of PI 3-kinase in the insulin signalling pathway {Section 1.2.4), is also 
unaffected by skeletal muscle contraction (Lund et al., 1998).
So how does contraction stimulate glucose transport? Calcium which is released from 
the sarcoplasmic reticulum in response to depolarisation of the plasma membrane may 
play a role in exercise-induced glucose uptake, since agents which increase intracellular 
calcium concentrations also stimulate glucose transport (for review see Hayashi et al.,
1997). This calcium-mediated effect may be due to activation of PKC-dependent 
pathways. Some studies have also suggested that exercise can cause the local release of 
bradykinin, a nonapeptide hormone, which may be involved in glucose transport. 
Indeed addition of exogenous bradykinin to L6  myotubes expressing Gq-coupled 
bradykinin receptors stimulates GLUT4 translocation to the plasma membrane in a PI 3- 
kinase-independent manner (Kishi et al., 1998). Aside from these examples, little 
definitive information is available as to how exercise increases glucose transport. 
Clearly much work is required to elucidate the contraction-signalling pathway to 
GLUT4.
1.5 Role of GTP binding Proteins in Vesicle Trafficking
1.5.1 GTPyS-stimuIated Glucose Transport
Baldini and co-workers first demonstrated that guanosine 5 ’-0-(3 -thiotriphosphate) 
(GTPyS) can display insulinomimetic effects in 1991 (Baldini et al., 1991). Using 
alpha-toxin permeabilised rat adipocytes, these researchers showed that GTPyS-induced 
a 3 to 6 -fold increase in GLUT4 translocation, while GTP had no effect. The 
stimulatory effects of GTPyS can be mimicked by treatment with AIF4', implicating the 
involvement of heterotrimeric G-proteins (Kanai et a l, 1993b). Indeed in Chinese 
Hamster Ovary cells (CHO) and 3T3-L1 adipocytes, activation of receptors coupled to 
Gq can stimulate glucose transport (Kishi et a l, 1996). More recently, the GTPyS 
responsive glucose transport pathway has been shown to be independent of insulin
33
receptor (IR) and insulin receptor substrate-1 (IRS-1) phosphorylation, and of PI 3- 
kinase and protein kinase B (PKB) targeting/activation (Elmendorf et al., 1998) 
(Sections 1.2.1-1.2.4). Instead GTPyS induces the tyrosine phosphorylation of a number 
of other signalling molecules including protein-tyrosine kinase-2, ppl25 focal adhesion 
tyrosine kinase, ppl30 Crk-associated substrate, paxillin and Cbl. Furthermore, in 
contrast to insulin, GTPyS has been reported to stimulate glucose transport both by 
increasing the rate of exocytosis and by appreciably decreasing the rate of endocytosis 
(Shibata et al., 1995).
1.5.2 Dynamin
Dynamin is a large, 100-kDa GTPase, originally isolated from calf brain, in a search for 
novel microtubule-based motors, nearly 10 years ago (Shpetner and Vallee, 1989). 
More recently dynamin has been implicated in the endocytic uptake of receptors, 
associated ligands and the plasma membrane following exocytosis (Robinson et al.,
1996). This function of dynamin was discovered by studies on Drosphila with a 
temperature-sensitive mutation in the dynamin gene, Shibire. At non-permissive 
temperatures these flies rapidly display paralysis as a result of their inability to recycle 
synaptic vesicle membranes at the neuromuscular junction (Robinson et al., 1996). 
Three dynamin isoforms have been identified to date, sharing 80% homology at the 
amino acid level; a brain-specific isoform, Dynamin I, a ubiquitous isoform, Dynamin II 
and a testis-specific isoform, Dynamin III (Urrutia et a l, 1997). Dynamins consist of a 
tripartite GTP binding site in the N-terminus, a pleckstrin homology (PH) domain and a 
C-terminal proline rich region (reviewed in Urrutia et al., 1997). Each dynamin gene 
has several variably spliced gene products, and so it is interesting to speculate a role for 
each in related but distinct endocytic processes.
One of the first proteins to be shown to associate with dynamin was the cytoskeletal 
protein tubulin. In fact, tubulin polymers can stimulate GTPase activity on dynamin by 
75-fold (Shpetner and Vallee, 1992). In addition to binding to the cytoskeleton, 
dynamin may also participate in cell signalling cascades by binding to SH3 domain- 
containing proteins, including the regulatory subunit (p85a) of PI 3-kinase (Section 
1.2.3) via its proline-rich domain (Herskovits et a l, 1993). It has also been shown to 
bind to the plasma membrane adaptor complex AP2 (Section 1.6.2), and can co- 
immunoprecipitate with the insulin receptor and IRS-1 via a common binding partner,
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Grb2 (Ando et al., 1994). One of the most intriguing properties of dynamin is its ability 
to self-assemble into helical filaments even in the absence of GTP (Hinshaw and 
Schmid, 1995). These ‘spirals’ have been seen in vivo around the necks of endocytic 
invaginations as electron dense ‘collars’. The unique distribution of dynamin has led to 
speculation that it acts as a ‘pinchase’, severing the membrane to release vesicles into 
the cytoplasm, as a result of GTP hydrolysis. Indeed inhibition of GTP hydrolysis, 
using GTPyS or dynamin with a mutation in the GTP-binding domain, leads to the 
accumulation of membrane invaginations at the plasma membrane (reviewed in 
Wamock and Schmid, 1996).
GLUT4 is internalised via clathrin coated pits (Sections 1.3.5 and 1.6.1) by an unknown 
mechanism. Several groups have examined the role of dynamin I in GLUT4 
endocytosis. To this end, wildtype and a GTPase negative mutants of dynamin 
(dynamin-K44E) were expressed in CHO cells expressing the insulin receptor and 
GLUT4 (CHOir-GLUT4) (Omata et al., 1997), in primary rat adipocytes (Al Hasani et al.,
1998), and in 3T3-L1 adipocytes, (Kao et al., 1998). All three studies showed an 
accumulation of GLUT4 at the cell surface under basal conditions in cells expressing 
the dynamin mutant. Furthermore insulin was only able to recruit GLUT4 from the 
intracellular pool to the plasma membrane in cells expressing the wild-type dynamin, 
and not in cells expressing the mutant. These results clearly demonstrate a role for 
dynamin in GLUT4 endocytosis, and illustrate that endocytosis may be required not 
only for the selective uptake of receptors and transporters but also as a means of 
balancing cell surface versus intracellular compartments and their respective 
components.
Only one group has studied the effects of the ubiquitous dynamin isoform (dynamin II) 
on GLUT4 endocytosis, (Volchuk et al., 1998). These experiments demonstrated that 
dynamin II is expressed in 3T3-L1 adipocytes in both the plasma membrane and low 
density microsome fraction, (a fraction enriched in Golgi structures), and that insulin 
causes a decrease in the association of dynamin II with the plasma membrane of * 50%. 
In addition, these authors have also assessed the role of amphiphysin in GLUT4 
trafficking. Amphiphysin is an SID domain containing protein, which binds to the 
proline-rich region of dynamin, and is thought to be important in recruiting dynamin to 
sites of endocytosis. Microinjection of a fusion protein containing the SID domain of 
amphiphysin into 3T3-L1 adipocytes inhibits TfR endocytosis and increases cell surface
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GLUT4. Furthermore a peptide containing the proline-rich domain of dynamin (which 
binds to amphiphysin) inhibits GLUT4 re-intemalisation following insulin stimulation. 
Taken together, these data suggest that both dynamin II and amphiphysin play a role in 
GLUT4 endocytosis in 3T3-L1 adipocytes.
1.5.3 RadGTPase
Rad is a small GTP-binding protein of the Ras superfamily, isolated from human 
muscle by subtraction cloning (Moyers et al., 1996). The expression of Rad is 
increased in some type II diabetics raising the possibility that Rad plays an important 
role in glucose homeostasis. Overexpression of Rad in the insulin-responsive cell lines, 
C2C12 murine myotubes and L6  rat myotubes, results in a 50-90% decrease in insulin- 
stimulated 2-deoxy-D-glucose transport, without a detectable change in GLUT4 
translocation (Moyers et a l , 1996). These data suggest that Rad negatively modulates 
the intrinsic activity of GLUT4.
1.5.4 ARF GTPases
ADP-ribosylation factors (ARFs) are 20-kDa nucleotide binding proteins, members of 
the Ras GTPase superfamily, which were originally isolated as a consequence of their 
ability to stimulate the ADP-ribosyltransferase activity of the cholera toxin A subunit 
(CTA) (Kahn and Gilman, 1984). We now know that ARFs have a multitude of 
functions; they act as molecular switches for many vesicular trafficking pathways, are 
activators of specific phospholipase Ds (PLDs) and are involved in the recruitment of 
coat proteins onto budding vesicles (reviewed in Roth, 1999) (Section J.6.6.2).
Mammalian ARFs can be divided into 3 classes based on size, amino acid sequence, 
gene structure, and phylogenetic analysis; ARFs -1,-2 and -3 are in class I, ARFs -4 and 
-5 are in class II and ARF6  is in class III (Roth, 1999). ARFs exhibit a vectorial pattern 
of signalling, which results from the necessary sequence of GTP binding, hydrolysis of 
bound GTP and release of the GDP product (Figure 1.5). ARFs act as binary switches, 
active in the GTP-bound form and inactive in the GDP-bound form. The most studied 
members of the ARF family are ARF1 and the atypical ARF, ARF6  (Chavrier and 
Goud, 1999).
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ARF1 was initially found to be a component of COPI vesicles isolated from Golgi 
membranes, and was later shown to be necessary for the formation of these vesicles in 
vitro (Rothman and Wieland, 1996). In addition, much data has now indicated a role 
for ARF1 in the formation of clathrin-coated vesicles containing the adaptor proteins 
API (Stamnes and Rothman, 1993) and AP3 (Ooi et a l , 1998) (Section 1.6.2). A 
definitive role for ARF1 in the regulation of vesicular trafficking came from 
experiments in vivo using ARF mutants defective in either GTP-binding or GTP 
hydrolysis. Mutants defective in GTP-binding prevented coat proteins from binding to 
the Golgi, and this resulted in the retrograde transport of Golgi membranes to the ER. 
In contrast, mutants defective in GTP hydrolysis allowed binding of coat proteins to the 
membranes however this binding was irreversible, and prevented the fusion of vesicles 
with the Golgi membrane (Rothman and Wieland, 1996).
ARF6  is the least conserved of the ARF protein family. It is associated with, and 
appears to control the integrity of peripheral membranes (Chavrier and Goud, 1999). 
Several studies have indicated that ARF6  may cycle between the plasma membrane and 
an internal compartment, depending on its nucleotide status (Radhakrishna and 
Donaldson, 1997). In CHO cells, a GTP bound, constitutively active mutant of ARF6  
(ARF6Q67L), is localised to the plasma membrane, where it causes extensive 
invaginations, inhibits transferrin internalisation, and induces a redistribution of TfRs to 
the plasma membrane (D'Souza-Schorey et al., 1995; D'Souza-Schorey et al., 1998). In 
contrast, a GDP bound ARF6  mutant (ARF6T27N) is associated with a peri-centriolar 
pool which contains TfRs and VAMP3 (D'Souza-Schorey et a l, 1995). In addition 
ARF6  binds to the actin cytoskeleton and induces actin rearrangement. This can be 
prevented by incubation with cytochalasin D, which redistributes ARF6  from the 
plasma membrane to the recycling endosomes (D'Souza-Schorey et al., 1995).
1.5.5 ARF-GEFS
Under physiological conditions, exchange of GDP for GTP on ARFs is a rate-limiting 
step in ARF activation. However this exchange process is rapidly accelerated by the 
action of Guanine nucleotide exchange factors (GEFs), seven of which are now known 
(for review see Roth, 1999) (Figure 1.5). ARF-GEFs exist in soluble and particulate 
forms and may be divided into three classes based on their size and their sensitivity to 
the fungal metabolite, brefeldin A. The large, ‘sensitive’ class contains the yeast
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proteins Sec7p, Gealp, Gea2p and the mammalian p200. The large ‘insensitive’ class 
contains the protein GBF1, recently identified by screening a cDNA library from a 
brefeldin A-resistant CHO mutant cell line (Claude et al., 1999). The smaller proteins, 
ARNOl, GRP1 and cytohesinl represent the final class and are all brefeldin A 
insensitive. These small proteins each contain a pleckstrin homology domain and may 
associate with specific membranes in response to the production of phosphoinositides. 
For example, GRP1, which was discovered as a result of a screen for mouse proteins 
which bind phosphoinositides (Klarlund et al., 1997), associates specifically with 
phosphatidylinositol-3,4,5-trisphosphate (PIP3). This lipid specificity may dictate 
recruitment of GRP1 to sites of PIP3 production and connect receptor-activated PI 3- 
kinase signalling pathways with proteins that mediate biological responses such as 
membrane trafficking (Klarlund et al., 1997).
All ARF-GEFs have a small catalytic Sec7 domain, which is responsible for guanine 
nucleotide exchange. However, when the Sec7 domain of ARNO is reacted with 
myristoylated ARF-GDP it fails to catalyse nucleotide exchange (Paris et al., 1997). 
Only in the presence of liposomes does the reaction proceed. This observation has led 
to the suggestion that the myristoylated amino terminus of ARF inhibits nucleotide 
exchange unless there is lipid nearby. ARFs are distinct from many other Ras-related 
proteins in their conformation in the nascent state. In the inactive form ARF-GDP 
adopts a conformation in which the N-terminal myristate is bound to a pocket on the 
surface of the protein, and amino-acids 41-47 form a p-strand at the edge of a sheet of 
seven strands. In 1998, Goldberg solved the structure of active ARF-GTP, and showed 
that following activation amino acids 41-47 leave the sheet, and move to a position 
similar to other itas-related proteins (Goldberg, 1998a). This extensive rearrangement 
requires that the N-terminus and myristate leave the binding pocket and that a loop 
between strands P2 and P3 invade the space. Also in 1998, Goldberg crystallised a 
complex of the Sec7 domain of Gea2p and ARF-GDP (Goldberg, 1998b). This 
structure revealed that, “the structure of ARF-GDP appears to be incompatible with the 
contours of the recognition site” of the Sec7 domain (Goldberg, 1998b). This indicates 
that ARF must undergo a conformational change, which facilitates entry into the Sec7- 
binding domain. Biochemical data mentioned above have indicated that ARF will not 
interact with the Sec7 domain in the absence of lipid. Thus either Sec7 can dislodge the 
myristoylated amino-terminus of ARF if there are lipids nearby to capture it, or the 
lipids themselves can draw it away from the binding pocket. The role of the myristate
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on the N-terminus of ARF is therefore to regulate where and when ARF-GDP can be 
activated by ARF-GEFs. This can be further demonstrated by the observation that 
ARNO can catalyse nucleotide exchange, even in the absence of lipid micelles, when 
ARF is present without the first 17 amino acids at the N-terminus (Paris et al., 1997).
1.5.6 ARF-GAPS
As well as ARF-GEFs, ARF function is aided by a number of ARF-GTPase activating 
proteins (ARF-GAPs), which catalyse GTP hydrolysis (Figure 1.5). Since GTP-binding 
and hydrolysis are equally critical features of ARF action, it is intriguing that many 
more ARF-GEFS have been identified than ARF-GAPs (Moss and Vaughan, 1998). 
One possible reason is that ARF-GAPs appear to exhibit a much broader specificity, 
catalysing GTP hydrolysis on a number of ARF isoforms.
The N-terminal domain (130 amino acids) of the rat ARF-GAP p47 is sufficient for 
GAP activity. This domain contains the zinc finger motif, a signature for ARF-GAP 
proteins (Roth, 1999). In addition to the catalytic domain, a non-catalytic domain is 
also required for ARF-GAP function. This non-catalytic domain, situated at the C- 
terminus is required for faithful ARF activation due to its role in membrane targeting 
(Roth, 1999). Recently it has been shown that ARF 1-GAP binds to membranes via an 
association with the transmembrane KDEL receptor, ERD2. The KDEL receptor was 
initially discovered as a receptor for soluble ER proteins, which are mistargeted to the 
Golgi. The first observation that KDEL receptors may also play a role in the secretory 
pathway came from studies of yeast mutants with deleted KDEL receptors. As 
expected, these mutants were unable to retrieve KDEL proteins from the Golgi back to 
the ER, but they also exhibited dysregulated transport through the Golgi (Semenza et 
a l , 1990). Later overexpression of KDEL receptors was shown to inhibit ARF1 
activation by interacting with ARF 1-GAP (i.e. preventing GTP hydrolysis on ARF1), 
via the non-catalytic domain. Interaction of KDEL receptors with ARF-GAPs is 
therefore important for regulating GAP recruitment and activity and for ARF1 
inactivation on membranes (Aoe et al., 1999).
Recently, a new family of proteins, the centaurins, has been described, which contain a 
zinc finger domain in the N-terminus, showing similarity to the rat liver ARF 1-GAP, 
and to the yeast GAP protein, Gcsl. In addition to the zinc finger domain, the
Figure 1.5 Vectorial Sequence of ARF Activation. Association of ARF with ARF-GEFs allows the exchange of GDP for GTP. Some ARF-GEFs are brefeldin A 
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centaurins, also contain two pleckstrin homology domains designated PH-N and PH-C. 
Centaurin-a (also known as p42m  or PIP3-binding protein in other species) was 
originally purified from rat brain based on its ability to bind to affinity columns of IP4 
analogues, and was later shown to exhibit highest affinity for PIP3 (Hammonds-Odie et 
a l, 1996). Using the human homologue of centaurin-a, centaurin-ai, tagged with green 
fluorescent protein (GFP-centaurin-ai) Venkateswarlu and colleagues 
(Venkateswarlu et a l, 1999), demonstrated that following PIP3 production GFP- 
centaurin-ai rapidly translocates to the plasma membrane in PC12 cells. Furthermore, 
centaurin-ai was able to functionally complement a yeast strain lacking Gscl (Agcsl), 
indicating its potential role as an ARF-GAP (Venkateswarlu et a l, 1999).
1.5.7 ARF and GLUT4
For the past several years interest in the involvement of a putative ARF in GLUT4 
trafficking has been growing. Since GLUT4 vesicles must bud from a number of 
different compartments, and some of these vesicles have been shown to be clathrin 
coated, the discovery of a function for ARF in GLUT4 trafficking has long been 
anticipated. Such a role has now been indicated in a recent publication analysing the 
effects of insulin and ARFs -5 and - 6  on glucose transport (Millar et a l, 1999). In this 
study, a myristoylated ARF6  peptide was shown to inhibit insulin-stimulated glucose 
transport and GLUT4 translocation by « 50%. A similar ARF5 peptide had no effect on 
GLUT4 translocation, but inhibited the appearance of both the TfR and GLUT1 at the 
cell surface. In addition ARF5 exhibited an insulin-induced redistribution from the 
cytosol to the plasma membrane, while the location of ARF6  at the plasma membrane 
was unchanged. These authors suggest that ARF5 is involved in the regulation of 
endosomal membrane traffic to the plasma membrane, while ARF6  controls the 
movement of GLUT4 in response to insulin (Millar et a l, 1999).
The discovery that the ARF-GEF, ARNO translocates to the plasma membrane in 
response to insulin increased excitement in this area of research. Like insulin- 
dependent GLUT4 translocation, ARNO is unaffected by brefeldin A, but sensitive to 
the PI 3-kinase inhibitors wortmannin and LY294002, and to co-expression of a 
dominant negative p85 mutant of PI 3-kinase (Venkateswarlu et a l, 1998). This 
suggests that the translocation of ARNO is as a consequence of insulin-stimulated PI 3- 
kinase activation and PIP3 production, and strongly implies that ARNO acts as a PIP3
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receptor (Venkateswarlu et a l , 1998). Insulin-induced translocation of ARNO may 
enable it to interact with ARF6 .
1.6 Coated Vesicles
1.6.1 Clathrin
One of the earliest steps in the transport of vesicles to their target membranes is the 
selection of their cargo. Usually this occurs by the concentration of the required protein 
via interactions with coat proteins, which are also required for vesiculation of the 
membrane. The vesicles then pinch off, and are trafficked to their appropriate 
membranes.
Thirty-five years ago, Roth and Porter first observed coated vesicles during their studies 
of yolk protein uptake in mosquito oocytes (Roth and Porter, 1964). With incredible 
foresight, they predicted that coat formation would be transient, would be responsible 
for the mechanical deformation of the membrane, and that components of the coat may 
have some bearing on the choice of cargo. Five years later, the coat was visualised 
using negative staining microscopy and was seen to consist of a spectacular lattice of 
polyhedral structures (Kaneseki and Kadota, 1969), which were later purified to near 
homogeneity and named clathrin (Pearse, 1975). Clathrin consists of both a heavy 
chain protein (HC) and two smaller polypeptide light chains (LCa and LQ>) which 
assemble together (three heavy chains and three light chains) to form the basic clathrin 
assembly unit, the triskelion. Clathrin triskelions are heterogeneous in nature, as the 
distribution of the two different light chains is random (Hirst and Robinson, 1998).
At about the same time as the characterisation of clathrin, Brown and Goldstein were 
defining a role for clathrin coated vesicles in their studies of low-density lipoprotein 
(LDL) (Goldstein et a l, 1976). From this work, they found that LDL was endocytosed 
far more rapidly than could be accounted for by simple bulk-flow endocytosis, and 
proposed that LDL was internalised by receptor-mediated endocytosis. Later, they 
observed, using electron microscopy, that LDL was concentrated in clathrin-coated pits 
at the cell surface and that incubating samples at 37°C before fixing, resulted in the 
pinching off of invaginations to form coated vesicles, which were later uncoated 
(Anderson et al., 1977). In the years that followed, a number of other proteins were
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shown to internalise via clathrin coated pits, including GLUT4, the TfR and the 
epidermal growth factor receptor (EGFR) (reviewed in Rea and James, 1997; Hirst and 
Robinson, 1998).
1.6.2 Adaptor Proteins
The principle proteins that drive clathrin coat formation are known as adaptor proteins 
(APs). In 1979 Keen and colleagues showed that clathrin coats could be stripped from 
vesicles by treatment with 0.5 M Tris-HCl (Keen et a l, 1979). Using gel filtration, 
these researchers also showed that in addition to clathrin, a number of other 100 kDa 
polypeptides were components of the extracted vesicle coat. These polypeptides, 
named adaptins (APs), facilitated the formation of clathrin lattices in vitro, and were 
shown, by ultrastructural studies, to bridge the gap between clathrin and the vesicle 
membrane (Vigers et al., 1986).
APs form heteromeric complexes which couple coated pit assembly to the entrapment 
of membrane receptors/transporters (Kirchhausen et al., 1997). Four adaptor complexes 
have been characterised to date. API localised to the TGN, AP2 localised to the plasma 
membrane, AP3 localised to the endosomal compartment and the newly described AP4, 
targeted to or near the TGN, (the latter two protein coats do not seem to involve 
clathrin) (reviewed in Kirchhausen et al., 1997; Dell'Angelica et al., 1999). All adaptor 
complexes consist of two 100 kDa adaptins (y-and p i- (API), a- and P2 (AP2), 8 - and 
p3- (AP3), e- and P4 (AP4)), and in addition, a medium « 45 kDa ju chain (pl, p2, p3, 
p4) and a small« 20 kDa a  chain (a l, a2, a3, a4) (Figure 1.6A). All adaptor subunits 
are derived from protein superfamilies, the most distantly related are the a-, y-, 8 - and e- 
subunits, which are thought to direct the complexes from the cytosol onto the host 
membranes (Schmid, 1997).
1.6.3 Structure of Adaptor Complexes
Only the structure of the AP2 complex has been studied thus far, although based on 
biochemical evidence, the conformations of the other adaptor complexes are likely to be 
similar. Using rotary shadowing, AP2 appears as a brick-like ‘head’ flanked by two 
symmetrically placed ‘ears’. The ears are attached to the head by » 6  nm hinge-like 
flexible regions, corresponding to the C-terminal domains of the a2- and P2- adaptins
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(Heuser and Keen, 1988). The bulk of the adaptor core is therefore composed of the N- 
terminals of both the a 2 - and (32- adaptins, along with the p2  and a 2  polypeptides.
Little is known about how newly synthesised adaptor complexes assemble in vivo, 
however using the yeast two-hybrid system, much has been learnt about the interactions 
between the various subunits. These studies indicate that a- and y-adaptins interact with 
both the a- and P-subunits, and that p-subunits also interact with p-subunits (Page and 
Robinson, 1995). Further interactions have been shown by studies using chimeras of a- 
and y-adaptins, which demonstrate that the p-subunit can be immunoprecipitated with 
these chimeras under non-denaturing conditions. Furthermore a stretch of amino acids 
between residues 130 and 330 of the a- and y-adaptins, is important for selecting 
whether a chimera binds to p i and a l  or to p2 and a2 (Page and Robinson, 1995). This 
in turn can dictate whether an adaptor complex binds to the plasma membrane or to the 
TGN. Interestingly more mammalian p- and a-subunits have been identified than their 
larger adaptin counterparts. The heterogeneity of the smaller subunits may be partly 
responsible for subtly targeting adaptor assembly onto distinct membranes (Schmid,
1997).
1.6.4 Function of Adaptor Complexes
In the absence of adaptors, clathrin can reassemble into cages in vitro (Keen et al 
1979; Crowther and Pearse, 1981). However, the size of these cages varies 
considerably, and their formation will only occur under non-physiological conditions 
(low ionic Ca2+ buffer, pH < 6.5). Addition of adaptor proteins allows the assembly of 
uniform clathrin baskets in a less stringent, physiological environment (Zaremba and 
Keen, 1983). Incubation of coated vesicles with the uncoating ATPase Hsc70 strips 
clathrin from the membrane but adaptors remain. If the clathrin-extracted membrane is 
then treated with elastase to remove adaptors, clathrin can no longer rebind (Schlossman 
et al., 1984; Moore et al., 1987). These data suggest that adaptors bind directly to 
clathrin and mediate its association with the membrane. Considerable evidence 
indicates that it is the p subunits of the adaptor complex which are responsible for the 
clathrin-adaptor interaction. In binding assays, purified p2-adaptin interacts with 
clathrin with a stoichiometry of one to one, and can compete with the entire AP2 
complex for clathrin binding (Ahle and Ungewickell, 1989). Interestingly AP3, which
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Figure 1.6 Structure and Assembly of the Adaptor Protein API. A. Globular 
structure of API showing ear-like appendages. The clathrin binding site is situated on the P-subunit and 
receptor tail signal sequences bind to the p/p-subunits. B. API binds to the TGN membrane following 














is located in endosomal clusters does not seem to contain a recognisable clathrin 
binding motif on the p3 hinge region, supporting the observation that this adaptor does 
not bind clathrin (Dell'Angelica et al., 1997). Perhaps AP3 binds another unique coat 
protein or is sufficient in coating the vesicle on its own.
In addition to their association with clathrin, adaptors also bind to the cytoplasmic tails 
of transmembrane receptors and transporters. In 1985, the first study demonstrating 
such an interaction was performed. In this study the M6 PR was shown to form 
aggregates with the plasma membrane adaptor complex AP2 when incubated under 
non-denaturing conditions (Pearse, 1985). Later, additional in vitro binding assays 
revealed that adaptors at both the plasma membrane and the TGN bind to receptor tails 
(reviewed in Schmid, 1997).
Most experimental data points to a role for the adaptor medium (p) chain in receptor tail 
interactions. Screening of a yeast two-hybrid library for proteins, which associate with 
a triple repeat of the cytoplasmic tail of TGN38, ‘captured’ two clones, both of which 
encoded the p2 subunit of AP2 (Ohno et a l, 1995). However a role for the P-subunit 
has also been suggested by the finding that purified asialoglycoprotein binds to the p2  
subunit protein band on Far-Western blots (Beltzer and Spiess, 1991). Furthermore, the 
a3 A-subunit has been shown, using the yeast two-hybrid system, to act as a receptor for 
non-tyrosine phosphorylated IRS-1 (Section 1.2.2), a component of the insulin- 
signalling cascade (VanRenterghem et a l, 1998) (Figure 1.6B).
1.6.5 Adaptors and Trafficking Signals
Adaptor proteins have been shown to interact with the cytosolic tails of transporters and 
receptors which carry specific signals for their internalisation and intracellular targeting. 
The most well characterised are the di-leucine (LL) and tyrosine based motifs (YXX0), 
and there is substantial evidence that these interact with all of the adaptor complexes via 
their p- or P-subunits, presumably at differential binding sites within these subunits (for 
review see Kirchhausen et al., 1997). A comparison of the abilities of p i and p2 to 
interact with tyrosine based sorting sequences was performed using the yeast two- 
hybrid system (Ohno et a l, 1996). Under defined experimental conditions the p2- 
subunit displayed higher avidity for tyrosine based sorting signals than pi. Moreover
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the two j l i  subunits were individually selective about the sequence environment 
surrounding the motif and the relative position of the aromatic amino acids. This 
suggests that subtle differences in a protein’s sequence may be responsible for its 
association with adaptor complexes at different loci within the cell, perhaps adaptor 
proteins ‘filter’ trafficking proteins as they pass through consecutive compartments. 
Indeed many proteins including GLUT4 (Section 1.3.5) encode a great deal of sorting 
information within their sequences. This apparent overlap of function may reflect the 
need for a combinatorial method of selection at a variety of sorting depots. 
Alternatively different domains may be exposed under differing conditions. In this 
respect it is interesting to recall that GLUT4 has a phosphorylation site adjacent to its 
di-leucine motif (Section 1.3.5), which may abrogate or enhance AP binding, depending 
upon its phosphorylation status. Indeed phosphorylation of a site 4 amino acids 
upstream of the LL motif in the M6 PR enhances its sorting into a post-Golgi 
compartment (Mauxion et a l, 1996).
Recently the crystal structures of the YXX0 binding domain of p2 complexed to 
peptides containing the signalling motifs of TGN38 and EGFR have been solved (Owen 
and Evans, 1998). This domain has a curved shape with 16 P-strands arranged into 2 
sub-domains with pockets for the aromatic and hydrophobic amino acids. Surprisingly 
the YXX0 signal interacts with the binding site in an extended conformation and not in 
a P-tum as predicted from biochemical analysis. The tight P-tum adopted by signalling 
motifs in solution may therefore act as a method of regulation such that when the signal 
is not required for internalisation, the motif displays the closed conformation, which 
may be ‘opened’ by interaction with cognate adaptor complexes. Furthermore the 
medium chain binding pocket for tyrosine based motifs was found to exclude LL 
sequences (Owen and Evans, 1998).
In 1998 a study of peptides, derived from a number of different proteins, was used to 
analyse the interaction of adaptor proteins with di-leucine motifs (Rapoport et al.,
1998). Using an approach in which samples were first frozen before cross-linking by 
photo-irradiation, Rapoport and colleagues have revealed a specific interaction of di­
leucine containing peptides (including a C-terminal peptide of GLUT4) with API. The 
site of binding was found to be on the pi subunit, similar to that observed for the 
asialoglycoprotein (Beltzer and Spiess, 1991). In addition, medium chains (p-subunits)
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have also been shown to interact with LL motifs (Rodionov and Bakke, 1998). Thus 
APs contain at least two physically separate binding sites for sorting signals.
Overexpression of proteins containing signalling motifs can induce a plethora of 
trafficking defects including inefficient receptor internalisation, mis-targeting of 
proteins to the plasma membrane, mislocalisation of adaptins etc. Indeed high levels of 
overexpression of proteins containing either tyrosine or di-leucine based signals reduces 
the internalisation of the TfR (Nordeng and Bakke, 1999). Furthermore mutation of the 
overexpressed proteins to remove the signalling motif allows TfRs to internalise as 
normal, indicating that the clustering of proteins into coated pits and their sorting is 
saturable. One development in the past few years is the realisation that many signalling 
motifs are degenerate in nature and that this may be a critical feature for the coated 
vesicle sorting machinery. Thus even weak affinity for a motif may be sufficient for 
internalisation, since the organisation of a coat will bring together multiple copies of 
APs, and other component proteins, which will strengthen the initial interaction 
(Kirchhausen et al., 1997).
1.6.6 Regulation of Adaptor Recruitment
1.6.6.1 Receptors for Adaptor Docking
Regulation of adaptor binding is tightly controlled: API and AP4 bind to the TGN and 
TGN-related compartments, AP2 is localised at the plasma membrane, and AP3 binds 
to peripheral and endosomal membranes (Hirst and Robinson, 1998). How this is 
achieved is poorly understood, however some evidence indicates that the choice of 
cargo may potentiate membrane recruitment. For example, in cells lacking the M6 PR, 
the total amount of API binding to the TGN is decreased by 25% (Le Borgne et al., 
1993). Conversely, cells overexpressing the M6 PR or the TfR have an increased 
abundance of clathrin lattices at the TGN and plasma membrane respectively (Miller et 
al., 1991; Le Borgne et al., 1993). However these proteins alone cannot provide the 
required specificity for adaptor recruitment, since they may be targeted with even 
greater efficacy to compartments that do not contain these adaptors. Indeed, at steady 
state the majority of the M6 PR is in the late endosomes, whereas the TfR is confined to 
the recycling/early endosomes (Hirst and Robinson, 1998). One possibility is that 
adaptors bind to docking proteins and that it is these which provide the necessary
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membrane selectivity. Some evidence to support this hypothesis was provided by the 
identification of a saturable, high affinity binding site for AP2 on brain membranes, 
(Virshup and Bennett, 1988). Furthermore, a possible candidate for an AP2 docking 
protein has come from work showing that AP2 can bind to agarose beads coated with 
recombinant synaptotagmin I (Zhang et al., 1994a). Other approaches to identify 
adaptor receptors have used chemical cross-linking or adaptin affinity columns, 
(Seaman et a l , 1996; Mallet and Brodsky, 1996). Using both of these methods a TGN- 
specific protein of 75-80 kDa has been identified which selectively binds to API. 
However in both cases sequence information could not be obtained due to a lack of 
material. Thus no definitive docking proteins for API have yet been elucidated 
(Seaman et a l , 1996; Mallet and Brodsky, 1996).
1.6.6.2 The Role o f GTPyS and Brefeldin A
Budding of vesicles from their respective membranes must be finely controlled in order 
to maintain the normal composition of various compartments. Association of API with 
membranes is stimulated by incubation with GTPyS and is inhibited by the fungal 
heterocyclic lactone, brefeldin A (Robinson and Kreis, 1992; Wong and Brodsky,
1992). In fact incubation of cells with brefeldin A induces severe morphological 
changes within the intracellular compartments, presumably as a result of the complete 
dispersion of adaptins from membranes to the cytosol (Robinson and Kreis, 1992; 
Wong and Brodsky, 1992). Members of the ARF family of small GTPases (Section 
1.5.4) mediate the actions of GTPyS and brefeldin A on API. Brefeldin A interferes 
with ARF recruitment by preventing GDP.GTP exchange by ARF-GEFs (Rothman, 
1996). Further evidence for the role of ARF in API recruitment comes from 
experiments in which an ARF-depleted cytosol fails to sustain efficient API 
recruitment, however full recruitment is restored by the addition of myristolyated ARF1 
(Traub et al., 1993). How ARF potentiates API binding is unknown but may be linked 
to its ability to stimulate phospholipase D (PLD). This in turn may modulate 
membranes by increasing local levels of acidic phospholipids, which may regulate the 
interaction of adaptors with receptor tails (Section 1.6.4).
In contrast to API, the association of AP2 with the plasma membrane, is unaffected by 
brefeldin A implying that ARF1 is not involved in AP2 recruitment. However GTPyS 
and exogenous PLD both result in mistargeting of AP2 to endosomal membranes, and
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inhibition of PLD by neomycin (which binds to its cofactor PIP2) inhibits binding of 
AP2 to both the endosomes and the plasma membrane (West et a l, 1997). These data 
although different from API suggest a role for PLD and ARF in AP2 recruitment, 
perhaps mediated via the brefeldin A-insensitive ARF, ARF6 .
Although treatment of cultured skeletal myotubes with brefeldin A causes fusion of 
endosomal-TfR with GLUT4-containing compartments (Section 1.3.3), incubation of 
adipocytes with brefeldin A has no effect on the insulin-stimulated GLUT4 pathway, 
and only decreases basal transport moderately (Bao et a l, 1995). These results suggest 
that the basal recycling of GLUT4 (responsible for maintaining the intracellular location 
of the transporter) may include a membrane budding step that is brefeldin A-sensitive, 
but that the insulin-stimulated GLUT4 pathway is predominantly brefeldin A- 
insensitive.
Different membrane compartments show varying susceptibility to brefeldin A, 
indicating that the drug affects multiple subcellular targets (Wong and Brodsky, 1992). 
In addition, its effects can be prevented by pre-treatment with [AIF4]" implicating 
heteromeric G proteins (as well as the small GTPase ARF) in the association of coats 
with their respective membranes, (Robinson, and Kries, 1992). Recently two groups 
have identified specific residues within the Sec7 domain which confer brefeldin A 
sensitivity on ARF-GEFs (Sata et al., 1999; Peyroche et al., 1999). Furthermore studies 
have shown that brefeldin A acts not by competing with ARF for the brefeldin A 
sensitive binding site on the Sec7 domain but by stabilising an abortive ARF-GDP-sec7 
domain complex (Peyroche et al., 1999).
1.6.6.3 Control o f Adaptors by Phosphorylation
One molecular switch, which may regulate adaptor-membrane assembly, is 
phosphorylation. Many of the subunits of the adaptor complex are found 
phosphorylated in the cytosol whereas membrane bound APs are not (Wilde and 
Brodsky, 1996). This may indicate that phosphorylation leads to the disassembly of AP 
subunits from clathrin. Interestingly, the kinase activity, which converts adaptors to the 
phosphorylated state, is associated with the clathrin-coated vesicles themselves (Wilde 
and Brodsky, 1996).
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Insulin causes the phosphorylation of a » 125 kDa polypeptide component of the plasma 
membrane adaptor complex (Corvera and Capocasale, 1990). This phosphorylation 
occurs exclusively on serine residues and is seen within 2  min of insulin stimulation. 
The function of this insulin-induced phosphorylation event is unknown but may regulate 
the formation of clathrin-coated pits in response to insulin.
1.6.6.4 Control o f Adaptors by Polyphosphoinositides
Adaptors bind polyphosphoinositides including PIP3. The binding of PIP3 is saturable 
and has highest affinity when APs are in their clathrin bound form. Using a bacterially 
expressed fusion protein encoding amino acids 5-80 of the N-terminus of AP2 Gaidarov 
et a l (Gaidarov et a l, 1996) demonstrated the importance of this region in PIP3 
binding. Interestingly this N-terminal domain is also close to a site thought to be 
responsible for membrane targeting (Page and Robinson, 1995).
As well as PIP3, IP6 can also bind to adaptors at physiological concentrations. When IP6 
is bound, adaptors and clathrin cannot form lattices. In the basal state, levels of PIP3 are 
extremely low (Stephens et a l, 1991; Cross et a l, 1997). Upon receipt of a signal, PIP3 
is generated by the action of PI 3-kinase and the transient production of this acidic lipid 
may allow it to displace IP6 from the adaptor binding site. With PIP3 bound, adaptors 
and clathrin can assemble into polyhedral lattices and vesicles may pinch off from the 
donor membrane. This lipid exchange mechanism may regulate protein recycling by 
controlling the formation of clathrin coated vesicles in response to exogenous stimuli. 
Indeed, the PI 3-kinase vps34p has been implicated in clathrin-dependent vacuolar 
protein sorting in yeast (Schu et a l, 1993).
As well as modulating clathrin-adaptor binding, PIP3 also regulates the interaction of 
adaptors with cytoplasmic receptor tails. PIP3 generally enhances the binding of adaptor 
proteins to cytoplasmic tails containing tyrosine-based motifs (Rapoport et a l, 1997) 
while inhibiting the interaction of adaptors with LL motifs (Rapoport et a l, 1998). 
Since sites for both tyrosine and di-leucine based motifs exist on the core of the adaptor 
complex, it is possible that binding of a phosphoinositol molecule results in the opening 
of one site and the occlusion of the other.
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1.6.7 Involvement of Cholesterol in Clathrin-Coated Vesicle Formation
Given the ability of clathrin and adaptors to self-assemble into cages, it was generally 
assumed that these proteins would play the major role in membrane deformation. 
However, fresh evidence has indicated a role for the lipid cholesterol in the mechanism 
of membrane curvature. In cells depleted of cholesterol by the use of beta-methyl- 
cyclodextrin flat coated membranes are observed by confocal microscopy of GFP- 
clathrin. These coated regions fail to detach from the plasma membrane, and the 
internalisation of the recycling endosomal marker, the TfR, is decreased by as much as 
85%, without affecting transport back to the cell surface (Subtil et a l 1999).
1.7 Mobilising GLUT4: Involvement of a Possible GLUT4-Vesicle 
Fusion Apparatus
“All the roads for membrane traffic may yet prove to be paved with the same kinds of 
molecules” speculated Rothman and collaborators fifteen years ago (Balch et a l, 1984). 
Since then a remarkable convergence of data has indeed revealed that the fundamental 
principles of membrane fusion and translocation between different vesicular pathways 
are conserved in eukaryotic cells.
One potential advantage of a specialised secretory compartment for GLUT4 is that the 
compartment itself will be mobile, fusing with acceptor membranes as a result of 
hormonal interjection (Rea and James, 1997). A useful paradigm for this comes from 
studies of small synaptic vesicles in neuroendocrine cells. In the brain, tiny vesicles 
rapidly transport neurotransmitter to the synapse in response to depolarising 
sensitisation (Rothman and Warren, 1994). Over the past several years much of the 
molecular circuitry, which has emerged from studies of these processes in neural 
tissues, has been shown to be replicated in the regulation of GLUT4, and analogous 
proteins have been characterised in many insulin-sensitive cells (Figure 1.7).
1.7.1 NSF and a-SNAP
Early dissectors of the fusion apparatus showed that vesicle transport could be inhibited 
in CHO cells by treatment with N-ethylmaleimide (NEM), and that this could be 
circumvented by the addition of fresh cytosol (Glick and Rothman, 1987). These data
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indicate that a cytoplasmic NEM-sensitive fusion protein is involved in protein 
trafficking. The N-ethylmaleimide-sensitive fusion protein (NSF) is a soluble tetramer 
purified by virtue of its ability to restore intercistemal Golgi transport in a cell free 
assay (Block et al., 1988). In yeast, the Sec 18 gene encodes NSF. Indeed the yeast 
protein encoded by this gene (Secl8 p) can replace NSF in a mammalian system for cell- 
free Golgi transport, adding substance to the theory of universality of transport across 
species barriers. In vivo, NSF seems to play a role in nearly all steps in the secretory 
pathway, from the ER to the plasma membrane, and in endocytosis (Beckers et al., 
1989).
NSF itself does not bind to membranes, requiring the addition of further cytoplasmic 
elements. Using in vitro binding assays in brain extracts three soluble NSF attachments 
proteins (SNAPs) have been defined and designated a, p and y (Clary et al., 1990). a- 
and y-SNAP have been identified in virtually all cell types whereas the P-isoform is 
confined to the brain (Whiteheart et a l, 1993). a-SNAP is the equivalent of the yeast 
protein Secl7p, shown by its ability to restore fusion activity to cytosolic extracts of 
yeast Secl7p mutants (Griff et a l, 1992). An important observation is that a- and p- 
SNAP bind competitively to the same site on alkaline extracted membranes indicating 
the existence of SNAP receptors which are integral membrane proteins (Sollner et a l,
1993).
Once bound NSF hydrolyses ATP. This hydrolysis results in the dissociation of NSF 
from the fusion apparatus. Originally NSF and a-SNAP were described as proteins 
responsible for facilitating vesicle targeting and fusion (Wilson et a l, 1991). However, 
current hypotheses include models in which NSF and a-SNAP play roles not in fusion 
per se but in ‘priming’ a pre- or post-fusion step, analogous to chaperones (Morgan and 
Burgoyne, 1995).
The Drosphila comatose mutant provides direct evidence for the involvement of NSF in 
exocytosis since the synaptic transmission defect observed in these flies is due to a 
temperature-sensitive mutation in Drosphila NSF-1 (Pallanck et al., 1995). A role for 
NSF in GLUT4 trafficking has recently been proposed by Cushman and colleagues who 
observed that in rat adipose cells expressing an ATPase-deficient NSF, the translocation 
of epitope-tagged GLUT4 was markedly diminished (reviewed in St Denis and 
Cushman, 1998).
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1.7.2 The SNARE Hypothesis
Every few minutes, vesicles with the surface area of the entire cistemae pass between 
the stacks in the Golgi apparatus. Maintaining the integrity of the cistemae in the face 
of this massive flux therefore requires a fusion mechanism of great specificity and 
organisation (Palade, 1975). The SNARE hypothesis was originally proposed by 
Rothman and colleagues who, using an affinity column of NSF/a-SNAP and a detergent 
solubilised brain extract, were the first to identify a novel group of protein receptors, 
now known as SNAP receptors or SNARES, (Sollner et al., 1993). The hypothesis 
itself suggests that donor (vesicular) and acceptor membranes contain cognate SNAREs, 
which mediate selective binding and therefore appropriate targeting of proteins to their 
compartments. This in turn dictates that there must be a large gene family of vesicular- 
(v-) and target- (t-) SNARES, in order to achieve the intricate trafficking required by 
most cells. Indeed, the search for such proteins has been extremely fruitful with the 
discovery of numerous syntaxin, SNAP-25 and VAMP homologues. However it has 
also become clear that, despite the vast evidence for their absolute role in vesicular 
transport, SNAREs do not act alone. Indeed a number of additional moieties are 
required to modulate their assembly, in other words, to act as the ‘fine control’.
1.7.3 Vesicle Associated Membrane Proteins (VAMPs)
In 1992, the first homologues of VAMP in insulin sensitive tissues were reported by 
Leinhard and colleagues (Cain et al., 1992). Subsequently, adipocytes were shown to 
express both VAMP2 and VAMP3 (cellubrevin) and both were targeted in significant 
amounts (25-40% of their total pools) to GLUT4 vesicles, (Volchuk et a l , 1995). 
Studies employing neurotoxins such as botulinum neurotoxin isoform B (BoNTx/B) 
which cleaves both VAMP2 and VAMP3 have shown partial inhibition of GLUT4 
translocation and glucose transport, (Tamori et al., 1996). However, recently a more 
specific role for VAMP2 in the insulin-regulated movement of GLUT4 has been 
demonstrated by two independent studies. In the first study compartmental ablation 
(Martin et a l, 1996a), was used to demonstrate that a large proportion of VAMP2 (in 
contrast to VAMP3) resides in the non-ablated GLUT4 storage compartment. In the 
second analysis, GST fusion proteins of VAMPs were employed, and these indicated 
that only GST-VAMP2 inhibits insulin-stimulated GLUT4 translocation, (Martin et al., 
1998). The latter study also showed that a synthetic N-terminal peptide of VAMP2 was
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sufficient to inhibit insulin-stimulated GLUT4 translocation, but had no effect on 
GTPyS stimulation of GLUT4 (Section 1.5.1) or insulin-stimulated translocation of 
GLUT1 (Section 1.3.3). These results suggest that GLUT1 and GLUT4 traffic to the 
plasma membrane from different compartments, (supported by confocal microscopy 
highlighting their differential localisation). Furthermore selective cleavage of VAMP2 
with IgA protease also leads to a loss of insulin-induced GLUT4 translocation as 
determined by GLUT4 fluorescence on plasma membrane sheets (Cheatham et al.,
1996). From these data, an obvious hypothesis would be that VAMP3 is responsible for 
the endosomal trafficking of GLUT4, whereas VAMP2 is necessary for its rapid 
translocation out of the GSVs and to the plasma membrane in response to insulin.
1.7.4 Syntaxins
Antisera against various syntaxin homologues have shown that the predominant 
syntaxin isoforms found at the adipocyte plasma membrane are syntaxins -2 and -4, 
with a much lower amount of syntaxin 3 (reviewed in Rea and James, 1997). To 
determine which (if any) of these syntaxins are capable of forming a fusion complex 
with GLUT4 vesicles, wyc-tagged NSF and recombinant a-SNAP, were mixed with 
solubilised membranes and ATP, and subjected to immunoprecipitation using an 
antibody directed against the myc tag. The resulting fusion complex was shown to 
contain VAMPs -2 and -3, and syntaxin 4, (Timmers et al., 1996). An absolute role for 
syntaxin 4 has subsequently been illustrated using microinjection of a peptide directed 
against syntaxin 4 (aal06-122) and a recombinant GST-fusion protein encoding the 
cytoplasmic tail of syntaxin 4, both of which block (40 % and 100 % respectively) 
insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes, (Macaulay et al., 1997; 
Cheatham et al., 1996).
1.7.5 Syntaxm-Binding Proteins
In addition to VAMPs, other proteins have been identified in neural tissues, which are 
capable of binding to syntaxins. One such protein is synaptotagmin, a calcium binding 
protein which has been described by Martin and colleagues as a ‘fusion clamp’ (Martin 
et al., 1995). These authors suggest that under conditions where fusion is not required 
synaptotagmin binds to syntaxin 1A and prevents it interacting with other members of 
the fusion complex. Upon depolarisation, there is rapid release of calcium, which
55
interacts with synaptotagmin resulting in a conformational change, which exposes 
syntaxin to the rest of the fusion itinerary. In adipocytes, calcium does not seem to play 
a role in GLUT4 translocation in response to insulin. Intriguingly, in muscle, exercise 
induced translocation of glucose transporter activity may involve calcium, (Holloszy 
and Narahara, 1967) (Section 1.4), and as such the search for synaptotagmin 
homologues is on-going.
Other syntaxin-binding proteins include SNAP-25 and munc-18, homologues of which 
have already been identified by screening cDNA libraries in adipocytes. Syndet or 
SNAP-23 is a ubiquitously expressed homologue of SNAP-25 (Wang et al., 1997). The 
interaction of syndet with components of the docking and fusion family has been 
studied using the technique of plasmon resonance (Rea et al., 1998). Full length syndet 
was immobilised on a carboxymethylated dextran CM5 chip by thiol disulphide 
exchange. Cytoplasmic domains of syntaxin 4 and VAMP2 were passed over the chip 
in a small volume of running buffer, and binding of these proteins to syndet was 
measured by changes in surface plasmon resonance. Results indicate that syndet forms 
a tertiary complex with syntaxin 4 and VAMP2. In the same study the authors also 
showed that incubation of permeabilised 3T3-L1 adipocytes with a synthetic 24 amino 
acid peptide of syndet or microinjection of anti-syndet antibodies results in the 
inhibition of insulin-stimulated glucose transport in these cells. In contrast to this study, 
experiments using an in vitro binding assay Foster and colleagues failed to show a 
tripartite complex of syntaxin 4, VAMP2 and the rat homologue of syndet, SNAP-23 
(Foster et al., 1998). This is surprising since using similar 3-way binding assays the 
neuronal syntaxin 1A-SNAP-25-VAMP2 is readily detectable. However the differences 
between the neuronal studies and the plasmon resonance experiments which show a 
tertiary complex and the study by Foster and colleagues which does not, may be related 
to the half-life of the triad complex. In neurones, small synaptic vesicles fuse rapidly at 
the synapse. This swift exocytosis is due to the vesicles being tethered close to the 
plasma membrane in a pre-fusion-competent state awaiting a calcium signal. Thus the 
tertiary fusion complex in the neurone may need to be particularly stable as it is 
required to pre-assemble. In contrast the rate of exocytosis of non-neuronal vesicles is 
comparatively slow. Docking and fusion may therefore occur almost simultaneously 
and hence the tripartite association need not be strong. This may mean that the half-life 
of the assembled complex is too short to be detected by in vitro binding assays. The 
observation of the fusion complex by plasmon resonance demonstrates the sensitivity of
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Figure 1.7 Assembly of the GLUT4 Vesicle Fusion Apparatus. In the resting state 
GLUT4 vesicle fusion with the plasma membrane is prevented by the interaction of Syntaxin 4 with 
Synip and SNAP-23. Insulin releases these fusion clamps allowing VAMP2 on the GLUT4 vesicles to 






















this technique and renders it invaluable in studies of this type. In muscle, in addition to 
syndet, there may also be an another SNAP25 homologue, (Wong et al., 1997).
Three Munc-18 isoforms (Muncl8 -a, -b and -c), have been identified in adipocytes 
(Tellam et a l , 1995). Of these isoforms only Munc-18c is capable of interacting with 
syntaxin 4, (as shown by in vitro binding assays with recombinant Munc-18 fusion 
proteins), (Tellam et al., 1997). Furthermore, Munc-18c and syntaxin 4 show 
remarkable overlap in terms of their subcellular distribution, being primarily targeted to 
the cell surface, (despite the lack of a membrane attachment domain in Munc-18c). In 
1998, Kasuga and co-workers showed that overexpression of Munc-18c in 3T3-L1 
adipocytes, by adenovirus-mediated gene transfer, results in the inhibition of insulin- 
induced GLUT4 translocation (but not GLUT1 translocation) in a virus dose dependent 
manner (Tamori et al., 1998). The same year, another group showed that Munc-18c 
competes for the binding of syntaxin 4 with VAMP2 (Thurmond et al., 1998). 
Immunoprecipitation experiments revealed that Munc-18c could co-immunoprecipitate 
with syntaxin 4 and that this complex was reduced in the insulin-treated state. Thus 
Munc-18c blocks fusion of GLUT4 vesicles by preventing VAMP2 from binding, and 
insulin releases this block by targeting Munc-18c to another site on the plasma 
membrane. This is analogous to the role of Munc- 18a in the neurone. Here, Munc-18a 
and VAMP2 bind to syntaxin 1A in a mutually exclusive manner. Protein Kinase C 
(PKC) which stimulates calcium-dependent exocytosis phosphorylates Munc-18a 
preventing it from binding to syntaxin 1A (reviewed in Rea and James, 1997).
Recently, in addition to SNAP-23 (syndet) and Munc-18c another protein has been 
identified which plays an important role in GLUT4 vesicle fusion. Synip was identified 
using the yeast two hybrid system with syntaxin 4 as the bait (Min et al., 1999). 
Northern blots hybridised with a radiolabeled probe consisting of part of the coding 
sequence of Synip revealed that it was only expressed abundantly in insulin-sensitive 
tissues. Transfection of differentiated 3T3-L1 adipocytes with cDNAs encoding both 
the full length Synip (Synip/WT) or the C-terminal domain of Synip (Synip/CT) 
showed that both constructs could co-immunoprecipitate with syntaxin 4 from basal 
cells. Treatment of cells with insulin resulted in a decrease in the Synip/WT: syntaxin 4 
complex but no change in the co-immunoprecipitation of Synip/CT and syntaxin 4. The 
disruption of the Synip/WT: syntaxin 4 complex by insulin may be due to modulation of 
the N-terminus since insulin was unable to dissociate the Synip/CT domain from
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syntaxin 4. Moreover, the binding of Synip to syntaxin 4 is unaltered by SNAP-23 but 
is inhibited by VAMP2. Overexpression of Synip/CT reduced insulin-stimulated 
glucose transport by » 50%, presumably as a direct result of competition with 
endogenous Synip. The aberrant binding of Synip/CT to syntaxin 4 in the presence of 
insulin presumably blocks the ability of VAMP2 positive GLUT4 vesicles to dock at the 
plasma membrane. Since syntaxin 4 binds to both VAMP2 and VAMP3 with high 
affinity and is therefore conceivably involved in the fusion of vesicles derived from 
both the GLUT4 storage compartment and the endosomes, both Synip and Mime-18c 
may provide a means of manipulating/regulating the docking and fusion of these 
differential populations.
1.7.6 Phosphorylation of Proteins Involved in the Fusion Complex
As well as regulation at the level of protein-protein interaction, the fusion complex may 
also be regulated by post-translational covalent modifications such as phosphorylation. 
Indeed protein kinase A (PKA) can phosphorylate syntaxin 4 (Foster et al., 1998) in an 
in vitro kinase assay. In its phosphorylated form syntaxin 4 is no longer able to 
associate with SNAP-23. This may add another tier of regulation to the fusion 
apparatus. For example, isoproterenol (Section 1.9.5), an activator of stimulatory G- 
proteins and hence adenylate cyclase and PKA can inhibit glucose transport by the 
formation of an occluded population of GLUT4 vesicles (Vannucci et al., 1992). One 
possible explanation for this phenomenon is that insulin stimulates the delivery of 
GLUT4 vesicles to the plasma membrane but since PKA is activated and hence syntaxin 
4 is phosphorylated, the fusion of the vesicles with the plasma membrane is blocked 
(Foster e ta l, 1998).
1.7.7 RabGTPases
Rabs, a branch of the Ras superfamily of small GTPases, have been implicated in 
vesicle docking and fusion as regulators of SNARE pairing (Chavrier and Goud, 1999). 
Mutant forms of Rab can block transport of vesicles along a route or change the size of 
an organelle. Over forty members of the Rab family have been characterised in 
mammalian systems, each localised to surfaces of distinct membranes (Zerial and 
Stenmark, 1993). This vast number of Rab proteins reflects the complexity of docking 
and fusion events in mammalian cells.
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In order to bind to membranes, Rabs must be prenylated on two cysteine residues at 
their C-termini. The enzyme which catalyses this prenylation is 
geranylgeranyltransferase (Anant et a l, 1998). Until both cysteines are modified, 
newly synthesised Rabs are bound in the cytosol by Rab escort proteins (REPs). REPs 
aid prenylation by presenting Rabs to geranylgeranyltransferase in the correct 
conformation. Following prenylation inactive Rab-GDP can anchor on to the 
membrane. Here, Rab-GDP is exchanged for Rab-GTP by Rab-specific nucleotide 
exchange factors (GEFs). Current models predict that Rab proteins catalyse membrane 
fusion in their GTP bound form, and are acted upon by a further two distinct classes of 
regulator proteins known as GTPase activating proteins (GAPs) and Guanine nucleotide 
dissociation inhibitors (GDIs) (Pfeffer, 1994). GAPs are responsible for returning Rabs 
back to their GDP bound state, following membrane fusion. GDIs retrieve Rabs from 
their fusion targets and recycle them back to their membranes of origin, where they may 
be re-activated by GEFs. At steady-state most Rabs are anchored on membranes, 
however some remain in the cytosol, stoichiometrically bound to GDI (for review see 
Chavrier and Goud, 1999) (Figure 1.8).
Genetic experiments have linked Rabs to SNAREs. For example, although the yeast 
ER-to-Golgi Rab, Yptlp is an essential gene product, overexpression of SNAREs can 
compensate for its loss (Schimmoller et a l, 1998). In addition, Rabphilin 3A, a protein 
that interacts with Rab3, shares high sequence homology with synaptotagmin, a 
syntaxin-binding protein which regulates calcium-dependent exocytosis in the neurone. 
It is interesting to speculate that Rabs may bind to v-SNAREs, while Rabphilins may 
interact with t-SNAREs, thus strengthening the overall fusion complex. The primary 
role of Rabs could therefore be to facilitate efficient SNARE binding, rather than as 
components of the fusion apparatus per se (Simons and Zerial, 1993). One interesting 
feature of Rab proteins is that GTP hydrolysis does not seem to be necessary for vesicle 
fusion to occur. Rather GTP loading of Rabs is the more important criteria. In fact a 
number of Rab effectors including the mammalian Rabaptin-5 and the yeast, exocyst, 
are predicted to ‘clamp’ Rabs in their GTP-bound conformation, thus ensuring that GTP 
hydrolysis does not pre-empt vesicle fusion (Schimmoller et a l, 1998).
Rab proteins involved in the endocytic pathway include Rab4 and Rab5, both of which 
are associated with the early endosomes. Overexpression of Rab5 increases the rate of 
endocytosis, and expands the early endosome pool. Therefore Rab5 is likely to be
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involved in plasma membrane to early endosome, and homotypic endosome-endosome 
fusion (Bucci et a l, 1992). Conversely, overexpression of Rab4 increases the reflux of 
proteins from the endosome to the plasma membrane and leads to the formation of 
endocytic tubules. This implies that Rab4 is part of the recycling endosome (van der 
Sluijs et a l , 1992)
In 1993, Rab4 was shown to exhibit an insulin-induced redistribution from microsomal 
membranes to a soluble fraction (Cormont et al., 1993). In addition, these authors also 
demonstrated that in the basal state, Rab4 could be detected on GLUT4 vesicles and that 
upon insulin-stimulation the amount of Rab4 on GLUT4 vesicles decreased. Later, the 
same group showed that insulin causes the phosphorylation of Rab4 by extracellular- 
signal-regulated kinase (ERK1), and suggested that this insulin-induced post- 
translational modification results in the movement of Rab4 from GLUT4 vesicles to the 
cytosol (Cormont et a l , 1994).
To study the role of Rab4 in insulin-stimulated GLUT4 translocation more precisely, 
3T3-L1 adipocytes were transiently transfected with cDNAs of both an epitope-tagged 
GLUT4-myc and Rab4 (Cormont et a l, 1996a). Using this system, the authors were 
able to demonstrate that increasingly high concentrations of Rab4 (in which Rab4 was 
found targeted to the cytosol) inhibit the appearance of cell surface GLUT4 under 
insulin conditions. Thus they speculate that Rab4 is involved in the intracellular 
retention of GLUT4 and that overexpression of cytosolic Rab4 acts as a sink for a 
factor(s) involved in insulin-stimulated GLUT4 translocation. This hypothesis was 
strengthened by the observation that a mutant of Rab4 lacking the geranylgeranylation 
sites was effective at inhibiting insulin-stimulated GLUT4 translocation, even at low 
expression levels (Cormont et a l, 1996a). A similar study showed that a synthetic 
peptide corresponding to the C-terminal hypervariable domain of Rab4, inhibited 
insulin-stimulated glucose transport in rat adipocytes (Shibata et a l, 1996). 
Furthermore, even in the presence of an internalisation inhibitor, the C-terminal Rab4 
peptide could still stunt insulin-induced GLUT4 translocation, suggesting that it act’s 
upon GLUT4 recruitment at the exocytic limb (Shibata et a l, 1996). Likewise, 
antibodies against Rab4 also inhibit insulin-responsive glucose transport.
Figure 1.8 Lifecycle of Rab Proteins. Newly synthesised Rabs are bound by Rab Escort Proteins (REPs) until prenylated on two cysteine residues by 
geranylgeranyltransferase. Rabs bind to the membranes where GTPase nucleotide exchange proteins (ARF-GEFs) exchange GDP for GTP. GTP hydrolysis on Rabs is 
catalysed by GTPase activating proteins (ARF-GAPs) and this results in membrane fusion. Following fusion, Rabs are retrieved from their target membranes and are recycled 











As well as insulin, exercise also induces GLUT4 translocation to the plasma membrane 
in skeletal muscle (Section 1.4). However, only insulin stimulates Rab4 translocation 
(Sherman et al., 1996), indicating that the regulation of GLUT4 by insulin and 
contraction may occur by different mechanisms. Interestingly, activation of PI-3-kinase 
by insulin leads to an increase in the GTPyS-loading of Rab4, (Shibata et al., 1997). 
Furthermore, pre-incubation with wortmannin blocks the insulin-induced redistribution 
of Rab4 from the microsomal membranes to the soluble fraction.
Finally, Rab4 is important in the genesis of membrane ruffles (Section 1.8). The GTP 
loading of Rab4, rather than its GTP hydrolysis, seems to be important for the insulin- 
induced association of Rab4 with actin, and for the concomitant GLUT4 translocation. 
Taken together, these data argue for a role for Rab4 via the cytoskeleton in insulin- but 
not exercise-sensitive GLUT4 trafficking pathways.
In addition to Rab4, Rab5 also exhibits an insulin-induced redistribution, decreasing by 
« 50% from the microsomal membranes. However Rab5 is not found on 
immunoprecipitated GLUT4 vesicles (Cormont et al., 1996b), and treatment of 
adipocytes with the PI 3-kinase inhibitor wortmannin (Section 1.2.3), has no effect on 
the insulin-stimulated redistribution of Rab5. Recently a new class of proteins thought 
to act as membrane tethers has been described (Waters and Pfeffer, 1999). Use of PI 3- 
kinase inhibitors has led to the identification of one such tethering protein known as 
early endosome antigen 1(EEA1) (Patki et al., 1997). This protein binds to both GTP- 
loaded Rab5 and to phosphatidylinositol 3-phosphate (PI-3-P). Binding of EEA1 to PI- 
3-P is mediated by a conserved zinc finger domain known as the FYVE domain (Patki 
et a l, 1998). Interestingly addition of excess EEA1 to an in vitro fusion assay can 
circumvent the requirement for both Rab5 and PI-3-P, allowing endosome fusion to 
occur even in the presence of wortmannin (which blocks the production of PI-3-P) and 
GDI (which sequesters Rabs) (Christoforidis et a l, 1999). Since treatment of cells with 
wortmannin leads to the formation of large swollen vacuoles (Shpetner et al, 1996) it is 
possible that PI-3-P regulates EEA1 and therefore regulates fusion. Further evidence 
has recently placed the PI-3 kinase activated kinase PKB upstream of Rab5, thus it is 
possible that PIP3 also indirectly regulates EEA1 (Barbieri et al., 1998).
Additional information concerning the temporal involvement of Rabs in the fusion 
process suggests that their action is subsequent to NSF and a-SNAP and may be
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required for the formation of the SNARE complex (Mayer and Whickner, 1997). 
Indeed a protein called Pral has recently been isolated (Martincic et a l , 1997) which is 
capable of interacting both with prenylated Rab GTPases and VAMP2, and may serve 
to couple these two protein families together in the control of vesicle docking and 
fusion. This protein is predominantly cytosolic but a small proportion cycles between 
the cytosol and the membrane. Although the intracellular location of Pral does not 
seem to alter in response to insulin in rat adipocytes (A. Gillingham, unpublished 
observation), it is possible that homologues of this protein will be found with specific 
roles in insulin-sensitive tissues.
1.7.8 Role of ATP
In addition to GTP, the nucleotide ATP is also known to be important in fusion and 
docking events. As well as activating cytosolic NSF, it also regulates the yeast protein 
Vps33p involved in fusion events between the prevacuolar compartment and the 
vacuole (Gerhardt et a l, 1998). Vps33p cycles between soluble and particulate forms in 
an ATP-dependent manner, which may facilitate the specificity of transport vesicle 
docking or targeting to the yeast vacuole/lysosome (Gerhardt et a l, 1998). As already 
discussed, many of the components of the fusion/docking repertoire are duplicated in 
cells and tissues, thus it will be of interest to determine if such a protein is required in 
insulin-induced GLUT4 translocation.
In conclusion, it is clear that many of the mechanisms employed in the release of 
neurotransmitter from small synaptic vesicles can be directly translated to explain, in 
part, the translocation of GLUT4 vesicles from the GSVs to the plasma membrane. The 
absolute role for members of a fusion apparatus in GLUT4 vesicle translocation has 
been convincingly demonstrated by a number of approaches. However, it is interesting 
to note that the inhibition of insulin-stimulated glucose transport, caused by disrupting 
the endogenous populations of SNAREs and SNARE regulators, is usually no more 
than 50%. This observation supports the view that the ‘insulin sensitive’ compartment 
is segregated from the recycling endosomal compartment, but also implies that the 
endosomes can partially respond to insulin or compensate for the loss of the GSVs 
(Section 1.3.5). Alternatively other proteins including vesicle tethers may be able to 
compensate for the loss of endogenous SNAREs.
1.8 Role of the Cytoskeleton in GLUT4 Trafficking
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It is not known where the primary site of insulin action is. It may be to promote vesicle 
fusion, however an equally plausible explanation is that insulin controls the actual 
movement of GLUT4 vesicles from deep within the cytoplasm to the plasma membrane. 
An advance in recent years in our understanding of the mobility of GLUT4 has been the 
discovery that an intact actin cytoskeleton is required for both insulin-stimulated 
glucose uptake and for the formation of membrane ruffles (Tsakiridis et al., 1994). 
Cytochalasin D, a fungal metabolite which caps the barbed (polymerising) ends of the 
actin molecule, has been widely used to study the role of the actin cytoskeleton in 
GLUT4 trafficking. Incubation of L6  myotubes, with cytochalasin D can reduce 
insulin-stimulated glucose transport by between 50 and 80%, without effecting basal 
transport (Tsakiridis et al., 1994; Wang et al., 1998). In addition to cytochalasin D, 
latrunculin B, a structurally distinct marine macrolid which disassembles actin filaments 
by binding to free actin monomers, also inhibits insulin-stimulated glucose uptake to 
approximately the same extent (Wang et al., 1998). The decrease in glucose transport 
induced by treatment with cytochalasin B has been shown to directly correlate with an 
inability of insulin to promote the movement of glucose transporters from the LDM to 
the cell surface. Furthermore incubation with cytochalasin D results in the failure of 
insulin to induce the formation of membrane ruffles, the role of which is presently 
unknown. Together these data provide compelling evidence for the role of actin 
filaments in glucose transport (Figure 1.9).
An important molecule in the insulin signalling cascade is PI 3-kinase (Section 1.2.3). 
Many factors besides insulin stimulate PI 3-kinase activity, for example, platelet- 
derived growth factor (PDGF) and epidermal growth factor (EGF), however none of 
these other stimuli induce the translocation of GLUT4 to the plasma membrane. Thus 
there must be a difference in the action of insulin and PDGF on PI 3-kinase. One 
fundamental difference is that insulin stimulates PI 3-kinase activity at an intracellular 
locus, while PDGF enhances PI 3-kinase activity at the plasma membrane (Clark et al., 
1998). In fact insulin causes an increase in PI 3-kinase p85a and pi 10(3 in the 
intracellular GLUT4 containing compartment, and this increase can be inhibited by 
cytochalasin D (Wang et al., 1998). Moreover microinjection of a constitutively active 
mutant of PI 3-kinase (PI 3-kinase pi 10*) causes the translocation of GLUT4 to the 
plasma membrane in 3T3-L1 adipocytes and induces the formation of actin filament
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ruffles (Martin et al., 1996b). This effect is inhibited by wortmannin and by the use of a 
PI 3-kinase mutant with a point mutation in the kinase domain (Martin et a l, 1996b). 
These data suggest that the localisation of PI 3-kinase activity is important for insulin- 
stimulated GLUT4 translocation via the actin cytoskeleton.
In fact inhibition of PI 3-kinase by wortmannin has far-reaching implications in terms of 
general membrane morphology. For example treatment of mammalian cells with PI 3- 
kinase inhibitors causes a marked change in endosomal structure, highlighted by 
tubulation and enlargement of endosomes containing TfR (although it has little effect on 
TfR recycling) (Shpetner et a l, 1996). These wortmannin-induced morphological 
changes demonstrate the importance of PI 3-kinases in maintaining the integrity of 
intracellular compartments as well as in GLUT4 translocation per se. The deleterious 
effect of PI 3-kinase inhibitors can be blocked by incubation with [AIFJ*, implying that 
a heteromeric GTP binding protein somewhere downstream of PI 3-kinase is involved 
in endosomal organisation (Shpetner et a l, 1996).
As well as PI 3-kinase, other molecules have been implicated in the insulin-induced 
translocation of GLUT4 and/or actin rearrangement. These include the small GTPase 
Rab4 (Vollenweider et a l, 1997), and the general receptor for phosphoinositides 1 
(GRP1) (Clodi et a l, 1998). In addition, a significant proportion of the t-SNARE 
SNAP-23 (Section 1.7.5) has been shown to co-sediment with detergent resistant 
cytoskeletal elements including actin (Foster et a l, 1999). Contrary to the role of PI 3- 
kinase which is presumably involved in the translocation of GLUT4 vesicles per se, the 
interaction of SNAP-23 with the actin cytoskeleton is more likely to facilitate the 
presentation of GLUT4 vesicles to the rest of the fusion apparatus at the plasma 
membrane.
The involvement of an intracellular scaffold in the maintenance of the internal 
population of GLUT4 has been shown visually using a green fluorescent protein 
chimera of GLUT4 (GFP-GLUT4) (Oatey et a l, 1997). Expression of GFP-GLUT4 in 
3T3-L1 adipocytes under basal conditions and collecting images by time-lapse confocal 
microscopy has shown that the majority of the GFP-GLUT4 vesicles are static as if 
tethered to an intracellular structure. The authors speculate that the role of insulin is to 
release the ‘anchor’ on the GFP-GLUT4 vesicles allowing them to translocate to the 
plasma membrane.
Figure 1.9 The Role of the Cytoskeleton in GLUT4 Translocation. Insulin signalling results in the association of PI 3-kinase with tyrosyl phosphorylated 
IRS1 at an internal membrane site. GLUT4 which is tethered to the actin cytoskeleton by a putative tethering protein is released by the actions of insulin and can traffic to the 
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The search for proteins important in tethering GLUT4 is ongoing. One such protein 
may be spectrin which has been shown, by immunoblotting, to be associated with 
GLUT4 vesicles (Tsakiridis et al, 1994). Another protein, which may act as the 
GLUT4 vesicle anchor, is fructose 1,6-bisphosphate aldolase. GST fusion proteins of 
the C-termini of GLUT1 and GLUT4, showed that aldolase associated selectively with 
GST-GLUT4, but not with GST-GLUT1. Introduction of the metabolic inhibitor 2- 
deoxy-D-glucose into permeabilised 3T3-L1 adipocytes disrupted the interaction 
between actin and aldolase, and inhibited insulin-stimulated GLUT4 exocytosis without 
affecting GLUT4 endocytosis (Kao et a l , 1999). In addition, microinjection of 
aldolase-specific antibodies can also inhibit GLUT4 translocation. It is interesting to 
note that data from our laboratory (Pryor, P.R., Koumanov, F. and Holman, G.D, 
unpublished observation) has shown that phosphatidylinositol 3,4,5 trisphosphate 
(PIP3), the lipid product of PI 3-kinase binds specifically to aldolase. The use of 
aldolase as a GLUT4 vesicle tether may therefore couple insulin signalling via PI 3- 
kinase with a negative feedback mechanism for glucose metabolism.
1.9 The Importance of pH in Membrane Trafficking Events
At the turn of the century Metchnikoff showed by feeding litmus paper to protozoa, that 
bacteria and other foreign bodies ingested by the phagocytic cells of the immune system 
are transferred to acidic structures in the cytoplasm, where they are digested 
(Metchnikoff, 1893). Since then the importance of intracellular pH not only in the entry 
and immune response to pathogens but also in the function of the biosynthetic and 
endocytic pathway has been recognised and documented (Mellman, 1992).
In the endocytic pathway material entering from the plasma membrane traffics through 
increasingly acidic compartments from endosomes to lysosomes. Likewise proteins of 
the exocytic route follow a similar pH gradient from the ER to the secretory vesicles. 
The level of acidity varies between intracellular organelles and its function depends 
upon the membrane compartment in question. For example, in lysosomes the low pH 
favours the activation of enzymatic hydrolases; in chromaffin granules the proton 
gradient is used to provide energy for the transport of biogenic amines; and in receptor- 
mediated endocytosis the difference in the pH between the endosomes and the external 
environment is used to provide asymmetry in the recycling circuit between the two 
compartments (Mellman, 1992). In the latter case, the disparity in pH allows receptors
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and their ligands to display differential association-dissociation kinetics depending on 
their acidic environment (Mellman, 1992). Acidification of endosomes is also required 
for the formation of endosome carrier vesicles (ECVs) which are responsible for 
shuttling proteins between the early and late endosomes (Clague et al., 1994) (Figure 
1.10). Acidity in organelles is maintained by vacuolar ATP-dependent proton pumps 
and by ion-exchangers including the Na+/H+ exchanger, NHE1, both of which shall be 
discussed in detail in this section.
1.9.1 Characteristics of v-ATPases
The v-ATPases are composed of two complex functional domains (Figure 1.11 A). The 
Vi domain, responsible for ATP hydrolysis, is a 570-kDa peripheral protein composed 
of 8  different subunits (A3, B3, C-H). The A and B subunits participate in the formation 
of the nucleotide binding site, with the catalytic domain localised by mutational analysis 
to the A subunit and an auxiliary non-catalytic domain localised to the B subunit. 
Proton translocation across the membrane is mediated by Vo. This domain is a 260 kDa 
integral membrane complex consisting of 5 different subunits (a, d, c, c’ and c” ). 
Electron microscopic images examining the structure of the v-ATPase from 
Neurospora, have revealed that this protein consists of a globular head attached to the 
membrane by a central stalk, with additional projections emanating from the base of the 
stalk (Dschida and Bowman, 1992). The information for targeting the v-ATPase exists 
within the Vo domain, which must be in the correct conformation to reach the vacuolar 
membrane. All the Vi subunits except the H polypeptide are required for the assembly 
and attachment of Vi to Vo.
Vacuolar proton pumps appear to be electrogenic and as such proton translocation can 
occur without direct molecular coupling to cations or anions. This means that 
acidification may be accompanied by the generation of a positive interior membrane 
potential. The exact mechanism, by which proton translocation is achieved, has not yet 
been established. However it is assumed that it will be similar to the rotaiy mechanism 
proposed for the F-ATPase of mitochondria. In this model the hydrolysis of ATP forces 
the rotation of the central subunits, and in doing so allows the transport of protons from 
one side of the membrane to the other (Vik and Antonio, 1994).
Figure 1.10 The Importance of pH in Intracellular Trafficking. The acidity of compartments increases along both the endocytic and biosynthetic pathways. 






















How does one pump help to maintain divergent intracellular compartments at different 
pH values? Several mechanisms have been proposed to explain this phenomenon: (1) 
The ATPase is able to rapidly dissociate and reassemble in response to stimuli. This 
mechanism is seen in yeast deprived of glucose. (2) Inhibitory disulphide bond 
formation at the v-ATPase catalytic site can regulate ATPase activity. Consistent with 
this hypothesis is the observation that oxidation of the v-ATPase from Neurospora leads 
to enzyme inactivation. (3) Altering the coupling efficiency of the ATPase can 
modulate function. For example, an increase in the coupling efficiency in the lemon 
fruit v-ATPase allows it to maintain a vacuolar pH of 2. (4) Small activator and 
inhibitor proteins have been detected, which modulate v-ATPase activity directly and 
(5) other ion channels, particularly Cl" channels, which dissipate the membrane potential 
induced by proton translocation, may be regulated and this regulation may control intra- 
compartmental pH. Support for this theory comes from the observation that Cl" 
conductance is modulated by protein kinase-A dependent phosphorylation (reviewed in 
Forgac, 1999).
1.9.2 Measurement of Vacuole Acidification
One of the most convenient methods to measure vacuolar acidification relies upon the 
properties of certain lipophilic weak bases. At neutral pH these reagents are uncharged 
and therefore membrane permeant. If allowed to equilibrate with cells or isolated 
organelles, these bases will accumulate within membrane vesicles that have acidic 
lumen. The degree to which the lipophilic base becomes concentrated within a 
compartment depends upon the magnitude of the transmembrane potential across it. 
One such reagent is the dye acridine orange. This dye can be used in optical 
measurements of pH since it exhibits a characteristic alteration in its absorbance spectra 
and fluorescence intensity as a consequence of increased concentration. As such, 
acridine orange has been exploited in morphological studies to identify acidic organelles 
in living cells (Mellman et al., 1986).
1.9.3 Inhibitors of V-ATPases
In 1984 a variety of naturally occurring bafilomycins, including bafilomyin Ai, were 
isolated from the mycelium of Streptomyces griseus (Werner et al., 1984) (Figure 
1.11 A, lower panel). Bafilomycins are members of the plecomacrolide-defined class of
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macrolide antibiotics which act as high affinity inhibitors of v-ATPases (Bowman et al.,
1988). Structure/activity studies (Drose et al., 1993), have revealed that the 
macrolactone ring of bafilomycin A] strongly contributes to its ability to act as a v- 
ATPase inhibitor. Derivatives carrying an open hemiketal ring, such as bafilomycin D 
can still inhibit vacuolar ATPases but do so with much lower affinity. Using [H3]- 
bafilomycin, the antibiotic binding site of the v-ATPase has been localised to the Vo 
domain (Mattson and Keeling, 1999). Subsequently Zhang and colleagues (Zhang et 
a l, 1994b) have pinpointed the binding site to a 116-kDa subunit of the Vo domain.
Bafilomycins can inhibit vacuolar ATPases without causing vacuolation. When added 
to cells in culture, plecomacrolides inhibit v-ATPases in a variety of organelles, 
increasing the luminal pH and causing a number of secondary effects including changes 
in the affinity of receptors for ligands, and in protein conformations and activities. For 
example, bafilomycin Ai inhibits lysosomal acidification and degradation of 
endocytosed EGF in the mammalian cell lines BNL CL.2 and A431, whereas 
internalisation of EGF and its transport to the lysosomes is not affected (Yoshimori et 
al., 1991).
TfR trafficking in CHO cells treated with bafilomycin Ai has also been studied 
(Johnson et al., 1993). In this case endosomal pH was seen to increase (neutralise) and 
TfR extemalisation was decreased by 50% while internalisation was unaffected. The 
slow rate of TfR recycling seen in the bafilomycin Ai treated cells could be completely 
abolished by substituting the two aromatic amino acids in the receptors internalisation 
motif (Section 1.6.5), however there was no change in the localisation of the plasma 
membrane adaptor, AP2. The simplest explanation for these results, is that 
intravesicular acidification is important for regulating the interaction of receptors with 
proteins involved in their retention and/or trafficking. As discussed in relation to the LL 
motif in GLUT4 (Section 1.3.5) cytosolic proteins act as molecular anchors, retaining 
proteins within compartments. Thus it is equally plausible that cytosolic proteins which 
bind to tyrosine based motifs also exist. Perhaps the change in pH induced by 
bafilomycin Ai, allows the formation of protein-protein interactions which do not 
normally exist, and hence result in a decrease in the rate of TfR exocytosis. 
Furthermore, some proteins involved in trafficking may require vesicular acidification 
in order to bind and become activated. Included in this family of proteins are the small
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GTPases ARF (Section 1.5.4) which are recruited to TGN membranes in response to a 
decrease in pH (Zeuzem et al., 1992).
The effect of bafilomycin Ai on the recycling of GLUT4 has also been examined 
(Chinni and Shisheva, 1999). Surprisingly, in this case, bafilomycin Ai stimulated 
GLUT4 translocation from the intracellular pool to the plasma membrane in 3T3-L1 
adipocytes. Bafilomycin Ai also caused a change in distribution of GLUT1 and Rab4, 
but had no effect on non-insulin sensitive proteins. The effects of the v-ATPase 
inhibitor were independent of insulin receptor autophosphorylation and independent or 
downstream of PI 3-kinase (Chinni and Shisheva, 1999).
Thus the unique pH of a compartment may act as a signature for it, enabling proteins to 
identify ‘where they are’, and allowing specific interactions of receptors with auxiliary 
proteins along the trafficking pathway. This may be a mechanism for differential 
sorting of proteins within the endo- and exocytic pathways.
1.9.4 Molecular Physiology of Na+/Hf Exchangers
Na+/H+ exchangers (NHEs) catalyse the electrically silent countertransport of Na+ and 
H4", controlling the transmembrane movement of salt, water and acid-base equivalents. 
They are therefore important for cell volume control, Na+ tolerance and pH regulation. 
Na+/H+ exchange was first demonstrated in 1972 in the bacterium Streptococcus 
faecalis and since that time the existence of the transporter in virtually all cell types has 
been described (Figure 1.1 IB) (for review see Wakabayashi et al., 1997).
In 1989, the first cDNA for a Na+/H+ antiporter was cloned through genetic 
complementation of an exchange-deficient mouse fibroblast cell line (Sardet et al.,
1989). The cDNA sequence consists of a 2445 base pair open reading frame, encoding 
a protein of 90-kDa. This protein is now known as NHE1. Since then at least 6  
mammalian NHE isoforms have been identified, NHEs 1-4 share 40% identity at the 
amino acid level. Based on hydropathy plots of their amino acid sequences, NHE 
proteins consist of 10-12 transmembrane spanning domains and a long cytoplasmic C- 
terminal tail, upon which several modulatory motifs are found (Wakabayashi et a l,
1997). Most NHE isoforms are primarily localised to the plasma membrane, but a
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distinct subset of vesicles (« 20%) contain a Na+/H+ exchange activity, with similar 
kinetic properties to that found at the cell surface, (Nass and Rao, 1998).
The cloning of transporter cDNAs and the development of exchanger-deficient cell lines 
has enabled the study of the specific function of each isoform in a defined environment. 
All the cloned exchangers exhibit Michaelas-Menton kinetics for external H* when 
expressed in the exchange-deficient cell line, PS 120, with Km values in the range of 5 to 
50 mM depending upon the species and isoform tested. In contrast, the concentration 
dependence to the internal H4- is much steeper. Aronson and co-workers have proposed, 
based on the analysis of Na+ transport by brush border membrane vesicles, that 
intracellular protons may act at an allosteric site on the exchanger as well as at the H* 
transport site itself (reviewed in Wakabayashi et a l, 1997). The cytoplasmic C-terminal 
domain (300 amino acids) although dispensable for Na+/H+ activity, controls the affinity 
of the transporter for these allosteric intracellular H* and is therefore sometimes known 
as the ‘transducer unit’. Partial or complete deletion of the C-terminal cytoplasmic 
domain reduces the rate of Na+/H+ exchange on the N-terminus in response to certain 
hormones.
NHE1 is the only ubiquitously expressed NHE isoform (NHE2-4 being confined to 
epithelial cells). It is a glycoprotein of 90 kDa, and is mainly responsible for 
maintaining intracellular pH. NHE1 is acted upon by various growth factors and 
hormones, including insulin, (Noel and Pouyssegur, 1995), and is modulated by G- 
proteins of the Ras and Rho families, (Hooley et a l, 1996). Microinjection of 
antibodies against the carboxy-terminal 157 amino acids of NHE 1 blocks activation of 
Na+/Hf exchange by hormones indicating that this part of the antiporter is required for 
hormone ‘sensing’. How hormones elicit changes in Na+/H+ exchange is not known but 
may be due to signalling cascades including a PKC-dependent pathway and a tyrosine 
kinase pathway, (Incerpi et a l, 1994). PI 3-kinase may also be important in regulating 
the function and localisation of NHE isoforms. Recently Ma and co-workers showed, in 
cells expressing mutant PDGF receptors lacking PI 3-kinase- and PKC- dependent 
pathways, that both pathways were required for PDGF-induced activation of NHE1 (Ma 
et a l, 1994). In addition, treatment of polarised epithelial cells with the PI 3-kinase 
inhibitors wortmannin and LY294002, results in a marked inhibition of NHE-3 
mediated H* extrusion, and the loss of NHE-3 from the cell surface due to impaired 
recycling (Kurashima et a l, 1998). Hormones and growth factors appear to regulate
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NHE1 by phosphorylation of the protein on serine residues in the cytoplasmic tail. The 
importance of phosphorylation has been revealed by the use of okadaic acid, an 
inhibitor of protein phosphatase 1 and 2 A (PP1 and PP2A), which can activate NHE1.
The Na+/H+ exchanger has been implicated in a number of pathophysiological 
conditions including cancer, hypertension and diabetes mellitus. In uncontrolled 
diabetes, where there may be high concentrations of extracellular glucose, the Na+/H+ 
activity of NHE 1 is elevated, (Semplicini et a l, 1989). In addition, exposure of cells to 
insulin causes an increase in intracellular pH (pHi), which has been suggested to be a 
result of activation of NaVrf" exchange, since insulin causes an increase in Na+ influx. 
Indeed insulin elicits an increase in the Vmax of NHE1 in erythrocyte membranes by 
enhancing the serine/threonine phosphorylation of the cytosolic loop. This is in contrast 
to EGF and thrombin, which also increase the phosphorylation content of the NHE 
transporter, but do not effect its turnover rate (Canessa and Manriquez, 1997). However 
it occurs, alkalinization may function as a vital component of tissues response to insulin, 
much as pH changes are involved in the regulation of fertilisation, proliferation and 
metabolism in other cellular contexts, (Schaffer and Lodish, 1994).
1.9.5 Inhibitors of Na+/H+ Exchange: Implications for GLUT4 Translocation
I. Amiloride. Amiloride and its analogues are potent inhibitors of Na+/H+ exchange. 
They consist of a substituted pyrazine ring, and with a pKa of 8.7 they exist as 
monovalent cations at physiological pH. Counillon et al. have identified a single amino 
acid mutation in Na+/H+ exchangers isolated from amiloride-insensitive Chinese hamster 
lung fibroblasts (Counillon et a l , 1993a). This F167 -» L substitution occurs in the 
middle of putative transmembrane helix 4, which may represent the site of amiloride 
sensitivity.
Insulin stimulates Na+/H+ exchange in parallel with glucose transport and glycolysis 
(Fidelman e ta l, 1982). Conversely, amiloride, which blocks Na+/H+ exchange, inhibits 
glucose transport (Fidelman et a l, 1982). However, amiloride is not absolutely specific 
for NHE1, also inhibiting a number of other ion transport systems. Therefore it is 
difficult to isolate the Na+/H+ pump, which in turn, leads to difficulties in interpreting 
the data.
II. HOE-694 and -642. In 1993, HOE-694 ((3-methylsulphonyl-4-piperidino-benzoyl) 
guanidine methanesulphonate), a novel compound with a structure distinct from 
amiloride was reported as a potent Na+/Hf pump inhibitor (Scholz et al., 1993). Later 
cariporide mesilate or HOE 642 ((4-isopropyl-3-methanesulphonyl-benzoyl) guanidine 
methanesulphonate) was also identified as a specific NHE1 inhibitor (Scholz et al., 
1995) (Figure 1.1 IB, lower panel). Both compounds consist of a substituted benzene 
nucleus, and both have been shown to be beneficial in preventing cardiovascular 
damage during ischemia/reperfusion. Since these compounds are far more specific for 
NHE1 than amiloride (Counillon et a l, 1993b), they will provide useful tools for re­
examining the role of this exchanger and of intracellular pH, in insulin-stimulated 
glucose transport and GLUT4 translocation.
Ill Isoproterenol. Isoproterenol inhibits Na+/H+ exchange via a p2-adrenergic receptor 
activation, which occurs through an adenylate cyclase stimulation and a cAMP- 
dependent mechanism, (Arsenis et a l, 1995). In addition, isoproterenol leads to a 
decrease in glucose transport and in the accessibility of insulin-stimulated GLUT4 at the 
adipocyte plasma membrane as judged by ATB-BMPA photolabelling, (Vannucci et al, 
1992). This effect occurs without an apparent change in the subcellular distribution of 
GLUT4 as determined by Western blotting. Thus these data suggest that insulin- 
stimulated glucose transporters can exist in two states in the plasma membrane, one 
which is functional and accessible to extracellular substrate, and one which is non­
functional. Thus the effect of isoproterenol is to retarget insulin-stimulated GLUT4 into 
‘occluded’, non-functional vesicles, (Vannucci et al., 1992), possibly as a result of 
Na+/H+ pump inhibition.
Figure 1.11 Schematic Diagram of the v-ATPase and the Sodium-Proton Exchanger A Model of the v-ATPase in the plasma membrane showing the 
V) domain in blue and the V0 domain in green. The lower panel shows the structure of the v-ATPase inhibitor bafilomycin Ai. (Adapted from Forgac, 1999). B. Model of the 
sodium-proton exchanger. The transporter consists of a membrane spanning N-terminal domain and a long cytoplasmic region at the C-terminus , The lower panel shows the 
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1.10 The Experimental Aims of the Work Described in this Thesis
The work described in this thesis has two main themes -  the function of intracellular pH 
and the role of adaptor proteins in controlling intracellular trafficking and recycling of 
the glucose transporter, GLUT4. Initially an isolation protocol for cardiomyocytes was 
developed. Then, several studies were performed to confirm that the cells were insulin- 
responsive in terms of their glucose transport and GLUT4 translocation.
Investigations were undertaken to determine whether perturbations in the cellular pH 
would alter glucose transport and transporter translocation to the cell surface. Several 
techniques were employed. Firstly cells were stained with the acidotrophic dye acridine 
orange to establish that changes in pH had taken place. Then 2-deoxy-D-glucose and 3- 
O-methyl-D-glucose transport assays, cell surface photolabelling, subcellular 
fractionation and confocal microscopy were used to analyse changes in hexose transport 
and glucose transporter localisation.
Several studies with adipocytes were performed to establish a role for adaptor proteins 
in GLUT4 trafficking. Both Nycodenz and glycerol gradients were used to establish 
whether adaptor proteins and GLUT4 co-localise. A technique for immunoisolating 
GLUT4 vesicles was developed and characterised in order to examine whether a direct 
interaction between adaptor proteins and GLUT4 vesicles exist. Furthermore, the roles 
of GTPyS, temperature and brefeldin A on the association of adaptor complexes with 
GLUT4 vesicles were all investigated. In addition, an analysis of the association of the 
small GTPase ARF1 with GLUT4 vesicles was performed. Again gradient 
sedimentation and vesicle isolation protocols were employed. Moreover, the role of 
insulin on the association of adaptor proteins with GLUT4 vesicles was investigated and 
a number of approaches including chemical cross-linking and immunoprecipitation 






Radiolabelled sugars and ECL Western blotting detection reagents were purchased from 
Amersham Pharmacia Biotech. Optiphase Safe™ scintillation fluid was from LKB. 
Collagenase Type 1 from Clostridium histolyticum was from Worthington Biochemical 
Corporation or from Serva. Bovine Albumin Cohn Fraction V was purchased from 
Intergen Co. Fatty acid Free Bovine Serum Albumin and Thesit (Nonaethylene glycol 
dodecyl ether) were from Boehringer Mannheim. Protein molecular weight markers were 
from Sigma or New England BioLabs. Other reagents were of analytical grade and 
were purchased from Sigma, BDH or Fisons.
2.1.2 Antibodies
• The source of antibodies and their appropriate dilutions for Western blotting 
(Section 2.9.3) and immunoprecipitation (Section 2.6.1) are shown in the tables 
below. All antibodies were diluted in Tris-buffered saline buffer (0.09% (w/v) 
NaCl, 1M Tris-HCl, pH 7.4) containing 0.1% (v/v) Tween-20, 1% (w/v) BSA, and 
0 .0 2 % (w/v) azide, unless otherwise stated.
• Rabbit antisera against GLUT1 and GLUT4 were raised in the laboratory of Dr. 
S.W. Cushman (National Institutes of Health, Bethesda, USA); using C-terminal 
peptides produced in our laboratory (Holman et al., 1990).
Table 2.1 Source and Dilution of Antibodies Used for Western Blot Analysis
Antibody Polyclonal/Monoclonal
Purified/Serum















M.S. Robinson, University o f 
Cambridge, U.K.
1:500-1:1000





University o f Bath, U.K.
1:250











M.S. Robinson, University of 
Cambridge, U.K.
1:500
Mouse anti-ARF Monoclonal (1D9) 
Purified
Alexis Corporation (U.K.) Ltd., 
Nottingham, U.K.
1:250-1:500





Rabbit anti-GLUT4 Polyclonal 
Serum and Purified
G.D.Holman, 
University of Bath, U.K.
1:4000



















Alpha Diagnostics International 




J.K.Ngsee, Loeb Reserach 
Institute, Ontario, Canada.
1:1000- 1:2000
Rabbit anti-PI 3- 
Kinase p85a
















University o f Bath, U.K.
1:5000
Mouse anti-TGN38 Monoclonal (2F 7.1) 
Purified
G. Banting, University of 
Bristol and P.Luzio, University 
o f Cambridge, U.K.
1:1000
Mouse anti - 
Transferrin Receptor
Monoclonal (CD 71) 
Purified
Chemicon International Inc., 
U.S.A.
1:1000
Rabbit anti-VAMP2 Polyclonal (L220) 
Purified
M.A. Krepper, Renal 
Mechanisms Section, NIH, 
Washington D.C., U.S.A.
1:500- 1:1000 
(made in TBS 
only)
BO
Mouse anti-VAMP2 Monoclonal R. Jahn, Max Planck Institute, 1:1000
(CL69.1)Purified Germany.
Table 2.2 Source and Dilution of Secondary Antibodies Used for Western Blot 
Analysis
Antibody Source Dilution




















Table 2.3 Sources and Concentration of Antibodies Used for Immunoprecipitation
Antibody Source Concentration Required for 
Immunopreciptation
Rabbit anti-GLUTl G.D. Holman, 
University o f Bath, U.K.
100 pi serum / 1 ml adipocyte 
cell lysate
Rabbit anti-GLUT4 G.D. Holman, 
University o f Bath, U.K.
20 pg purified antibody / 1 ml 
adipocyte cell lysate
Rabbit anti-GLUT4 G.D. Holman, 
University o f Bath, U.K.




(ATB-[3H]-BMPA) (« 10 Ci/mmol) and the biotinylated derivative Bio-lc-ATB-BMPA 
were synthesised as described in (Clark and Holman, 1990; Koumanov et al, 1998) by 
Professor G.D. Holman.
2.2 Isolation of Insulin Sensitive Cells
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2.2.1 Preparation of Bovine Serum Albumin Solution
10 g of BSA (Fraction V) per 60 ml of double-distilled water was dissolved overnight at 
4°C. The BSA was filtered through a Millipore type A membrane filter (0.8 pm pore size) 
under vacuum and the pH of the solution was adjusted to 7.6 with 10 M NaOH. Double 
distilled water was added to give a final BSA concentration of 10% (w/v). The BSA was 
divided into 40 ml aliquots and stored at -20°C until required.
2.2.2 Isolation of Rat Adipocytes
2.2.2.1 Preparation o f Buffers
All buffers, unless otherwise stated, contained the following Krebs-Ringers-HEPES buffer 
(KRH) consisting of 140 mM NaCl, 4.7 mM KC1, 2.5 mM CaCl2, 1.25 mM MgCl2, 2.5 
mM NaH2PC>4, 10 mM HEPES. The pH was adjusted to 7.6 at 20°C. BSA was added as 
required. Buffer stock solutions were prepared as 10-time concentrates, one containing 
HEPES and NaH2PC>4 (pH 7.6), and the other containing NaCl, KC1, CaCl2 and MgS04) 
and were stored at 4°C for up to 1 month.
2.2.2.2 Preparation o f Isolated Rat Adipocytes
Isolated adipose cells were prepared from the whole epididymal fat pads of male Wistar 
rats (180-200 g) as described, (Taylor and Holman, 1981; Simpson et al., 1983). The rats 
were stunned and the necks dislocated. The epididymal fat tissue was quickly removed 
and rinsed in 1% (w/v) BSA/KRH buffer at 37°C. The washed tissue was placed in KRH 
buffer (4pads/ 5mls) containing 3.5% (w/v) albumin, 5 mM glucose, and 0.70 mg/ml 
collagenase (Worthington) and minced finely with scissors. The tissue suspension was 
shaken rapidly in a shaking water bath at 37°C for approximately 40 min until most of the 
tissue lumps were digested. The resulting cell suspension was filtered through a nylon 
mesh (250 pm mesh size, Lockertex), returned to 37°C and the cells were allowed to float. 
The infranatant buffer was removed using a needle (2 mm dia. x 100 mm) attached to a 20 
ml plastic syringe, and 15-20 ml 1% (w/v) BSA/KRH buffer was added. The cells were 
gently resuspended and then allowed to float. This washing procedure was repeated 3-4
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times. The cell suspension was adjusted to a cytocrit of 40%, (using a capillary tube which 
was centrifuged at 1500 g  for 30 sec, and expressed as the ratio of the length of the packed 
cell fraction in the tube to the total length of the suspension in the tube).
2.2.3 Isolation of Rat Cardiac Myocytes
2.2.3.1 Preparation of Btffers
All buffers, unless otherwise stated, contained the following cardiomyocyte Krebs- 
Ringers-HEPES buffer (cKRH buffer): 6  mM KC1, 1 mM Na2HP04, 0.2 mM NaH2P 04, 
1.4 mM MgS04, 128 mM NaCl, 10 mM HEPES. Buffer stock solutions were prepared 
as 10-time concentrates, one containing HEPES, NaH2P04, and Na2HP04 (the pH was 
adjusted to 7.4 with 10 M NaOH), and the other containing NaCl, KC1, and MgSG4. 
Stock solutions were stored at 4°C for up to 1 month.
Prior to use, the cKRH buffer was gassed with 0 2 for 20 min. From the cKRH buffer, a 
number of other buffers were prepared on the day of use:
• Buffer A: cKRH buffer supplemented with 5.5 mM glucose, 2 mM ultrapure pyruvic 
acid (Sigma) and 20 mM inosine (Aldrich).
• Buffer B: buffer A supplemented with 0.7% (w/v) BSA, 1.1 mg/ml collagenase, 2.65 
mg/ml hyaluronidase Type 1-S, 15 mM 2,3-butanedione monoxime (BDM).
• Buffer C: buffer A supplemented with 0.2 mg/ml DNAse I (Boehringer Mannheim), 
15 mM 2,3-butanedione monoxime (BDM), 200 pM CaCl2, and 2% (w/v) BSA.
• Buffer D: buffer A supplemented with 1 mM CaC12 (physiological calcium 
concentration), and 2% (w/v) BSA.
• Buffer E: buffer A containing 1 mM CaC12 and 2% (w/v) Fatty acid free Albumin, 
Fraction V, (Boehringer Mannheim).
• Buffer F  (no glucose or pyruvate): cKRH Buffer containing 1 mM CaCl2 and 2% 
(w/v) Fatty acid free Albumin, Fraction V, (Boehringer Mannheim).
• Heparin Solution: Heparin Grade 1A isolated from porcine intestinal mucosa was 
reconstituted in 0.9% (w/v) NaCl (1000 Units/ml) and filter sterilised through a 0.2 
pm filter (Sartorius). Aliquots were stored at 4°C.
2.2.3.2 Preparation o f Isolated Rat Cardiac Myocytes
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Calcium-resistant1, rod-shaped cardiomyocytes from adult male Wistar rats (260-280 g 
fed ad libitum) were prepared using a method originally described by (Fischer et al., 
1991) with some modifications. Briefly, animals were anaesthetised with 350 pi 
Sagatal™ (Pentobarbitone Sodium b.p., 60mg/ml, (Rhone Merieux)) before 
administration of 500 units of heparin solution via the tail vein. After 5 min the neck 
was dislocated and the heart rapidly removed into semi-frozen Buffer A (0-4°C). The 
heart was immediately mounted on to a catheter and perfused by the method of 
Langendorff, (LangendorfF, 1895) with Buffer A, at 37°C, for 5 min in order to remove 
blood and metabolites from the coronary vessels and atrial and ventricular chambers. 
The perfusion was then switched to Buffer B equilibrated with oxygen and was 
recirculated by means of a peristaltic pump.
After 15 min 100 pM CaCh was added to the recirculating buffer. The CaCl2 
concentration was raised to 200 pM after a further 3 min. The heart was perfused for a 
total of 18 min prior to its’ removal from the catheter. The heart tissue was dissociated 
in a buffer containing 10 ml Buffer B and 10 ml Buffer C prewarmed to 37°C and under 
an oxygen atmosphere. Incompletely digested tissue was passaged gently through a 1 
ml syringe and incubated for a further 10 min at 37°C. During this last incubation, the 
calcium concentration was increased in 200 pM steps until the final concentration was 
800 pM.
The digested suspension was filtered through a 250 pm2 nylon gauze (Lockertex,) and 
the cardiomyocytes were allowed to settle for 3-4 min to form a loose pellet. The 
supernatant was removed and the cells resuspended in 20 ml Buffer D. The cells were 
allowed to settle again for 3-4 min at room temperature and the supernatant was 
removed. The pellet was resuspended in 10 ml Buffer E and the cell suspension was 
incubated for 20-30 min at 37°C under an oxygen atmosphere to allow the cells to 
recover from the isolation procedure. Viability was assessed by counting the number of 
rod-shaped (viable) versus round-shaped (dead) cells under the light microscope.
1 cardiac myocytes are designated “calcium tolerant” when they survive the reintroduction of calcium at
physiological concentrations after a period of calcium-free incubation or perfusion (Fischer et al., 1991)
2.3 Treatment of Isolated Cells with Insulin
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2.3.1 Preparation of Insulin
Monocomponent porcine insulin was a gift from Dr. G. Daniellson, Novo Nordisk. 1.0 mg 
of insulin was dissolved in 1.0 ml of 0.03 M HC1 and the solution made up to 3.0 ml with 
double-distilled water. 1.0 ml of this solution was then diluted to 50 ml with 1% (w/v) 
BSA/KRH buffer, pH 7.6. The resulting insulin solution (1 mM) was divided into 500 pi 
aliquots and stored at -20°C until required. The solution was not refrozen once it had been 
thawed.
2.3.2 Stimulation of Adipocytes with Insulin
20 nM insulin (1 mM stock, Section 2.3.1.) was used to stimulate isolated rat adipocytes 
(40% cytocrit), for 20 min at 37°C. Basal cells were also maintained at 37°C during this 
time.
2.3.3 Stimulation of Cardiac Myocytes with Insulin
Prior to manipulation the cells were washed once in Buffer F, (to reduce the glucose and 
pyruvate concentrations), and divided into the required number of aliquots. Cells 
designated ‘insulin’ were stimulated for 30 min with 30 nM insulin. During this time 
both basal and insulin-stimulated cells were maintained at 37°C, under oxygen pressure 
with gentle shaking.
2.4 Glucose Transporter Studies
2.4.1 Assay for 3-O-Methyl-D-Glucose Uptake in Rat Adipocytes
Uptake of 3-O-methyl-D-glucose was determined by the method of Whitesell and 
Gliemann, (Whitesell and Gliemann, 1979). 50 pi of a 40% adipocyte suspension was 
added to 10 pi of radiolabeled sugar (200 pM 3-O-methyl-D-glucose (33.3 pM final 
concentration) containing 0.15 pCi of 3-0- [14C] methyl-D-glucose) in KRH buffer. 
Uptake was terminated by rapidly adding 3 ml 300 pM phloretin in albumin-free KRH
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buffer (the phloretin was first dissolved in ethanol such that the final concentration of 
ethanol was 0.5% (v/v)). Timings of 10 s or less were carried out using a metronome set at 
2 beats/sec. Uptake was measured for 3 s in insulin-stimulated cells and 120 s in basal 
cells (these times should give fractional filling values (F) of approximately 0.5). All 
measurements were carried out in triplicate.
"Background” values (b) (indicating extracellular trapped radioactivity) were determined 
by adding 3 ml of 300 pM phloretin in KRH buffer to the sugar before the addition of the 
cells. "Infinity" values (cpnia) (indicating equilibrium distribution of radioactivity) were 
determined by incubating insulin-treated cells with sugar for at least 2 0  min. 
Approximately 1 ml of silicon oil (Dow Coming 100/200 cs, obtained from BDH) was 
layered on top of the buffer, and the tubes were centrifuged (MSE bench centrifuge, swing- 
out rotor) at 1000 g for 45 sec. The cell layer was removed from the top of the oil using 
small pieces of pipe-cleaner (5 mm), and placed in a scintillation vial. 8  ml of scintillation 
fluid (Optiphase Safe™) was added. The rate constant of sugar uptake (v/s) was 
calculated from the fractional filling (F) using the following equation, which assumes that 
the rate of filling (approaching equilibrium) is a single exponential function of time:
F = cpuifb V = (-ln[l-F])
cpma-b S t
2.4.2 Assay of 2-Deoxy-D-glucose Uptake in Rat Cardiac Myocytes
Uptake was determined using a modification of the method described by Fischer, 
(Fischer et a!., 1991). Cells were either maintained in the basal state or insulin- 
stimulated as described, {Section 2.3.2). The cell suspension was divided into 900 pi 
aliquots in glass tubes (4.5 cm x 1.5 cm) with sealed lids, which were connected to an 
oxygen supply by means of a small needle. The transport assay was started by the 
addition of 2-deoxy-D-glucose to a final concentration of 100 pM (containing 0.5 pCi 
of 2-deoxy-D-[3H]-glucose, (specific activity: 1 mCi/ml) as a tracer). Sugar uptake was 
terminated by transferring the cell suspension to eppendorff microfuge tubes containing
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100 pi 6 .8  mM phloretin in Buffer F, (final concentration of phloretin was 400 pM). 
The samples were quickly mixed and immediately centrifuged at 3500 g for 1 min. The 
supernatants were removed and the cells were washed 3 times with 1 ml Buffer F 
containing 400 pM phloretin. Cells were lysed with 1 ml ice-cold 0.1 M NaOH, and 
aliquots were taken for protein determination, {Section 2.9.5).
The lids of the eppendorff tubes were removed and the entire tube placed in scintillation 
vials. Samples were counted in 8  ml of scintillant (Optiphase Safe™,) in a Packard 
1500 TRI-CARB or 1600 TR liquid scintillation counter. Background counts were 
determined by addition of cells to eppendorf tubes that contained 2-deoxy-D-glucose 
pre-mixed with 400 pM phloretin. These cells were washed and lysed exactly as 
described above.
2.4.3 Bis-Mannose Photolabelling Of Cell-Surface Glucose Transporters In 
Adipocytes
18.5 MBq (final concentration of label was 100 pM) ATB-[3H]-BMPA or 500 pM Bio- lc- 
ATB-BMPA was added to 500 pi of cells (40% cytocrit) in 1% (w/v) BSA/KRH buffer in 
35 mm polystyrene dishes (Nunc/Gibco BRL) at 18°C. Cells and label were mixed, then 
irradiated for 1 min in a Rayonet RPR-100 photoreactor containing 300 nm lamps. 
Following irradiation, the cells were washed into universal tubes (Sarstedt) with 20 ml 1% 
(w/v) BSA/KRH buffer at 18°C and pulse spun in a bench centrifuge (IEC centra-3) to 
1000 g. The infranatant buffer was removed using a needle (2 mm dia. x 100 mm), and the 
cells were resuspended in 20 ml 1% (w/v) BSA/KRH buffer and washed once more. The 
cells were solubilised by the addition of 2% (w/v) Thesit in PBS buffer containing protease 
inhibitors at 18°C. The unsolubilised material was removed by centrifugation at 20,000 g 
for 20 min. The samples were processed as described in Section 2.4.5.
2.4.4 Bis-Mannose Photolabelling Of Cell-Surface Glucose Transporters In 
Cardiac Myocytes
Basal and insulin-stimulated cells {Section 2.3.2) were transferred to 35 mm diameter 
polystyrene dishes (Nunc/Gibco BRL) and incubated at 18°C for 5 min to slow 
transporter recycling. 18.5 MBq ATB-[3H]-BMPA or 500pM Bio-lc-ATB-BMPA was
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added to the samples. Cells were irradiated for 1 min in a Rayonet RPR-100 
photoreactor containing a 50/50 distribution of 300 nm and 350 nm lamps. Following 
irradiation, cells were transferred to 15 ml falcon tubes and washed once with 15 ml 
Buffer F and twice with 15 ml HES buffer (20 mM HEPES pH 7.2, 1 mM EDTA, 255 
mM sucrose plus protease inhibitors: 1 pg/ml leupeptin, 1 pg/ml aprotonin, 1 pg/ml 
pepstatin A, 1 pg/ml antipain, 100 |nM (4-(2-aminoethyl) benzenesulfonyl fluoride 
(AEBSF)), at 18°C. Following the final wash, the cell pellets were resuspended in 500 
pi HES buffer and homogenised with 30 strokes using a muscle homogeniser. The 
homogenates were transferred to 3 ml polycarbonate tubes and made up to a total 
volume of 3 ml with HES buffer. The samples were centrifuged at 541,000 g in a 
Beckman TL-100 benchtop ultracentrifuge with a TLA-100.3 fixed rotor for 30 min at 
4°C. The resulting total membrane pellets were washed in 3 ml HES buffer plus protease 
inhibitors and the centrifugation step was repeated. The final pellets were resuspended in 
800 pi PBS buffer (12.5 mM Na2HPC>4, 154 mM NaCl, pH 7.2, containing protease 
inhibitors), and transferred to clean eppendorff tubes. 200 pi 10% (w/v) Thesit solution 
was added to the samples to give a final concentration of Thesit of 2% (w/v). The 
samples were rotated at room temperature for 20 min. Unsolubilised material was 
removed by centrifugation at 20,000 g for 20 min. The samples were processed as 
described in Section 2.4.5.
2.4.5 Processing Photolabelled Transporters
2.4.5.1 Immunoprecipitation o f A TB-f HJ-BMPA Labelled Transporters and Gel Slicing
ATB-[3H]-BMPA-photolabelled glucose transporters from the solubilised supernatants of 
adipocytes or cardiomyocytes were immunoprecipitated using Protein A sepharose beads 
coupled to either GLUT1 or GLUT4 antibodies {Section 2.6.1). The resulting precipitates 
were resolved on a 10% SDS-PAGE gel. After staining and destaining {Section 2.9.4), 
lanes from the gel were cut into 0 .6 6  cm slices and dried individually in open scintillation 
vials in an 80°C ovea Dried gel slices were solubilised with 500 pi 2% (v/v) NH4OH in 
30% (v/v) H2O2 in sealed vials at 80°C. 8  ml of scintillation cocktail (Optiphase Safe™) 
was added and 3H counts determined using a Packard Tri-Carb 1600 Scintillation counter. 
A graph of slice number versus disintergrations per minute (d.p.m) was constructed. The 
radioactivity associated with the labelled transporters was determined by adding up the
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counts from the slices that formed the peak and subtracting the counts from the same 
number of slices that contained no label (background counts).
2.4.5.2 Streptavidin Precipitation ofBio-lc-ATB-BMPA Labelled Glucose Transporters
50 pi of a 50% slurry of Immunopure streptavidin beads (Pierce) (stored in ethanol) were 
used per condition. The beads were washed twice with 1 ml ice-cold PBS buffer 
containing protease inhibitors, to remove the ethanol. The photolabelled transporters from 
solubilised supernatants of adipocytes or cardiomyocytes (Sections 2.4.3 and 2.4.4) were 
incubated with the streptavidin beads overnight at 4°C with end-to-end rotation. 
Following this incubation, the streptavidin beads were washed 4 times with 1ml PBS 
buffer containing 1% (w/v) Thesit, 4 times with 1ml PBS buffer containing 0.1% (w/v) 
Thesit and once with 1ml PBS buffer only. Bound biotinylated glucose transporters were 
eluted in 30 pi ‘high SDS’ sample buffer (62.5 mM Tris-HCl, pH 6.7,3% (w/v) SDS, 50% 
(v/v) glycerol, 0.02% (w/v) bromophenol blue) by heating at 95°C for 30 min. The eluate 
was collected and the elution procedure was repeated. The resulting eluates were pooled 
and loaded carefully using sequencing tips on to 10% SDS-PAGE gels, transferred to 
nitrocellulose and blotted with GLUT1 or GLUT4 antibodies (Sections 2.9.1 -  2.9.3).
2.5 Subcellular Fractionation of Insulin Sensitive Cells
2.5.1 Subcellular Fractionation of Rat Adipocytes
This procedure was carried out essentially as described by Weber (Weber et at., 1988). 
Briefly, cells were washed twice in HES buffer at 20°C and then resuspended in HES 
buffer to give a 40% cytocrit. The cells were rapidly homogenised (basal first) with 10 
strokes of a 55 ml Potter-Elvehjem homogeniser, (Thomas Scientific), with a specific 
clearance of 150 pm. The homogenates and subsequent fractions were centrifuged in a 
Beckman TL-100 benchtop ultracentrifuge with a TLA-100.3 fixed rotor (or a TLS-55 
swing-out rotor, where indicated). Initially, each sample was centrifuged at 17, 500 g for 
2 0  min resulting in a crude membrane pellet, a microsomal/cytosolic fraction and a layer 
of fat. The microsomal/cytosolic fractions were removed, using 19 gauge needles attached 
to 5 ml syringes, and used for fractionation of the microsomal membranes. The pellets
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Figure 2.1 Method for the Subfractionation of Rat Adipocytes. Adipocytes were 
homogenised and spun at 1000 g. The fat was removed and the resulting supernatant was centrifuged 
at 17,500 g  for 20 min. The resulting supernatant was centrifuged at 49,000 g  for 9 min to produce the 
high density microsomes (HDM). The supernatant from this spin was centrifuged at 541,000 g  for 17 
min to produce the low density microsomes (LDM) and the cytosol (CYT). The pellet from the 
original 17,500 g spin was resuspended in HES buffer and layered onto the top of a sucrose cushion 
which was centrifuged at 105,000 g  for 20 min. The resulting plasma membranes were pelleted and 
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containing plasma membranes, mitochondria and nuclei were resuspended in 300 p.1 HES 
buffer and loaded onto 0.6 ml sucrose cushions (1.12 M sucrose (38.3% (w/v), 20 mM 
HEPES pH 7.2, 1 mM EDTA) and spun at 105, 000 g for 20 min in the swing-out rotor. 
The mitochondria and nuclei were recovered in the pellets. The plasma membranes were 
collected from the sucrose cushions, resuspended in HES buffer to 3 ml and centrifuged at 
74,000 g for 9 min. The resulting plasma membrane (PM) pellets were resuspended in 3 
ml HES buffer and repelleted at 74,000 g for 9 min.
The supernatants (containing the microsomal membranes) obtained from the 17,500 g spin 
were centrifuged at 49, 000 g for 9 min to pellet the high-density microsomes (HDMs). 
The resulting post-HDM supernatants were centrifuged at 541, OOOg for 17 min to pellet 
the low-density microsomes (LDMs). Both microsomal fractions were resuspended in 
HES buffer. The remaining supernatants were the cytosol fractions. All fractions were 
assayed for protein content {Section 2.9.5\ aliquoted and stored at -70°C.
2.6 Immunoprecipitation
2.6.1 Immunoprecipitation of Proteins
Immunoprecipitation of a required protein from cardiomyocytes or adipocytes was 
performed as follows: Cells were solubilised by incubation with 2% (w/v) Thesit in PBS 
buffer containing protease inhibitors for 20 min at room temperature. Any 
unsolubilised material was removed by centrifugation at 20,000 g for 20 min at 4°C.
5 mg of Protein A-Sepharose CL-4B (Sigma) was washed and swollen in 1 ml PBS 
buffer, pH 7.2 for 10 min, then incubated for at least 2 h at 4°C with relevant affinity- 
purified antibodies or antiserum, {Table 2.3\ in 1 ml PBS buffer containing protease 
inhibitors. Unbound antibodies were removed by washing the protein A-Sepharose 
pellets twice in 1 ml PBS buffer, pelleting by centrifugation at 3500 g for 1 min in a 
MSE microcentaur microfuge. Cell lysates were incubated with antibody-protein A- 
Sepharose conjugates for 2 h or overnight at 4°C.
The immunopellets were washed 6  times with 1 ml 1% (w/v) Thesit or Triton X-100 
(v/v) in PBS buffer and once with 1 ml PBS buffer. The protein-antibody complexes 
were dissociated from the Protein A-Sepharose beads by incubating the immunopellets
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for 20 min in 6  M urea electrophoresis sample buffer ( 6  M urea, 10% (w/v) SDS, 1% 
(w/v) bromophenol blue) and 100 mM 2-p mercaptoethanol at room temperature with 
occasional vigorous vortexing. Eluted proteins were analysed by SDS-PAGE, {Section 
2.9.1).
2.6.2 Immunoprecipitation of GLUT4 Vesicles
2.6.2.1 Preparation o f GLUT4 Vesicles on Staphylococcus aureus cells
GLUT4 vesicles were isolated on Staphylococcus aureus Cowan I cells (Staph cells) 
expressing Protein A. Initially Staph cells were prepared by heating to 95°C in extraction 
buffer (50 mM Tris-HCl, pH 7.2, 150 mM NaCl, 104 mM SDS, 10% (v/v) 2-p 
mercaptoethanol), at a ratio of 50 mg Staph cells per ml buffer. Staph cells were 
pelleted at 13, 400 g  for 1 min and resuspended in extraction buffer. Cells were heated 
and centrifuged as before, then washed 3 times with 1 ml HES Buffer (10 mM HEPES, 
pH 7.2, 5 mM EDTA, 255 mM sucrose). Finally Staph cells were resuspended in HES 
buffer at 50 mg/ml and stored as 1 ml aliquots at -20°C until required.
Aliquots of Staph cells (40 pi) were incubated with 50 pi rabbit anti-GLUT4 serum or non 
specific rabbit serum (pre-immune control) in 1 ml HES buffer for 2 h at 4°C with end-to- 
end rotation. Staph cells were washed 3 times with 1 ml of HES buffer, centrifuging at 13, 
000 g for 1 min between washes. Post-HDM supernatants were initially precleared by 
incubation with Staph cells coupled to rabbit IgG, for a minimum of 30 min at 4°C with 
rotation. Supernatants were then transferred to Staph cells bound with rabbit IgG (pre- 
immune control) or rabbit anti-GLUT4 IgG and rotated for 2 h at 4°C. Staph cells were 
subsequently washed once in HES buffer and twice in HES buffer containing 100 mM 
KC1. Vesicular proteins were solubilised by incubating Staph cell pellets with 100 pi 2% 
(w/v) Thesit in HES buffer at room temperature for 20 min. Bound GLUT4 protein was 
eluted by heating pellets to 95°C in sample buffer (62.5 mM Tris-HCl, pH 6.7, 1% (w/v) 
SDS, 50% (v/v) glycerol, 0.02% (w/v) bromophenol blue) with 20 mM dithiothreitol 
(DTT), for 5 min.
2.6.2.2 Preparation o f GLUT4 Vesicles on Acrylamide beads
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One ml of Reacti-Gel (GF-2000) support (acrylamide beads) (Pierce) was prepared by 
washing once with 2 0  ml ice cold double distilled H2O and then once with 2 0  ml borate 
buffer (100 mM NaBH3, 0.9% (w/v) NaCl, pH 8.5), using a Buchner funnel, and Whatman 
No. 1 filter paper. The acrylamide beads were then split into two aliquots; one was 
coupled to 500 pg purified rabbit anti-GLUT4 antibody (no azide) and the other to 500 pg 
purified rabbit IgG (Sigma), by rotation in borate buffer, overnight, at 4°C. The coupling 
buffer was then removed and the beads quenched for 1 h at 4°C with 2 M Tris-HCl, pH 
8.0. Following this incubation, the beads were washed 4 times in PBS buffer (to remove 
Tris-HCl pH 8.0 buffer and unbound antibody), and stored at 4°C, as a 50% (w/v) slurry in 
PBS buffer, until required.
On the day of use, 50 pi of the 50% (w/v) slurry per condition, (both non-specific rabbit 
IgG and rabbit anti-GLUT4 antibody coupled beads) were blocked for at least 2 h with 2% 
(w/v) BSA in PBS buffer, at 4°C. The beads were then washed twice in PBS buffer and 
twice in HES buffer, pH 7.2, (pulse spinning to 2000 g  between washes). Post-HDM 
supernatants were rotated with beads coated either in non-specific rabbit IgG (control) or 
rabbit anti-GLUT4 IgG (GLUT4 vesicles), for 2 h at 4°C (no pre-clearing step was 
required). Beads were washed once in HES buffer and twice in HES buffer containing 100 
mM KC1. Vesicular proteins were solubilised by incubating beads with 100 pi 2% (w/v) 
Thesit in HES buffer at room temperature for 20 min. Bound GLUT4 protein was eluted 
by heating pellets to 95°C in sample buffer (62.5 mM Tris-HCl, pH 6.7, 2% (w/v) SDS, 
50% (v/v) glycerol, 0.02% (w/v) Bromophenol Blue) with 20 mM dithiothreitol (DTT), for 
5-10 min.
2.7 Gradient Centrifugation
2.7.1 Nycodenz Gradient Centrifugation
Post-HDM supernatants (Section 2.6.1) were analysed by Nycodenz velocity gradient 
centrifugation. The iso-osmotic medium 5-(N-2, 3-dihydroxypropylacetamido)-2,4,6- 
triiodo-N, N’-bis(2,3-dihydroxypropyl)isophthalamide (Nycodenz™) was prepared as a 
27.6% (w/v) stock in Gradient buffer (20 mM HEPES, pH 7.5, 3 mM KC1 and 0.3 mM
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EDTA) and stored at room temperature. All other Nycodenz gradient solutions were 
prepared by diluting the 27.6% (w/v) Nycodenz stock solution with a sucrose diluent 
composed of 7.45% (w/v) sucrose in the Gradient buffer.
Table 2.4. Properties of Nycodenz™-Sucrose Gradients
% (w/v) Nycodenz™ 27.6 18.4 13.8 9.2
Dilution ratio Nycodenz 
Sucrose Diluent
1 :0 2 :1 1 :1 1 :2
Density (g/ml) 20°C 1.148 1.105 1.086 1.066
Refractive index 20°C 1.3784 1.3669 1.3613 1.3553
Linear gradients (9.2 - 27.6% (w/v)) were constructed by layering 9 ml of each 
Nycodenz gradient solution, (1.148 g/ml to 1.066 g/ml) in to 38 ml polyallomer 
centrifuge tubes, (Beckman Instruments Inc., Palo Alto, USA), on ice. Gradients were 
sealed and placed on their sides for 1 h to allow rapid diffusion resulting in the 
formation of a smooth gradient. 2 ml of post-HDM supernatant per condition were 
dialysed overnight against Gradient buffer at 4°C, primarily to remove the sucrose. 
Gradients were then centrifuged at 4°C in a SW28 Titanium swing-out rotor (Beckman 
Instruments Inc.), at a speed of 63,000 g for 2 h 30 min. Gradient fractions (1 ml) were 
collected from the bottom to the top of the tube by the use of a capillary tube and pump. 
Aliquots of each fraction (100 pi) were analysed by SDS-PAGE {Section 2.9.1) and 
Western Blotting, {Section 2.9.3).
2.7.2 Glycerol Gradient Centrifugation
Post-HDM supernatants from basal and insulin-treated rat adipocytes were diluted 5-fold 
in Gradient buffer D (10 mM HEPES, pH 7.2,150 mM NaCl, 1 mM EGTA, 1 mM MgCl2, 
1 pg/ml leupeptin, 1 pg/ml aprotonin, 1 pg/ml pepstatin A, 1 pg/ml antipain, 100 pM 
(4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF), and loaded on to a 27.5 ml 5- 
25% (v/v) discontinuous glycerol gradient over an 8  ml 50% (w/v) sucrose cushion. 
The gradients were centrifuged at 80, 000 g for 16 h at 4°C. Gradient fractions (1 ml) 
were collected from the bottom of the tube. Aliquots of each fraction (100 pi) were
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analysed for constituent proteins by SDS-PAGE (Section 2.9.1) and Western Blotting, 
(Section 2.9.3).
2.8 Confocal Microscopy
2.8.1 Indirect Immunofluorescence Microscopy
Following incubation with stimulatory or inhibitory compounds (indicated in the figure 
legends), cardiomyocytes (1 ml) were transferred to 15 ml falcon tubes, (if possible the 
cells were maintained in Buffer E containing glucose and pyruvate (Section 2.2.3)). The 
cells were fixed by incubation with 7.5 ml 4% (w/v) paraformaldehyde in PBS buffer pH
7.2 for 20 min at 20°C with gentle rocking. The cells were washed 3 times with 15 ml 
PBS buffer at 20°C spinning at 300 g  for 1 min between washes. The cells were 
permeabilised in 7.5 ml Permeabilisation buffer (0.1% saponin, 1% (w/v) BSA, 3% (v/v) 
goat serum (Sigma) in PBS buffer pH 7.2) for 45 min with gentle rocking. Following 
permeabilisation the cells were centrifuged at 300 g and the pellets were resuspended in 
250 pi Permeabilisation buffer and transferred to eppendorff tubes. 250 pi 4 pg/ml mouse 
anti-GLUT4 antibody (1F8 clone, Biogenesis Ltd., Poole) or rabbit anti-GLUT4 antibody 
was added to each sample (2 pg/ml final concentration) in Permeabilisation buffer. The 
samples were rocked gently for 60-90 min, then washed three times with 1 ml 
Permeabilisation buffer and incubated for 1 h with 500 pi 1:60 dilution of rhodamine 
labelled anti-mouse IgG antibody or fluorescein labelled anti-rabbit IgG antibody (Jackson 
Laboratories) in Permeabilisation buffer. The cells were washed 6  times with 1 ml 
Permeabilisation buffer and mounted onto a glass coverslip using Vector Shield mounting 
medium, (Vector Laboratories). Cardiomyocytes were viewed using a Zeiss confocal 
scanning microscope (LSM 510, Carl Zeiss Microscopy, Germany) with a 458/488 nm 
laser (for fluorescein labelled samples) or a 543 nm laser (for rhodamine labelled samples).
2.8.2 Vital Fluorescence Microscopy
Cardiomyocytes were stained with acridine orange following the method described by 
(Yoshimori et a l 1991). Briefly, cardiomyocytes were incubated with acridine orange 
at a final concentration of 5 pg/ml in Buffer E {Section 2.2.1.2) for 10 min at 37°C with 
continuous gassing with O2. The cells were subsequently washed twice with 15 ml 1%
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(w/v) BSA/cKRH buffer, centrifuging at 300 g between washes. The cells were 
immediately mounted onto coverslips using Vector Shield mounting medium, (Vector 
Laboratories), and viewed using dual lasers for fluorescein and rhodamine (458/488nm 
and 543 nm) staining.
2.9 Protein Biochemistry Techniques
2.9.1 SDS-Polyacrylamide Gel Electrophoresis
Sample buffers (62.5 mM Tris-HCl, pH 6.7, 1% (w/v) SDS, 50% (v/v) glycerol, 0.02% 
(w/v) Bromophenol Blue) were prepared as 1-time, 3-time and 5-time concentrates and 
stored at room temperature. 10% (v/v) 2-P-mercaptoethanol or 20 mM dithiothreitol 
(DTT) (final concentration) were added as reducing agents, at the time of use. Protein 
samples (except those for glucose transporter analysis) were heated at 95°C for 2-3 min. 
Samples for GLUT1 and GLUT4 analysis were incubated with sample buffer and 
reducing agents at room temperature for 20 min. One exception to this rule was the 
study of glucose transporters biotinylated with Bio-lc-ATB-BMPA. In this case 
samples were heated to 95°C to dissociate the biotin-streptavidin interaction (Section 
2.4.5.2).
Electrophoresis was carried out using the discontinuous buffer system of Laemmli 
(Laemmli, 1970), with either linear slab gels formed using the Protean II XI system 
with 16 cm plates, or the mini-PROTEAN II electrophoresis apparatus for minigels, 
(both Bio-Rad). Gels were prepared according to the manufacturers instructions, using 
the following buffer system: acrylamide/bis-acrylamide (30% (w/v) T, 2.7% (w/v) 
C)(National Diagnostics, Flowgen), resolving gel buffer (1.5 M Tris-HCl, pH 8 .8 , 0.4% 
(w/v) SDS), stacking gel buffer, (0.5 M Tris-HCl, pH 6 .8 , 0.4% (w/v) SDS), 10% (w/v) 
ammonium persulphate (APS) (Bio-Rad) and N,N,N,N’ -tetramethylethylenediamine 
(TEMED) (Bio-Rad). For both systems the resolving gels (lower gel) were made to 
0.375 M Tris-HCl, pH 8 .8  and 0.1% (w/v) SDS, with acrylamide concentrations in the 
range of 7-15%. Stacking gels (upper gel) were made to 0.125 M Tris-HCl, pH 6 .8  and 
0.1% (w/v) SDS with acrylamide concentration of 6 %, (or 4% when using < 7% 
resolving gel). Polymerisation was initiated by the addition of TEMED and APS, both 
to 0.05% (v/v) (final concentration). The electrophoresis buffer was 25 mM Tris-HCl, 
pH 8.3, 192 mM glycine, 0.1% (w/v) SDS. Large gels were run at constant current (25
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mA through the stacking gel and 35 mA through the resolving gel for 1.5 mm gels) for 
approximately 6  h until the bromophenol blue tracking dye had just run off the gel or 
overnight at 12 -15 mA. Minigels were run at a constant 180 V for approximately 60 
min.
Molecular weight markers were either High Molecular Weight markers (HMW 
markers) (Sigma) consisting of myosin (205 kDa), P-galactosidase (116 kDa), 
phosphorylase b (97.4 kDa), bovine albumin ( 6 6  kDa), ovalbumin (45 kDa) and 
carbonic anhydrase (29 kDa), or Broad range Protein markers (BMW markers) (New 
England BioLabs) consisting of myosin (212 kDa), MBP-P-galactosidase (158 kDa), P- 
galactosidase (116 kDa), phosphorylase b (97 kDa), serum albumin ( 6 6  kDa), glutamic 
dehydrogenase (55.6 kDa), maltose binding protein 2 (42.7 kDa), lactate dehydrogenase 
(36.4 kDa), triose phosphate isomerase (26.6 kDa), trypsin inhibitor (20 kDa), lysozyme 
(14 kDa), aprotonin (6.5 kDa) and insulin A, B chain (2.3-3.4 kDa)
2.9.2 Electrophoretic Transfer of Proteins to Nitrocellulose
SDS-polyacrylamide gel electrophoresis was carried out in the conventional manner. 
The stacking gel was removed and the resolving gel placed in continuous Transfer 
buffer, (39 mM glycine, 48 mM Tris base, 0.0375% (w/v) SDS and 20% (v/v) 
methanol, pH 8 .8 ). Proteins were transferred using a Multiphor II NovaBlot 
electrophoretic transfer unit (Pharmacia LKB Biotechnology) by the semi-dry transfer 
method. Briefly, nine pieces of Whatman paper (3mm) (Munktell, Pharmacia Biotech) 
were soaked in Transfer buffer, pH 8 .8 , and placed at the anode of the transfer 
apparatus. A nitrocellulose sheet (Gelman Sciences, 45 pM pore size) soaked in 
Transfer buffer, was placed on the stack, followed by the gel. The final 9 sheets of filter 
paper were placed on the gel and the cathode placed on top of the stack. A fixed current 
(equivalent to the surface area of the gel ((cm2) x 0 .8 )) was applied for a period of 1 h 
and 50 min. After which the electric current was turned off and the gel was placed in 
coomassie blue stain {Section 2.9.4) to check that the transfer was complete. The 
nitrocellulose filter was rinsed in water before staining with Ponceau S (0.1% (w/v) 
Ponceau S in 3% (v/v) trichloroacetic acid,) for 1-2 min to visualise protein bands. The 
positions of the molecular weight markers were recorded.
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2.9.3 Western Blotting
The nitrocellulose membrane was rinsed briefly in Transfer buffer pH 8 .8  to completely 
re-hydrate it, then washed in Tris-buffered saline buffer (0.09% NaCl, 1M Tris-HCl, pH 
7.4) containing Tween-20 at a final concentration of 0.1% (v/v) (TBS-T) to remove the 
Ponceau S stain. The membrane was then placed in blocking solution consisting of 5% 
(w/v) dried skimmed milk powder in TBS-T, and incubated with gentle rocking for 30- 
60 min at room temperature or overnight at 4°C. This procedure blocks non-specific 
binding. The nitrocellulose was rinsed in TBS-T and incubated with the primary 
antibody, at the required dilution, (Table 2.1) in TBS-T containing 1% (w/v) BSA, for 
60-90 min at room temperature. After extensive washing in TBS-T, the nitrocellulose 
was incubated for 30 min at room temperature with the secondary antibody at the 
required dilution (Table 2.2) in blocking solution. Once again the membrane was 
washed extensively.
Bands were visualised using enhanced chemiluminescence (ECL) or ECL Plus as 
described by the manufacturers (Amersham Pharmacia Biotech), and exposed to
TTtVT TWTautoradiography film (Hyperfilm ECL , Amersham Pharmacia Biotech.) until an 
image was apparent upon developing. In experiments where protein bands were 
quantified by densitometry, multiple exposures of the blots were performed to ensure 
that the analysis was performed in the linear range of signal densities.
2.9.4 Coomassie Blue Staining
Protein bands were visualised by staining with Coomassie brilliant blue reagent (0.2% 
(w/v) Coomassie blue R-250 in 10% (v/v) glacial acetic acid, 30% (v/v) MeOH, 60% 
(v/v) ctt^O) for 1 h, followed by destaining (30% (v/v) MeOH, 10% (v/v) glacial acetic 
acid, 60% (v/v) distilled H2O). The gels were dried at room temperature between two 
layers of Biotrace membrane presoaked in destaining solution containing 8.7% (v/v) 
glycerol.
2.9.5 BCA Protein Determination
Protein concentrations were determined by the Pierce bicinchoninic (BCA) method of 
protein determination. The standard curve was made with 1-10 pg of BSA solution (1
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mg/ml stock in 0.1 M NaOH) in 10 \x\ of 0.1 M NaOH prepared in a Microtitre plate 
(Labsystems, Helsinki, Finland). Reagent A (1% BCA-NO2, 2% NaCCb.^O, 0.16% 
Na2tartarate, 0.4% NaOH, 0.95% NaHCCb) and Reagent B (4% (w/v) C11SO4.5 H2O) 
were mixed in the ratio 50:1 and 200 \x\ of this working solution was added to each of 
the standards, and to the samples. The plate was incubated at 37°C for 20 - 30 min or 
until sufficient colour development was apparent. The plate was read at 595 nm in a 
microplate spectrophotometer.
2.9.6 Data Analysis
Graphical data was plotted using GraphPad PRISM version 3.0, (GraphPad Software, 
Inc.,). Statistical analysis was carried out using the PRISM programme with paired 
one- and two- tailed t tests as indicated in the figure legends. Densometric analysis was 
performed using Molecular Analyst™/PC version 1.5, (Bio-Rad Laboratories).
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3.0 Development of an Isolation Protocol for the Preparation 
of Insulin Sensitive Cardiac Myocytes
Studies of cells in suspension offer a number of advantages over whole organ 
experiments. In particular vascular factors are eliminated, cells are subject to 
homogenous environmental conditions and manipulation and control of the 
experimental conditions is facilitated. A plethora of methods has been available for 
isolating cardiomyocytes for many years. However most of these methods are hindered 
by the inability of isolated myocytes to remain viable in buffers containing 
physiological concentrations of Ca2+. Moreover the study of glucose transport in 
functionally intact cardiomyocytes, as in adipocytes, is complicated by their sensitivity 
to the actions of unspecific factors during the isolation procedure and subsequent 
manipulation (Fischer et al., 1991).
Most studies of glucose transport in isolated cardiomyocytes have reported an insulin- 
stimulated increase in glucose transport of 1.5 to 3-fold over control values (Lindgren et 
al., 1982; Eckel et al., 1983; Chen et a l, 1985; Shanahan et a l, 1986). However this 
hormone stimulates the rate of glucose transport in perfused rat heart by 6  to 8 -fold 
(Zaninetti et a l, 1988). Moreover in skeletal muscle preparations and in adipocytes 
isolated under carefully controlled conditions insulin has been shown to stimulate 
glucose transport by up to 20- and 40-fold respectively (Whitesell and Abumrad, 1985; 
Zorzano et a l, 1986; Ploug et a l, 1987; Okuno and Gliemann, 1987). To date, only 
two methods have been published which claim to yield cardiomyocytes which are 
highly responsive to insulin (Haworth et a l, 1984; Fischer et a l, 1991). Using these 
methods as a starting point, a cardiomyocyte isolation procedure was set up in our 
laboratory.
Myocytes are the cells most commonly isolated from the adult heart, in which they 
comprise approximately 2 0 % of the total cell number and 80% of the total cell mass 
(Jacobson and Piper, 1986). Ventricular cardiomyocytes can be identified by their 
elongated shape, cross-striations and mass of myofilaments. These cells tend to be 
irregular in shape with many branched protrusions and typically exhibit a rod-like 
morphology (Figure 3.1 A, green arrow). Cells which do not survive the isolation 
procedure ‘round up’ and lose their structural integrity {Figure 3.1A, blue arrows). At
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Figure 3.1 Isolation of Rod-Shaped Cardiomyocytes. Cardiomyocytes were isolated 
using a procedure originally described by Fischer and colleagues (Fischer et al., 1991), with some 
further modifications. Following rapid removal, the heart was perfused with a KRH buffer to wash out 
blood and metabolites from the chambers. The perfusion buffer was then switched to one containing 
collagenase and hyaluronidase to digest the tissue. Following a period of perfusion, the heart was 
removed from the apparatus and further digestion was carried out in a waterbath. A. Viable cells 
display a rod-shaped morphology (indicated by the green arrow), while dead cells ‘round up’ (indicated 
by the blue arrows). B. A magnified view of a single cardiomyocyte (x 40), showing complex 




high magnification the irregularity of a typical cardiomyocyte can be clearly seen 
{Figure 3. IB). In this figure parts of the myocyte appears blurred, being out of the focal 
plane, while other regions have a sharp distinct appearance. Myocytes isolated from rat 
heart are usually binucleate, although a single nucleus is seen in approximately 2 0 % of 
cells and this is strain and species specific. Heart muscle cells range in length from 35 
to 130 |liM  and in width from 12 to 30 pM, although cells as wide as 90 pM have been 
documented (reviewed in Dow et al., 1981).
3.1 Testing Conditions Required for Efficient Insulin-Stimulated 
Glucose Transport
In order to isolate a population of viable, insulin sensitive cardiomyocytes, a number of 
variables were examined in detail, and shall be discussed here. The basic isolation 
protocol consisted of washing the blood and metabolites from the heart by retrograde 
perfusion via the aorta (with Buffer A) as originally described over 100 years ago 
(Langendorff, 1895) {Figure 3.2). The heart was then exposed to a perfusion buffer 
containing proteolytic enzymes (Buffer B). Once the tissue was soft it was removed 
from the catheter and treated mechanically (in Buffers B and C) to disperse the cells. 
This method results in the isolation of a larger number of cells that immersing small 
chunks of myocardial tissue directly into the dissociating buffer (Piper et al., 1990). 
The cells were then washed in Buffers D and E to remove proteolytic enzymes and non- 
viable cells. The viability of the preparation was assessed by examining the numbers of 
rod-shaped (living) versus spherical (dead) myocytes by light microscopy. This simple 
test has been suggested to be more reliable than the exclusion of dyes such as trypan 
blue in adult ventricular myocytes (Nag et al., 1983; Cheung et a l, 1985).
(i) Choice of Collagenase
Bacterial collagenase is common to nearly all methods of cell isolation (Dow et a l, 
1981). Interestingly crude collagenase is more effective than the purified enzyme in 
digesting heart tissue indicating that a combination of collagenases (e.g. collagenase A- 
a  and collagenase B-a) and contaminating proteolytic enzymes are required. These 
proteolytic enzymes are responsible for cleaving the external connections that hold the 
cardiomyocytes together, however they may also damage the cell themselves. 
Therefore the use of such reagents should be minimised, being just long enough to
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permit digestion of the extracellular matrix, but not so long as to damage the cell itself. 
Since optimal combinations of proteolytic enzymes have yet to be described, 
commercially available crude enzyme preparations were tested for yield and viability of 
isolated myocytes. However the isolation of large numbers of myocytes was not the 
only criteria tested, as trace elements in crude collagenase preparations, such as metals 
and trypsin can stimulate basal levels of glucose transport (Fischer et a l, 1991). As 
such, batches were tested for their suitability with respect to insulin stimulation of 
glucose transport in isolated myocytes, as well as to the speed of the digestion and the 
yield of myocytes obtained.
(ii) Duration of the Isolation Procedure and Minimising Temperature Changes
A quick preparation is required to minimise the time when oxygen and substrate 
supplies are interrupted. However during the perfusion step itself a normal supply of 
oxygen and substrates cannot be maintained. This is because the microvascular bed is 
rapidly dissolved, abolishing the normal microcirculation. Thus tissue dissociation 
should be as rapid as possible. A tail vein injection of heparin was found to markedly 
improve the success rate of the cellular isolation and improved the insulin: control ratio, 
presumably as a result of its ability to inhibit blood clot formation and therefore to 
prevent anoxia/ischemia within the heart chambers. The heparin injection also aided the 
speed of the digestion, decreasing the time when energy supplies were limited.
During the isolation procedure and subsequently, care was taken to avoid changes in 
temperature which are known to increase the basal rate of glucose transport in rat 
adipocytes (Whitesell and Abumrad, 1985; Okuno and Gliemann, 1987). Thermal 
equilibration of the perfusate buffer at 37°C was assured by a water-jacketed delivery 
system. The mounted heart was also encased in a water jacket maintained at 37°C 
(Figure 3.2).
Figure 3.2 Schematic Diagram of a Heart Perfusion Apparatus. Buffer is gassed with oxygen and circulated via a peristaltic pump through a perfusion 
chamber where it is warmed to 37°C. The buffer then enters the heart which is mounted on a catheter and surrounded by a 37°C water jacket. Digestion of the heart is 














(iii) The Re-introduction of Calcium (The Calcium Paradox)
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Cell cohesion depends upon the presence of calcium. Therefore during the isolation of 
myocytes it is necessary to remove almost all of the perfusate calcium in order to cause 
cell separation. However when physiological concentrations of calcium are re­
introduced the cells are intolerant, and round up. This is known as the ‘calcium 
paradox’. A number of factors have been proposed to be responsible for this. These 
include transient leaking from the sarcolemma, low Ca2+ in the perfusate that favours 
hyperpermeability and ischemic conditions which may reduce the activity of 
sarcolemmal ion pumps (Piper et a l , 1990). These conditions lead to an increase in the 
intracellular Na+ concentration during the perfusion. Upon re-addition of Ca2+, 
Na+/Ca2+ exchange leads to rapid Ca2+ overload and this inhibits relaxation processes 
that are normally initiated when Ca2+ dissociates from troponin binding sites. This in 
turn leads to hypercontracture and deterioration of the cells (Altschuld et al., 1980; 
Haworth et al., 1982), due to separation of the intercalated discs and of the basement 
membrane and plasma membrane components of the sarcolemma. Such gross loss of 
cellular architecture explains the irreversibly of the paradox.
In order to avoid the calcium paradox traces of calcium must remain in the perfusion 
buffer, and the buffer and cells should be kept warm in order to promote the efflux of 
intracellular Na+. Usually there is no need to add addition Ca2+ to the perfusate buffer 
as some calcium is already present. This Ca2+ comes from endogenous Ca2+, Ca2+ in the 
collagenase, Ca2+ in the albumin and in the salts. Potassium is also required in the 
perfusate to ensure recovery from the calcium paradox, (consistent with the observation 
that hypokalemia produces myofibrillar contractions and the appearance of myofibrillar 
insertion plaques at the intercalated discs (Emberson and Muir, 1969)). In addition 
magnesium can protect against contracture and sustain the phosphocreatine 
concentration (Dow et al., 1981).
Early restoration of Ca2+ is beneficial. Haworth and colleagues found that addition of 
Ca2+ to the recirculating perfusate after 10 min of Ca2+-free perfusion had no effect on 
cell mortality and resulted in the isolation of a higher number of Ca2+-tolerant cells 
(Haworth et al., 1989). Therefore a stepwise re-calcification was performed, beginning 
at a relatively early stage of the perfusion (after approximately 15 min of tissue 
digestion).
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Cells which become hyperpermeable or ‘leaky’ may contract spontaneously due to the 
flow of ions across the damaged sarcolemma (Dani et al., 1979). This contraction has a 
phasic property passing down the cells in a wave-like manner (Reiser et al., 1979), in 
contrast to the beat induced by electrical stimulation which is characterised by 
synchronous, uniform sarcomere shortening (Krueger and Wittenberg, 1979). The 
myocytes prepared using our isolation protocol do not beat spontaneously even in the 
presence of 1 mM Ca2+. However they can be induced to contract by stimulation in an 
electrical field {Section 3.4). This indicates the presence of a membrane potential in the 
quiescent state, and demonstrates that the cells are viable and intact.
(iv) Use of BDM
2,3-butanedione monoxime (BDM) is a nucleophilic agent which has been used as a 
component of cardioplegic solutions (Mulieri et al., 1989). It possesses a ‘phosphatase­
like’ activity and induces a rapid, dose-dependent and reversible abolition of the 
cytosolic continuity existing between cells via gap junctional channels (Verrecchia and 
Herve, 1997). Furthermore BDM has been shown to inhibit Ca2+ (Coulombe et al.,
1990), Na+ (Sada et a l, 1985) and K+ (Lopatin and Nichols, 1992) currents. Indeed 
treatment of frog skeletal muscle with BDM causes the release of Ca2+ from the 
sarcoplasmic reticulum (Horiuti et al., 1988). The actions of BDM may be through the 
dephosphorylation of cellular phosphoproteins such as ion channels and connexins at 
gap junctions. Thus BDM may protect against the calcium paradox by inhibiting ion 
channels during the isolation procedure. Therefore consistent with the method of 
Fischer and colleagues (Fischer et a l, 1991), BDM was added to Buffers B and C.
(v) Choice of Albumin (Use of Fatty Acid Free BSA)
Some albumin batches are harmful to cells and others stimulate basal glucose transport 
in myocytes (Fischer et a l, 1991). This is consistent with observations made in rat 
adipocytes (Okuno and Gliemann, 1987). Thus albumin batches were tested for their 
suitability to isolate insulin-responsive adipocytes and these batches were used in 
Buffers B to D for the isolation of cardiomyocytes. A further complication in choosing 
an albumin batch for use in the isolation of insulin-responsive cardiomyocytes is that 
free fatty acids found in albumin preparations can acutely inhibit glucose utilisation in 
cardiac muscle in vivo (Jenkins et a l, 1988). Minimal basal transport rates have been 
reported in the presence of fatty acid free bovine serum albumin from Boehringer
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(Fischer et al., 1991). However due to the expense of this reagent it was used in the 
final buffers only (Buffers E and F), in which cells were allowed to recover following 
the isolation procedure and in which glucose transport assays were performed.
Initial experiments were performed as closely as possible to the method described by 
Fischer and co-workers (Fischer et al., 1991) with some small modifications due to the 
lack of facilities. For example, instead of an orbital shaker, cells were dispersed in a 
shaking water bath in glass vials connected directly to an oxygen supply by means of 
small blunt-ended needles. Following isolation cells were allowed to recover from the 
procedure for 30 min at 37°C. The cells were then washed once in Buffer F (which did 
not contain glucose or pyruvate), then either left untreated (basal) or treated with 30 nM 
insulin for 30 min at 37°C. Following this incubation 100 pM 2-deoxy-D-glucose plus 
a tracer of 2-deoxy-D-[3H]-glucose was added to the cells and glucose uptake was 
measured over a period of 10 min. Glucose transport was terminated by the addition of 
phloretin. In early experiments only a small increase in the insulin:basal ratio was 
observed {Figure 3.3A, blue panels). Many of the cells appeared round, and the yield of 
myocytes was relatively low being of the order of 2 x 106 cells.
3.1.1 The Effects of Trypsin
It has been reported that cells are more tolerant to Ca2+ when trypsin is added during the 
final stages of tissue digestion (Haworth et al., 1989). Several reasons have been 
reported to explain this observation. Firstly, the number of damaged cells can be 
reduced by the addition of trypsin since damaged cells are more quickly digested than 
intact cells. Secondly it has been shown that the gap junctions of Ca2+-susceptible cells 
often retain shreds of junctional regions from the cells with which it was formerly 
contiguous (Fry et al., 1979). These unseparated gap junctions, which are exposed to 
the external buffer, may be sites of Ca2+ entry. Thus trypsin may remove these 
membrane shreds enabling gap junctions to close. Thirdly and as already mentioned 
Ca2+ susceptibility may be due to a high concentration of internal Na+ which gives rise 
to a high rate of Ca2+ uptake following its re-introduction (Altschuld et a l, 1980). 
Addition of trypsin at the same time as Ca2+ has been shown to aid in the retention of K+ 
(Haworth et al., 1982). Furthermore leaking of Na+ and K+ is at a much lower rate in 
trypsin treated cells than in untreated cells (Haworth et a l, 1982). Thus it has been 
suggested that the levels of intracellular Na+ in trypsin-treated cells are lower than those
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in control cells (Haworth et a l , 1982) and this results in the isolation of a greater 
number of ‘calcium-tolerant’ cells.
In order to ascertain whether the loss of cell viability in early cell isolations was due to 
the calcium paradox, trypsin was added to Buffer C at a concentration of 2 mg/ml. 
Since tryptic digestion of insulin receptors has been reported (Eckel, 1989), the cells 
were only incubated with the enzyme for a short period before the reaction was 
terminated by the addition of Buffer D containing 10 pg/ml trypsin inhibitor. Following 
isolation the cells were again incubated at 37°C for 30 min, before glucose uptake was 
determined using 2-deoxy-D-glucose (Figure 3.3A, yellow panels). Trypsin increased 
the yield and calcium tolerance of the myocytes but also increased the basal glucose 
transport. This is consistent with earlier findings (Haworth et al., 1984).
3.1.2 The Effects of Hyaluronidase and DNAse
Hyaluronidase has been used by a number of authors in combination with collagenase to 
aid the digestion of cardiac tissue (Haworth et a l , 1982; Jacobson and Piper, 1986). 
This raises the possibility that N-acetylglucosamine-glucuronic acid polymers are major 
inter-myocyte molecules. Thus hyaluronidase was added to the dissociating buffer 
(Buffer B). Addition of hyaluronidase resulted in a marked increase in the number of 
cells isolated (6-8 xlO6 cells/heart). This increase in cell number was probably due to a 
decrease in the time of the perfusion and hence a decrease in the time in which 
substrates and oxygen are limited. However some batches of cells appeared ‘sticky’ and 
rapidly formed clusters. This made them difficult to handle in suspension. This 
‘stickiness’ was due to the release of DNA from damaged cells. Thus the cells were 
incubated with deoxyribonuclease (DNAse), which prevented the clumping from 
occurring. The combination of hyaluronidase and DNAse decreased the need for 
excessive mechanical agitation to fully disperse the cells. The decreased mechanical 
stimulation and the rapid perfusion of the heart resulted in an increase in insulin- 
stimulated glucose transport to a level which was approximately 1.9-fold higher than 
control values (Figure 3.3B, red panels).
Figure 3.3 The Effects of Trypsin, DNAse and Hyaluronidase on Insulin-Stimulated Glucose Transport in Cardiomyocytes. Cardiomyocytes 
were prepared as described in Sections 3.1.1 and 3.1.2. Following isolation, cells were allowed to recover from the procedure by incubation at 37°C for 30 min with continuous 








© -  
8 1



















B asal Insulin B asal Insulin B asal Insulin B asal Insulin
- Trypsin + Trypsin - DNAse I 
Hyaluronidase




A small decrease in the level of mechanical agitation appeared to increase the viability 
of the myocytes and increase their susceptibility to insulin, consistent with earlier 
findings in rat adipocytes (Whitesell and Abumrad, 1985; Okuno and Gliemann, 1987). 
Thus all steps which involved a level of mechanical stimulation were examined and it 
was decided to attempt to eliminate all centrifugation steps from the isolation protocol. 
One difficulty caused by the removal of the centrifugation steps was how to enrich the 
myocyte preparation with rod-shaped cells and remove dead myocytes. The study of 
cell responses to regulatory processes such as insulin stimulation can be severely 
complicated by the presence of damaged cells in the preparation, which distort the 
results. The enrichment of rod-shaped cells was achieved by the addition of a series of 
steps in which the cells were allowed to settle by gravity through an albumin-rich buffer 
(Buffers D and E). The dead cells that remained floating were aspirated and the 
remaining cells were resuspended. 70-80% of the cells isolated using this method were 
rod-shaped. Furthermore insulin-stimulated glucose transport measured by the uptake 
of 2-deoxy-D-glucose was increased to 4.1-fold over unstimulated controls (Figure 
3.4A, green panels).
3.1.4 The Effects of Inosine
In order to ensure that the levels of intracellular ATP were maintained during the 
isolation procedure, inosine was added to all of the buffers as an alternative energy 
source. This reagent has been previously used as an energy substitute in models of 
insulin resistance in cell culture (Hresko et al., 1998). The use of inosine resulted in an 
increase in cell viability and ‘robustness*. Measurements of insulin-stimulated glucose 
transport in myocytes isolated in the presence of inosine revealed an increase in glucose 
uptake of 11.2-fold over basal controls (Figure 3.4B purple panels).
The results of the 2-deoxy-D-glucose transport assays are shown in Table 3.1. It is clear 
from this data that the increases in glucose transport in insulin-stimulated cells over 
unstimulated controls are due entirely to a reduction in the levels of basal transport. No 
change in the level of insulin stimulation was achieved, consistent with earlier studies in 
cardiomyocytes (Fischer et a l 1991).
Figure 3.4 The Effects of Centrifugation and Inosine on Insulin-Stimulated Glucose Transport in Cardiomyocyte. Cardiomyocytes were 
prepared as described in Sections 3.1.3 and 3.1.4. Following isolation, cells were allowed to recover from the procedure by incubation at 37°C for 30 min with continuous 0 2 
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Table 3.1 Insulin-Induced Increases in Glucose Transport in Isolated 








Mean s.e.m. Mean s.e.m.
No additions 0.045 0.004 0.062 0.003 1.4
Trypsin 0.050 0.015 0.054 0.014 1.1
; DNAse/ 
Hyaluronidase
0.027 0.003 0.051 0.005 1.9
Centrifugation
0.014 0.002 0.057 0.002 4.1
Inosine 0.005 0.002 0.056 0.005 11.2
3.1.5 Insulin-Stimulated Glucose Transport is Linear and is Sensitive to 
Cytochalasin B
Cytochalasin B is a potent inhibitor of glucose transport (Lindgren et a l, 1982). Since 
it is hydrophobic (Figure 3.5A, top panel) it can pass through the plasma membrane 
interacting with the endofacial glucose binding sites of transporters both at the cell 
surface and within the cell. Cytochalasin B is therefore a useful reagent for assessing 
the concentration of 2-deoxy-D-glucose that is taken up into cells in a non-specific 
manner. Thus following isolation, cells were either left untreated (basal), or treated 
with 30 nM insulin for 30 min. Prior to the addition of the 2-deoxy-D-glucose, the cells 
were split into aliquots and some were treated with 10 jliM  cytochalasin B for 5 min. 2- 
Deoxy-D-glucose transport was then measured over a period of 30 min.
Cytochalasin B inhibited both basal and insulin-stimulated glucose transport. The rate 
of transport in cytochalasin B-treated cells was equivalent to approximately 30% of the 
rate of transport in basal cells {Figure 3.5A). The level of 2-deoxy-D-glucose transport, 
when the non-specific uptake of sugar was considered, is shown in Figure 3.5B. These 
experiments also showed that glucose transport is linear in cells obtained by this
Figure 3.5. The Effect of Cytochalasin B on Basal and Insulin Stimulated Glucose Transport in Cardiomyocytes. Cardiomyocytes were prepared 
as described in Methods 2.2.3. Following isolation, cells were allowed to recover from the isolation procedure by incubation at 37°C for 30 min with continuous 0 2 gassing. 
Cells were then stimulated with 30 nM insulin for 30 min at 37°C or were left untreated (basal). The cells were then split into two aliquots and one aliquot from each condition 
was treated with 10 pM cytochalasin B for 5 min before the addition of 2-Deoxy-D-[3H]-glucose. 2-Deoxy-D-[3H]-glucose uptake was performed as described in Methods 
2.4.2. A. Transport data from all four condition namely basal (• ) , insulin (• ) , basal + cytochalasin B ( • )  and insulin + cytochalasin B (• ) . B. Shows the same data but with 
the cytochalasin B data subtracted from the respective basal ( • )  and insulin ( • )  samples. The structure of cytochalasin B is shown in the grey panel.
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modified isolation procedure (without inosine) over a period of at least 30 min (Figure
3.5).
3.2 Photolabelling Cardiomyocytes with Bis-Mannose Photolabels
3.2.1 The Use of ATB-[3H]-BMPA
Since its first report, ATB-[3H]-BMPA (Figure 3.6A, top panel) has been used 
extensively to study the properties of glucose transporter isoforms. The photolabel 
displays a high affinity for the erythrocyte glucose transporter GLUT1 (with a Ki of 
approximately 300 pM) as well as for the insulin sensitive isoform GLUT4 (the Ki for 
basal and insulin-stimulated glucose transport in rat adipocytes is 247 pM) (Holman et 
al., 1990). Furthermore, the photolabel is cell impermeant and therefore only labels cell 
surface glucose transporters.
To assess whether the changes induced by insulin on glucose transport were due to 
changes in the levels of glucose transporters at the plasma membrane, cells (isolated in 
the absence of inosine) were transferred to petri-dishes and mixed with 18.5 MBq of 
ATB-[3H]-BMPA (the final concentration of the label was 100 pM). The cells were 
then irradiated for 3 min in a photoreactor with 350 nm lamps, then washed to remove 
unbound tritiated label, solubilised in a detergent buffer and subjected to isoform 
specific antibody immunoprecipitation with antibodies against GLUT1 and GLUT4. 
The precipitates were resolved by SDS-PAGE, and the gel was sliced into 0.66 cm 
slices. The slices were dried and solubilised in a solution composed of H2O2 and NH3 at 
80°C. The solubilised gel slices were allowed to cool, then scintillant was added and 
the radioactivity was determined using a scintillation counter.
Using this method a single broad peak was observed at approximately 45 kDa for both 
GLUT1 (Figure 3.6A) and GLUT4 (Figure 3.6B). These peaks could be abolished by 
the addition of 500 mM D-glucose with the photolabel (data not shown) and were 
therefore determined to represent GLUT1 and GLUT4 protein labelled at the cell 
surface. As expected, upon insulin stimulation an increase in the incorporation of the 
photolabel was observed, suggesting an increase in glucose transporters at the cell 
surface. The insulin-stimulated translocation of GLUT1 and GLUT4 to the cell surface 
was approximately 2-fold and 3.5-fold respectively (Figure 3.6).
Figure 3.6 Photolabelling Cardiomyocytes with ATB-[3H]-BMPA. Cardiomyocytes were prepared as described in Methods 2.2.3. Following isolation the 
cells were either left untreated ( • )  or treated with 30 nM insulin ( • )  for 30 min at 37°C. Cells were then transferred to petri-dishes and photolabelled with 18.5 Mbq ATB-[3H]- 
BMPA. Cells were washed and solubilised in a Thesit detergent buffer. Following solubilisation glucose transporters were immunoprecipitated on protein A sepharose beads 
coupled with either anti-GLUTl antibodies (A) or anti-GLUT4 antibodies (B). The precipitates were washed, eluted and resolved by SDS-PAGE. The resulting gel was dried, 
sliced and solubilised in a H20 2/NH3 solubilisation buffer. Liquid scintillant was added and the radioactivity was counted in a Packard 1600 TR scintillation counter. The 
structure of ATB-BMPA is shown in the grey panel
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3.2.2 The Use of Bio-lc-ATB-BMPA
One of the disadvantages of the original bis-mannose derivatives is their dependence on 
radioactivity as the mode of detection. A problem associated with this is that despite 
the efficiency of the photolabel to crosslink to the transporter, (approaching 100%), 
only a small fraction of the total label added to a solution occupies the binding site (this 
is because of the relatively low affinity of the hexose analogues for the binding site). 
Therefore, large quantities of tritiated compound have to be added to solutions and 
extensive washings of cells and membranes have to be performed in order to reduce the 
background radioactivity. Thus new cell-impermeant bis-mannose photolabels have 
now been developed with biotinyl groups attached to ATB-BMPA by a hexanoic acid 
spacer (Bio-lc-ATB-BMPA) {Figure 3.7A). The Ki value for the inhibition of glucose 
transport activity in insulin-stimulated rat adipocytes using the new photolabel is very 
similar to that previously reported for ATB-[3H]-BMPA, being 273 ± 28 jliM  
(Koumano vetaL,  1998).
Thus photolabelling of cardiomyocytes (isolated with inosine) was performed exactly as 
described for the ATB-[3H]-BMPA photolabel, except that the final concentration of the 
label was 500 pM and a 50:50 mixture of 350 nm and 300 nm lamps were used for 1 
min. Following UV irradiation-induced cross-linking, the biotinylated glucose 
transporters were detected utilising the interaction of the biotin moiety for streptavidin 
molecules. Thus myocytes were solubilised in a detergent buffer and biotinylated 
transporters were precipitated on streptavidin beads. The resulting precipitates were 
analysed by SDS-PAGE and Western blotting with antibodies against GLUT4. An 
aliquot of cells irradiated without photolabel (unlabelled), solubilised and precipitated 
on streptavidin beads was run as a control. No bands were detected in this lane of the 
Western blot {Figure 3.7A). In contrast a single band migrating just above the 45 kDa 
marker was observed in both the basal and insulin-stimulated cardiomyocyte samples 
which had been photolabelled. Insulin increased the level of cell surface GLUT4 by 
approximately 5.4-fold as judged by densitometry {Figure 3.7B).
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Figure 3.7 Photolabelling Cell Surface GLUT4 in Cardiomyocytes using Bio-lc- 
ATB-BMPA. Cardiomyocytes were prepared as described in Methods 2.2.3. Following isolation 
cells were either left untreated (B) or treated with 30 nM insulin for 30 min (I). Cells were transferred 
to petri-dished and photolabelled with 500 jiM Bio-lc-ATB-BMPA (shown in A, top panel). Some cells 
were irradiated without photolabel (U). Cells were washed and solubilised in Thesit detergent buffer. 
Following solubilisation, biotinylated glucose transporters were precipitated on streptavidin beads. The 
precipitates were washed, eluted and resolved by SDS-PAGE. The resulting gel was transferred to 
nitrocellulose and Western blotted with antibodies against GLUT4 (A). The Western blot was analysed 















3.3 Confocal Microscopy of Basal and Insulin-Stimulated 
Cardiomyocytes
An immunocytochemical analysis of GLUT4 in cardiac myocytes was also performed. 
Cells were either left untreated or treated with 30 nM insulin for 30 min at 37°C. 
Cardiomyocytes were then fixed by incubation in 4% paraformaldehyde, followed by 
permeabilisation with 0.1% saponin. Cells were incubated with monoclonal mouse 
anti-GLUT4 antibodies for 1.5 h, then washed extensively before incubation with 
rhodamine-conjugated anti-mouse antibodies. Following this incubation the cells were 
washed again, mounted and viewed using a Zeiss laser scanning microscope.
As expected GLUT4 in basal unstimulated cells was predominantly intracellular 
(Figure 3.8A). The fluorescent pattern was particularly intense around the perinuclear 
region (indicated by the arrow), which probably represents the trans-Golgi network, or 
an endosomal sorting station. In addition, the pattern of GLUT4 staining was striated 
which may indicate that the transporters are bound to some sort of myofibril scaffold. 
Treatment of cells with insulin, resulted in a marked translocation of immunoreactive 
GLUT4 to the cell surface and periphery {Figure 3.8C), with a loss of labelling from 
around the nucleus. These results were confirmed using a different set of primary 
antibodies directed against the C-terminus of GLUT4. In this case the secondary 
antibodies were labelled with fluorescein {Figure 3.8B and D).
3.4 Contraction-Stimulated Glucose Transport in Cardiomyocytes
Stimulation of GLUT4 translocation to the plasma membrane of skeletal muscles has 
been suggested to occur by two mechanisms, one activated by insulin and insulin-like 
factors and the other activated by contraction and hypoxia (Hayashi et al., 1997). When 
these two pathways are stimulated simultaneously glucose transport and GLUT4 
translocation are increased in an additive manner (Lund et al., 1995). Insulin-stimulated 
glucose transport appears to be mediated at least in part by PI 3-kinase because it is 
inhibited by wortmannin (Clarke et a l , 1994). In contrast, contractile or hypoxia- 
mediated glucose transport are not affected by wortmannin (Lund et al., 1995; Yeh et 
a l, 1995).
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Figure 3.8 Analysis of the Distribution of GLUT4 in Cardiomyocytes.
Cardiomyocytes were isolated as described in Methods 2.2.3. The cells were then either left untreated 
(A, B) or treated with 30 nM insulin for 30 min (C, D). The myocytes were fixed with 
paraformaldehyde, permeabilised with saponin and probed with either mouse antibodies against GLUT4 
and rhodamine-conjugated secondary antibodies (shown in red) or rabbit antibodies against GLUT4 and 
fluorescein-conjugated secondary antibodies (shown in green). The samples were viewed using a Zeiss 






Figure 3.8 cont. Analysis of the Distribution of GLUT4 in Cardiomyocytes.
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Only one study has addressed the issue of contraction-stimulated glucose transport in 
isolated cardiac myocytes. Using field stimulation of adult ventricular cardiomyocytes 
the effect of contractile activity on 3-0-methyl-D-glucose uptake was addressed (Kolter 
et al., 1992). Cells that had been subjected to a contraction stimulus of 5 Hz for 5 min 
exhibited an increase in glucose transport of 224% over control values (Kolter et al., 
1992). However, somewhat controversially, insulin failed to produce a significant 
additional stimulation of glucose transport. Furthermore in a later study, the same 
group reported that treatment of cardiomyocytes with wortmannin completely blocked 
the contraction-induced stimulation of glucose transport, (Till et al., 1997), in contrast 
to established studies in skeletal muscle (Lund et al., 1995; Yeh et al., 1995).
To re-address the issue of whether cardiac muscle is indeed different to skeletal muscle 
with respect to contraction-stimulated glucose transport, a contraction chamber was 
developed (.Figure 3.9A and B). This chamber consisted of a perspex box with two 
platinum electrodes through which an electrical current was passed. The cell 
suspension was placed between the electrodes and stirred gently with a flea to allow for 
oxygen diffusion. The cells were stimulated with biphasic pulses (5 Hz, 150 V of 165 
ps duration) and viewed using a light microscope. Cells were quiescent in the resting 
state but contracted synchronously when an electrical current was passed between the 
electrodes.
A preliminary experiment {Figure 3.9C) revealed that contracting the cells at a 
frequency of 5 Hz for 5 min increased their glucose transport rates by 1.5-fold over 
controls. However the level of glucose transport in the basal cells in this experiment 
was particularly high and therefore the level of contraction-induced stimulation was 
probably underestimated. At present the reasons for this are unclear. Consistent with 
earlier results (Kolter et a l, 1992), the combined effects of 30 nM insulin and 
contraction (5 Hz for 5 min) did not significantly increase glucose transport above the 
levels induced by 30 nM insulin alone {Figure 3.9C). Subsequent preliminary 
experiments have revealed that shorter pulse times (under 30 sec) can also stimulate 
glucose transport and appear less damaging to the cells (data not shown).
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Figure 3.9 The Effect of Contraction on Glucose Transport in Cardiomyocytes.
Cardiomyocytes were prepared as described in Methods 2.2.3. Following isolation cells were either left 
untreated (basal), treated with 30 nM insulin for 30 min (insulin), stimulated for 5 min with a 5 Hz, 150 
V biphasic pulse of 165 p.s duration (contraction) or a combination of both 30 nM insulin and the 
contraction stimulus (insulin + contraction). 2-Deoxy-D-[3H]-glucose transport was measured as 
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3.5 Discussion
Although heart, skeletal muscle and adipose tissue are all insulin sensitive, the majority 
of studies of glucose transport and insulin action have been performed in adipocytes, 
(Whitesell and Gliemann, 1979; Suzuki and Kono, 1980; Cushman and Wardzala, 
1980). This is mainly due to the establishment of an effective protocol for the isolation 
of highly insulin responsive adipose cells that are relatively easy to manipulate under 
defined conditions. In contrast techniques to isolate functionally intact cardiac 
myocytes have been rather more difficult to establish for a number of reasons. For 
example, heart muscle cells are firmly connected to one another by intercalated discs 
and an established extracellular matrix (Piper et al., 1990). Indeed it took over 200 
years to resolve the debate as to whether the heart was catenary or syncytial, such is the 
nature of the close interactions between the cells (Dow et a l , 1981). Furthermore the 
cardiomyocyte is a large, rigid cell which is more easily damaged by mechanical impact 
than many other cell types (reviewed in Piper et a l, 1990). However a number of 
isolation protocols have now been documented and several of these have been 
characterised with respect to glucose transport (Lindgren et a l, 1982; Eckel et a l, 1983; 
Haworth et a l, 1984; Fischer et a l, 1991).
The isolated cardiomyocytes obtained by the modified procedure described in this 
chapter are calcium tolerant and highly responsive to insulin with respect to glucose 
transport. The stimulation observed upon treatment with maximally effective 
concentrations of hormone is higher than the effects reported by most groups and 
similar to those obtained by Haworth (Haworth et a l, 1984) and Fischer (Fischer et a l,
1991), upon whose methods the protocol was initially based (Table 3.2).
The high insulin : control ratio obtained in these myocytes is probably due to a 
relatively low basal level of transport, rather than a stronger response to insulin. Indeed 
the level of insulin stimulation remained constant, while basal transport was shown to 
decrease as the isolation protocol was optimised (Table 3.1). This is because 
methodological artefacts are more likely to accelerate hexose influx than to inhibit it 
(Haworth et a l, 1984).
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Table 3.2. Insulin-Stimulated Glucose Uptake: A Comparison of Published 
Studies.
Authors Insulin : Basal Ratio
(Lindgren et a l , 1982) 2 - 3
(Eckel et al., 1983) 1.5-1.8
(Chen et a l, 1985) 1.4-1.5
(Haworth et a l , 1984) *10
(Bihler et al, 1985) 1.7-2 .2
(Geisbuhler et al, 1987) *2.5
(Fischer etal., 1991) 8 - 2 0
This work 4 - 1 5
It has long been known that the use of appropriate chemicals and minimal mechanical 
agitation is important for the isolation of adipocytes with a low basal glucose transport 
rate (Whitesell and Abumrad, 1985; Okuno and Gliemann, 1987). This work indicates 
that these restrictions are also fundamental in the isolation of cardiomyocytes which can 
respond markedly to insulin. It is hoped that further manipulation of the isolation 
conditions may lead to the isolation of myocytes which are able to respond to insulin at 
a level approaching that observed in adipocytes.
Cytochalasin B -insensitive glucose uptake accounts for approximately 20-30% of the 
total non-inhibited basal glucose uptake in these cells. This is consistent with values 
obtained in adipocytes (Okuno and Gliemann, 1987; Suzuki, 1988). In adipocytes, this 
relatively high rate of cytochalasin B-insensitive glucose uptake is attributed both to the 
actions of non-mediated diffusion and to another transporter, possibly a fructose 
transporter (Okuno and Gliemann, 1987). This raises the possibility that this is also the 
case in cardiac myocytes.
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It is noteworthy that insulin-stimulated an increase in both the cell surface content of 
GLUT1 and GLUT4, consistent with previous studies (Fischer et a l, 1997). ATB-[3H]- 
BMPA incorporation was increased approximately 2-fold for GLUT1 and 3.5-fold for 
GLUT4. These values are slightly lower than those already reported (Fischer et a l, 
1997). A number of possible reasons can be proposed for this. Firstly, the myocytes 
were isolated without inosine (as this was discovered to be beneficial at a later stage). 
This may have increased the numbers of transporters at the cell surface under basal 
conditions consistent with results from the glucose transport assays (Table 3.1). 
Secondly the cells were irradiated for 3 min. This could lead to an increase in 
photolabelled transporters as they recycle between the plasma membrane and the 
internal membranes, distorting the ‘snapshot’ results. Later experiments employing the 
biotinylated photolabel Bio-lc-ATB-BMPA were performed on cells isolated in the 
presence of inosine. In this case the duration of the irradiation was reduced to 1 min 
and a shorter (and therefore stronger) UV wavelength was employed. Under these 
conditions the insulin: control ratio for GLUT4 labelling increased to 5.2-fold, similar 
to previous reports (Fischer et a l, 1997).
Immunocytochemical analysis of GLUT4 in isolated cardiomyocytes revealed that the 
transporter resides in an internal locus in the basal state. Upon insulin stimulation the 
insulin-sensitive transporter was found to translocate to the plasma membrane and the 
cell periphery. The pattern of staining was punctate and vesicular. The distribution of 
GLUT4 observed in our cardiomyocyte preparation supports studies performed in 
adipocytes (Slot et a l, 1991a) and cardiac muscle (Slot et a l, 1991b). In these cells the 
insulin-responsive glucose transporter is found in the trans-Golgi reticulum (TGR) and 
in an intracellular tubulovesicular compartment from where it undergoes insulin 
dependent movement to the cell surface (Rea and James, 1997).
Initial experiments have shown that contraction can also stimulate glucose transport in 
isolated cardiomyocytes. Future work could concentrate on the controversial 
observation that the contraction and insulin stimuli do not appear to be additive in 
cardiac myocytes (Kolter et a l, 1992; Till et a l, 1997). Trafficking in cardiac 
myocytes could be analysed by using biotinylated photolabels. Plasma membrane 
transporters from cells stimulated with insulin, with contraction or with a combination 
of both stimuli could therefore be tagged and the rate of loss of transporters from the 
cell surface measured by taking advantage of the biotin-avidin interaction {Figure
Biotinylated
photolabel
Figure 3.10 Method for Studying the Trafficking of GLUT4 in Insulin-Responsive Cells Cell surface GLUT4 is biotinylated using the photolabel Bio- 
PEG80. Avidin is then added at various timepoints. The cells are solubilised and the biotin label is detected. The longer the period between the photolabelling and the addition 
of avidin the higher the biotin signal. From measurements taken at various timepoints the rate of internalisation can be determined. Right hand panels show erythrocytes 
labelled with Bio-PEG80 and detected using fluorescein-conjugated anti-biotin antibodies (C). The detection of the photolabel is abolished by the addition of Neutravidin at a 
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3.10A, B). If the stimulatory effects of insulin and contraction are mediated via separate 
pools then the combined rates of decay of transporters from the cell surface should be 
the same as the sum of the individual decays. If the rate of decay is slower then this is 
indicative of transporter mixing. However if the insulin- and contraction-mediated 
signalling pathways are non-additive but there is upstream convergence of signalling, 
then it may be difficult to differentiate between the two pools using kinetic experiments.
Another approach is to address the issue of separate insulin and contraction pools at the 
morphological level using confocal microscopy. The highly organised nature of the 
myocyte lends itself perfectly to such an analysis. Thus a combination of anti-GLUT4 
and anti-biotin antibodies could be employed to detect any differences in the 
localisation of photolabelled glucose transporters that respond to insulin compared with 
those that are stimulated by contraction. In particular GLUT4 localisation could be 
compared to the markers giantin and the TfR, which were used to show that two distinct 
GLUT4 pools reside in skeletal muscle, one stimulated by insulin and one by exercise 
(contraction) (Ploug et a l, 1998). Initial experiments using erythrocytes labelled with
Bio-PEG80, a new photolabel with a long (500 A) spacer arm, have revealed the 
potential of such an approach. Here, photo-tagged erythrocytes could be detected with 
fluorescein-conjugated anti-biotin antibodies (Figure 3.10C), whereas the addition of 
0.2 mg/ml Neutravidin blocked this detection {Figure 3.10D).
In summary, the ability to isolate functionally intact, insulin responsive myocytes has 
provided a new model for the study of both insulin-regulated and contraction-regulated 
processes in our laboratory.
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4.0 The Role of Intracellular pH in the Regulation of Glucose 
Transport Activity and Glucose Transporter Translocation
4.1 Studies with the Sodium-Proton Pump Inhibitor HOE-642 
(Cariporide) in Cardiac Myocytes
Intracellular pH is controlled by two major ion transport mechanisms. In the presence 
ofH C03', intracellular pH (pH,) is regulated by the activation of CI/HCO3' and Na+/H+ 
exchange mechanisms whereas in the absence of HCCV, Na+/H+ antiport is the only 
mechanism available to regulate pHi by exchanging extracellular Na+ for intracellular 
H4 (Arsenis et a l , 1995). The Na4/ ^  antiporters (NHEs) are a family of proteins that 
are thus responsible for the regulation of cellular pH and volume (Grinstein and 
Rothstein, 1986). The most well characterised of these Na+/H+ pumps is NHE1. This 
pump is quiescent above a certain cellular pH and is activated by acidification of the 
cytosol. It is also activated by a variety of growth factors and hormones, and by 
hyperosmotic shrinking. Activation by these stimuli is mediated not by prior 
acidification of the cytosol but by an alkaline shift of the pH-dependence of the 
antiporter. This in turn leads to alkalinisation of the cytosol above the normal set point 
(Wakabayashi et al., 1997). Like many hormones, insulin activates the Na+/H4 
exchanger in a variety of cells, and this is one of the earliest responses of cells to insulin 
stimulation (Arsenis and Tarvin, 1986).
Amiloride is an inhibitor of Na+/H4 exchange. Early studies have shown that treatment 
of cells with amiloride not only inhibits insulin-induced alkalinisation of the cytoplasm, 
but also markedly reduces insulin-stimulated glucose transport into these cells (Klip et 
a l , 1986; Goto et a l , 1993). This occurs both by inhibition of GLUT4 translocation, 
and by a decrease in the ‘effectiveness’ of insulin on the insulin-signalling pathway 
(Goto et a l , 1993). However the actions of amiloride are not absolutely specific for 
Na+/H+ exchangers and as such it is difficult to assess whether the inhibition of glucose 
transport activity is as a direct consequence of Na+/H4 inactivation or mediated by 
secondary effects of the drug.
Recently the discovery of a new class of NHE inhibitors has allowed the re-examination 
of the involvement of Na+/H4 antiport in glucose transporter regulation. These
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compounds constitute a class of benzoyl guanidine derivatives which include the drugs 
HOE-694 and HOE-642 (Cariporide). These inhibitors have an affinity for NHE1 
which is two or more orders of magnitudes higher than for the isoforms NHE2 and 
NHE3 (Counillon et a l 1993b). Furthermore these compounds have recently been 
shown to inhibit NHE activity in perfused rat heart in vivo (Scholz et al., 1993; Scholz 
e ta l , 1995).
4.1.1 Changes in the Intracellular pH Assessed with the Acidotrophic Dye 
Acridine Orange
In order to study the effects of Na+/H+ exchange activity on glucose transport, 
cardiomyocytes were first analysed for changes in pH induced by insulin, and by 
inhibition of the NHE1 antiporter. Modulation of the intracellular pH induced by 
insulin and HOE-642 was analysed by vital staining with acridine orange. This dye is 
an acidotrophic weak base which is taken up by living cells and accumulates in acidified 
compartments. At low concentrations acridine orange fluorescence is green, however 
when allowed to accumulate the fluorescence changes to orange. When unstimulated 
cardiomyocytes were stained with 5 pg/ml acridine orange for 10 min at 37°C, the 
nuclei and in particular the nucleoli and the cytoplasm displayed green fluorescence, 
whereas orange/red fluorescence was observed in a granulated pattern dispersed within 
the cytoplasm. This distribution pattern suggests that the orange fluorescence is due to 
acidified lysosomes. Furthermore a compartment of intermediate acidity, which stained 
yellow was observed in the perinuclear region, and may represent an endosomal sorting 
station or the trans-Golgi network {Figure 4.1 A). Treatment of cardiomyocytes with 30 
nM insulin for 30 min at 37°C before addition of the acridine orange stain caused a 
complete disappearance of the orange fluorescence, whereas the green fluorescence 
remained, {Figure 4. IB). A small number of yellow compartments around the nucleus 
also remained. Addition of 20 pM HOE-642 for 10 min at 37°C, prior to the addition of 
insulin, resulted in a marked decrease in cytoplasmic pH, indicated by the yellow colour 
of the acridine orange stain {Figure 4.1C). The number and colour of the granular 
compartments within the cytosol was reminiscent of the unstimulated control cells 
{Figure 4.1A). This suggests that HOE-642 has blocked the activation of the Na+/Hf 
pump by insulin, resulting in a failure of the cell to increase the cytosolic pH.
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Figure 4.1 The Effect of HOE-642 on the Intracellular pH As Judged By Vital 
Fluorescence. Cardiomyocytes were prepared as described in Methods 2.2.3. The cells were either 
left untreated (A), treated with 30 nM insulin for 30 min (B), or treated with both 30 nM insulin and 20 
pM HOE-642 (C). The cells were then incubated for 10 min with 5 pg/ml acridine orange, then 
washed and mounted in Vectorshield. The cells were viewed using a Zeiss confocal scanning 








4.1.2 Inhibition of Insulin-Stimulated Glucose Uptake in Cardiac Myocytes 
Treated with HOE-642
To directly test whether NHE1 activity is necessary for the activation of glucose 
transport in response to insulin, the uptake of 2-deoxy-D-glucose into cardiomyocytes 
was analysed. Thus following isolation, cells were either left untreated (basal), treated 
with 30 nM insulin for 30 min, treated with 20 juM HOE-642 for 10 min or treated with 
a combination of both 20 pM HOE-642 and 30 nM insulin. All samples were incubated 
at 37°C for a total of 40 min. Rates of basal and insulin-stimulated 2-deoxy-D-glucose 
uptake in cardiomyocytes are shown in Figure 4.2. In agreement with previous findings 
insulin increased glucose transport activity » 6 fold above rates measured for basal 
glucose uptake (Fischer et al., 1991). The absolute rates of 2-deoxy-D-glucose uptake 
being 0.010 ± 0.0026 nmoles/min/mg of protein and 0.059 ± 0.0034 nmoles/min/mg of 
protein for basal and insulin-stimulated cardiomyocytes respectively.
We have previously demonstrated in cardiomyocytes that 2-deoxy-D-glucose uptake is 
linear for at least 30 min under the experimental conditions used in this study {Section
3.1.5). Furthermore, others have shown that when the total intracellular concentration 
of 2-deoxy-D-glucose is less than 20 mM, then only 2% of the total intracellular 2- 
deoxy-D-glucose is present in the unphosphorylated form (Hansen et al., 1995). Thus 
the rate of 2-deoxy-D-glucose uptake should accurately reflect glucose transport 
activity.
Treatment of cardiomyocytes with HOE-642 prior to the addition of insulin, resulted in 
a marked inhibition of insulin-stimulated glucose transport by » 35% {Figure 4.2), 
whereas HOE-642 treatment had little or no effect on basal glucose transport activity. 
The absolute rates for 2-deoxy-D-glucose being 0.011 ± 0.0034 nmoles/min/mg of 
protein and 0.039 ± 0.0047 nmoles/min/mg of protein for HOE-642 treated samples 
from basal and insulin-stimulated cells, respectively.
4.1.3 The Effect of HOE-642 on Cell-Surface Levels of GLUT4 and GLUT1
To determine whether there was a correlation between HOE-642 inhibition of glucose 
transport activity and glucose transporter translocation to the plasma membrane, the cell 
impermeant photolabel Bio-lc-ATB-BMPA was employed. This photolabel only labels
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Figure 4.2 Inhibition of Insulin-Stimulated Glucose Uptake in Cardiac Myocytes 
Treated with HOE-642. Cardiomyocytes were prepared according to Methods 2.2.3. Cells were 
treated with 20 pM HOE-642 for 10 min at 37°C where appropriate before stimulation with 30 nM 
insulin for 20 min at 37°C, or were left untreated. 2-Deoxy-D-[3H]-glucose uptake was measured as 
described in Methods 2.4.2. The results shown are from 4 independent experiments (paired, two-tailed 
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the transporters accessible at the plasma membrane, and as such is a useful tool to 
analyse changes in the distribution of glucose transporters between the intracellular 
compartments and the plasma membrane. Following incubation either with 30 nM 
insulin, with 20 pM HOE-642 or with a combination of both reagents at the same 
concentrations, cardiomyocytes were labelled with 500 pM Bio-lc-ATB-BMPA by 
photo-irradiation. The cells were then washed extensively to remove unincorporated 
biotinylated reagent, and solubilised in a detergent buffer. Following this incubation 
insoluble material was removed by centrifugation and a small volume of this 
supernatant was retained for analysis. Biotin-tagged transporters were precipitated on 
streptavidin beads, then eluted and resolved by SDS-PAGE and Western blotting with 
antibodies against GLUT1 and GLUT4. The results of representative experiments are 
shown in Figures 4.3 and 4.4.
Analysis of GLUT1 by photolabelling showed that insulin caused an approximately 2.5- 
fold increase in the levels of this transporter at the plasma membrane {Figure 4.3). This 
is in agreement with other studies which have used the ATB-[3H]-BMPA label to 
analyse cell surface GLUT1 in cardiomyocytes (Fischer et al., 1997). Surprisingly 
treatment of cardiomyocytes with HOE-642 followed by insulin resulted in little change 
in the plasma membrane content of GLUT1, indeed in some cases a slight augmentation 
of cell-surface GLUT1 was observed {Figure 4.3A). To check that an equal amount of 
protein had been added to the streptavidin beads and that HOE-642 had no significant 
effect on the total intracellular concentration of GLUT1, an equal volume of the 
detergent solubilised supernatant (retained prior to the streptavidin precipitation) was 
analysed by SDS-PAGE and Western blotting with antibodies against GLUT1. No 
change in the amount of immunoreactive GLUT1 was observed in any of the samples 
analysed {Figure 4.3B).
Next we examined changes in plasma membrane GLUT4. GLUT4 at the cell surface 
increased following insulin stimulation by approximately 4.6-fold over basal levels 
(ranging between 3- and 6-fold over 4 separate experiments). Again this is in 
agreement with published studies showing that insulin increases cell surface GLUT4 by 
« 5.7 fold in cardiomyocytes (Fischer et a l, 1997). In contrast to GLUT1 but in 
agreement with the transport activity data, the level of GLUT4 at the plasma membrane 
decreased following HOE-642 and insulin treatment in combination, by approximately 
36% {Figure 4.4A). No change in the total amount of GLUT4 was detected in the
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Figure 4.3 The Effect of HOE-642 on the Cell Surface Levels of GLUT1 As 
Judged By Photolabelling. Cardiomyocytes were prepared as described in Methods 2.2.3. The 
cells were either left untreated (B), treated with 30 nM insulin (I), or treated with both 20 pM HOE-642 
and 30 nM insulin (IH). The cells were photolabelled with 500 pM Bio-lc-ATB-BMPA, washed and 
solubilised in a Thesit detergent buffer. Photo-tagged GLUTs were precipitated on streptavidin beads. 
The resulting precipitates were analysed by SDS-PAGE and Western blotting with antibodies against 
GLUT1 (A). A small amount of solubilised protein from before the streptavidin precipitation was kept 
to check for equal loading (B). The material from the streptavidin precipitation was analysed by 










Figure 4.4 The Effect of HOE-642 on the Cell Surface Levels of GLUT4 As 
Judged By Photolabelling. Cardiomyocytes were prepared as described in Methods 2.2.3. The 
cells were either left untreated (B), treated with 30 nM insulin (I), or treated with both 20 pM HOE-642 
and 30 nM insulin (IH). The cells were photolabelled with 500 pM Bio-lc-ATB-BMPA, washed and 
solubilised in a Thesit detergent buffer. As a control an aliquot of cells was irradiated without 
photolabel (U). Photo-tagged GLUTs were precipitated on streptavidin beads. The resulting 
precipitates were analysed by SDS-PAGE and Western blotting with antibodies against GLUT4 (A). A 
small amount of solubilised protein from before the streptavidin precipitation was kept to check for 
equal loading (B). The material from the streptavidin precipitation was analysed by densitometry (C). 
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detergent solubilised supernatants indicating that (a) an equal amount of protein had 
been incubated with the streptavidin beads and (b) HOE-642 has no significant effect on 
the total amount of GLUT4 in cardiomyocytes.
In order to determine an approximation for the amount of GLUT4 at the cell surface of 
cardiomyocytes under the conditions tested, we compared a standard curve of low 
density microsomal protein (LDM) with photolabelled samples by SDS-PAGE and 
Western blotting with an antibody raised against GLUT4. LDM protein is known to 
contain approximately 60 pmoles of GLUT4 per mg (Simpson et al., 1983; Holman et 
al., unpublished observation). Densitometric analysis of these Western blots indicated 
that under basal conditions approximately 74.4 fmoles of GLUT4 per mg of membrane 
protein were present at the cell surface. Upon insulin stimulation this increased to 341.4 
fmoles of GLUT4 per mg of membrane protein. Treatment with HOE-642 in 
conjunction with insulin decreased the level of GLUT4 at the cell surface to 219.8 
fmoles per mg of membrane protein {Figure 4.4C).
4.1.4 Distribution of the Insulin-Sensitive Glucose Transporter GLUT4 Revealed 
by Confocal Microscopy
To confirm the photolabelling results, the distribution of GLUT4 in cardiomyocytes was 
analysed by confocal microscopy. Thus following isolation, cardiomyocytes were 
either left untreated (basal), treated with 30 nM insulin for 30 min, or treated with a 
combination of 20 pM HOE-642 for 10 min and 30 nM insulin for 30 min. 
Cardiomyocytes were then fixed by incubation in 4% paraformaldehyde, followed by 
permeabilisation with 0.1% saponin. Cells were incubated with monoclonal mouse 
anti-GLUT4 antibodies for 1.5 h, then washed extensively before incubation with 
rhodamine conjugated anti-mouse antibodies. Following this incubation the cells were 
washed again, mounted and viewed in Vectorshield. The results shown are 
representative of 10 cells selected at random per condition per experiment, and of two 
independent experiments. All cells were viewed in approximately the same focal plane.
As expected GLUT4 in basal unstimulated cells was predominantly intracellular 
{Figure 4.5A). The fluorescent pattern was vesicular with particularly intense labelling 
around the perinuclear region (indicated by the arrow), which presumably represents the
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Figure 4.5 The Effect of HOE-642 on the Distribution of GLUT4 in 
Cardiomyocytes. Cardiomyocytes were prepared as described in Methods 2.2.3. The cells were 
either left untreated (A), treated with 30 nM insulin (B), or treated with 20 p.M HOE-642 followed by 
30 nM insulin for 30 min (C). The cells were fixed with paraformaldehyde, solubilised with saponin 
and probed with mouse antibodies against GLUT4. The cells were then washed and incubated with 
rhodamine-conjugated anti-mouse antibodies. As a control some cells were treated with the secondary 
antibody alone (D). The samples were viewed using a Zeiss laser scanning microscope (LSM510) with 
543 nm lasers.
A.





trans-Golgi network, or an endosomal sorting station. GLUT4 was also localised below 
the plasma membrane. GLUT4 appeared to distribute to striations and displayed a 
labelling pattern reminiscent of the arrangement of actin filaments. Following insulin 
stimulation a sizeable proportion of GLUT4 was redistributed to the plasma membrane, 
and to peripheral tubulo-vesicular structures in the cytoplasm. These structures 
appeared punctate and connected as if on ‘strings’ (Figure 4.5B). This in agreement 
with immunolocalisation studies in cardiac muscle (Slot et a l , 1991b) which showed 
that under basal conditions less than 1% of the total GLUT4 is localised to the various 
domains of the plasma membrane (sarcolemma, intercalated discs and transverse 
tubules). Following insulin stimulation GLUT4 increased at the cell surface and 
transverse tubules by 42-fold (Slot et a l , 1991b).
Treatment of cardiomyocytes with HOE-642 in conjunction with insulin, failed to block 
the re-distribution of GLUT4 to the plasma membrane. In some cases the pattern of 
GLUT4 was less striated, and more vesicular. Some fluorescence around the 
perinuclear region remained and GLUT4 was seen to run in ‘rows’ between the two 
poles of the myocyte, perhaps associated with microtubules (Figure 4.5C). Control 
experiments in which only the secondary antibody was incubated with the 
cardiomyocytes revealed little non-specific staining {Figure 4.5D).
4.2 Studies of the Sodium-Proton Pump Inhibitor HOE-642 in Rat 
Adipocytes
4.2.1 Inhibition of Insulin-Stimulated Glucose Uptake in Rat Adipocytes Treated 
with HOE-642
The confocal microscopy results in cardiomyocytes prompted us to analyse the effects 
of HOE-642 on insulin-stimulated glucose transport and GLUT4 translocation in 
another insulin-responsive cell, from which sufficient material could be obtained for 
subfractionation analysis. Thus adipocytes were first tested for their ability to respond 
to HOE-642 by analysis of 3 -O-methyl-D-glucose uptake in cells either left untreated 
(basal), treated with 20 juM HOE-642, treated with 20 nM insulin or treated with a 
combination of both reagents. 3-O-methyl-D-glucose uptake was assayed over a 90 s 
period for basal and basal/HOE-642 samples and over a 3 s period for insulin and 
insulin/HOE-642 samples to allow analysis of sugar uptake over the linear region of the
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Figure 4.6 Inhibition of Insulin-Stimulated Glucose Transport in Rat Adipocytes 
Treated with HOE-642. Adipocytes were prepared according to Methods 2.2.2. Cells were then 
treated with 20 pM HOE-642 for 10 min at 37°C or were left untreated. Following the HOE-642 
incubation, adipocytes were treated with 20 nM insulin for 20 min or were left untreated. 14C-3-0- 
methyl-D-glucose uptake was performed as described in Methods 2.4.1. The results shown are 









3-O-methyl-D-glucose transport curve (Whitesell and Gliemann, 1979; Taylor and 
Holman, 1981).
The rates of 3-0-methyl-D-glucose uptake are shown in Figure 4.6. Insulin increased 
the rate of 3-O-methyl-D-glucose uptake by approximately 58-fold over basal levels, 
similar to rates demonstrated previously (Holman et al., 1990). The absolute values for 
transport being 0.0032 ± 0.0005 s'1 and 0.1887 ± 0.0206 s'1 for basal and insulin- 
stimulated adipocytes, respectively. Addition of HOE-642 inhibited insulin-stimulated 
glucose transport by approximately 30%, while HOE-642 had little effect on 3 -0  
methyl-D-glucose transport in basal adipocytes. The absolute rates of transport being 
0.0024 ± 0.0005 s'1 and 0.1322 ± 0.0106 s'1 for HOE-642 samples from basal and 
insulin-stimulated adipocytes, respectively. This is in good agreement with the effects 
of HOE-642 observed in cardiomyocytes {Section 4.1.2).
4.2.2 The Effect of HOE-642 on Cell Surface Levels of GLUT4 in Rat Adipocytes
To examine whether the inhibition of insulin-stimulated glucose transport in rat 
adipocytes observed by treatment with HOE-642 was due to a reduction in accessible 
glucose transporters at the cell surface, plasma membrane GLUT4 was analysed by 
photolabelling with Bio-lc-ATB-BMPA. Insulin increased GLUT4 at the cell surface 
7.3-fold over basal levels. This is lower than previously published photolabelling 
results performed with the ATB-[3H]-BMPA photolabel in which insulin was shown to 
increase cell surface GLUT4 by 15-fold over basal control levels (Holman et al.y 1990). 
However these results indicate that an increase in GLUT4 translocation to the cell 
surface alone is not completely sufficient to compensate for the increase in glucose 
transport activity observed following insulin stimulation. This implies that the intrinsic 
activity of the glucose transporters can be modulated by the actions of insulin.
Pre-treatment of adipocytes with HOE-642 followed by insulin stimulation resulted in a 
decrease in cell surface labelling of GLUT4 by approximately 30% {Figure 4.7A), 
closely paralleling the results obtained in cardiomyocytes {Figure 4.4). Furthermore, 
HOE-642 had no effect on the total levels of GLUT4 detected in the solubilised 
supernatants from adipocytes {Figure 4.7B). In a second experiment serial dilutions of 
LDM protein were performed to produce a standard curve of GLUT4 which was 
compared with photolabelled GLUT4 in adipocyte plasma membranes. Thus in basal
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Figure 4.7 The Effect of HOE-642 on the Cell Surface Levels of GLUT4 in 
Adipocytes As Judged By Photolabelling. Adipocytes were prepared as described in 
Methods 2.2.2. The cells were either left untreated (B), treated with 20 nM insulin (I), or treated with 
both 20 pM HOE-642 and 20 nM insulin (IH). The cells were photolabelled with 500 pM Bio-lc-ATB- 
BMPA, washed and solubilised in a Thesit detergent buffer. As a control an aliquot of cells was 
irradiated without photolabel (U). Photo-tagged GLUTs were precipitated on streptavidin beads. The 
resulting precipitates were analysed by SDS-PAGE and Western blotting with antibodies against 
GLUT4 (A). A small amount of solubilised protein from before the streptavidin precipitation was kept 
to check for equal loading (B). The material from the streptavidin precipitation was analysed by 
densitometry (C). The results shown are representative of 2 independent experiments.
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cells 309.3 fmoles of GLUT4/ 500pl40% cells were detected in the plasma membrane. 
This increased to 2242.1 fmoles of GLUT4/ 500pl 40% cells upon stimulation with 
insulin, and was inhibited by HOE-642 to a level of 1583.8 fmoles of GLUT4/ 500pl 
40% cells (Figure 4.7C).
4.2.3 Subfractionation of Rat Adipocytes Treated with HOE-642
Adipocytes contain a large single lipid droplet that displaces their cytoplasm to the 
periphery and gives them the shape of a small ring, measuring 2.55 ± 0.25 pl/cell 
(Arsenis et al., 1995). Thus the scant cytosolic space in adipose cells complicates their 
analysis by confocal microscopy and as such the levels of GLUT4 in the plasma 
membrane and low density microsomes were determined by subcellular fractionation. 
As well as facilitating the analysis of GLUT4 distribution in adipocytes, the use of 
fractionation also gave us an independent, alternative method to confocal microscopy, 
with which to address this issue.
Adipocytes were either left untreated, treated with 20 nM insulin or with 20 nM insulin 
and 20 pM HOE-642. The cells were then fractionated (see Methods, Section 2.5.1) by 
centrifugation to give four subcellular fractions: the plasma membrane (PM), the low 
density microsomes (LDM), the high density microsomes (HDM) and the cytosol 
(Weber et al., 1988). GLUT4 in the plasma membranes and the low density 
microsomes was analysed by SDS-PAGE and Western blotting.
In the basal state, immunoreactive GLUT4 was primarily localised to the low density 
microsomal fraction, with little GLUT4 at the plasma membrane. Upon insulin 
stimulation GLUT4 translocated to the plasma membrane with a paralleled decrease in 
the low density microsomes. Pre-treatment of adipocytes with HOE-642 did not 
significantly effect the redistribution of GLUT4 from the low density microsomes to the 
plasma membrane upon insulin stimulation (Figure 4.8). Thus the subfractionation data 
obtained from adipocytes correlates with the confocal micrographs of GLUT4 in 
cardiomyocytes.
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Figure 4.8 Subfractionation of Rat Adipocytes Treated with HOE-642. Adipocytes 
were prepared as described in Methods 2.2.2. Once isolated, the cells were either left untreated (B), 
treated with 20 nM insulin (I), or treated with both 20 pM HOE-642 and 20 nM insulin (IH). The cells 
were then subfractionated as described in Methods 2.5.1 to produces the low density microsomes 
(LDM) and the plasma membrane (PM). 20 pg of each of these fractions was analysed by SDS-PAGE 
and Western blotting with antibodies against GLUT4. The results shown are representative of 2 
separate subfractionations. Data for basal (■), insulin (■) and insulin + HOE-642 (■) from the 
densitometric analysis of both subfractionations is shown in the lower panel with the results normalised 







4.2.4 Comparison of the Effects of HOE-642 and Isoproterenol in Rat Adipocytes
Catecholamines belong to a group of hormones that cause insulin resistance by 
inhibiting insulin receptor binding and glucose transport activity in rat adipocytes 
(Arsenis and Tarvin, 1986). For example, isoproterenol attenuates insulin-stimulated 
glucose transport, particularly when adenosine is inactivated by adenosine deaminase. 
Furthermore treatment of adipocytes with isoprenaline results in the formation of an 
occluded population of vesicles which cannot be detected by photolabelling in intact 
adipocytes but which is detected by Western blotting of subcellular fractions or by 
photolabelling isolated membranes (Vannucci et a l, 1992). These alterations occur 
with a concomitant decrease in extracellular pH (Maijomaki et a l, 1994). In 
accordance with these observations, several studies have shown that isoproterenol 
inhibits NHE1 activity in rat adipocytes and that this inhibition occurs through 
activation of a (32-adrenergic receptor mechanism, which is achieved by adenylyl 
cyclase stimulation and a cAMP dependent pathway (Arsenis et a l, 1995).
Thus a comparison of the inhibition of insulin-stimulated glucose transport induced by 
isoproterenol, with that induced by HOE-642 in cells treated with adenosine deaminase 
was performed. As expected insulin-induced a massive increase in 3-O-methyl-D- 
glucose transport over basal levels (« 40-fold). Isoproterenol decreased insulin- 
stimulated 3-0-methyl-D-glucose transport by 73.6% from 0.1773 ± 0.0064 s’1 to 
0.0467 ± 0.0199 s'1. Similarly, although not to such a great extent, HOE-642 inhibited 
insulin-stimulated 3-O-methyl-D-glucose transport by » 50%. The inhibition in the 
presence of adenosine deaminase was higher, than that observed in its absence {Section 
4.2.1).
4.2.5 Localisation of the Sodium-Proton Pump in Rat Adipocytes
HOE-642 may alter membrane traffic by disrupting pH gradients in acidic vesicular 
compartments. Indeed many intracellular organelles including endosomes, clathrin 
coated vesicles, Golgi and other endomembrane structures contain specific ion pumps 
and channels to maintain their unique intraorganellar pH. Furthermore it has not yet 
been established whether NHE1 is sequestered in an intracellular compartment and 
translocated to the plasma membrane upon stimulation (Lin and Barber, 1996). 
Moreover a pharmacological profile for cloned NHE4 with respect to HOE-642 has yet
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Figure 4.9 Comparison of the Effects of Isoproterenol and HOE-642 on Insulin- 
Stimulated Glucose Transport in Rat Adipocytes. Adipocytes were prepared according 
to Methods 2.2.2. An aliquot of cells was removed (B) and the remainder were washed once in KRH 
supplemented with 200 nM adenosine. Cells were either left untreated (B), treated with 20 nM insulin 
(IA), treated with 20 nM insulin plus 1 pM isoproterenol and 1 U/ml adenosine deaminase 
(IA+ADA+Iso) or treated with 20 nM insulin plus 20 pM HOE-642 and 1 U/ml adenosine deaminase 
(LA+ADA+HOE-642) for 30 min at 37°C. Following treatment 14C-3-0-methyl-D-glucose uptake was 
performed as described in Methods 2.4.1, except that cells were adjusted to give a 15% cytocrit. The 
results shown are representative of 3 separate experiments (paired, two-tailed t-tests with 95% 
confidence intervals).
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to be produced (Loh et a l, 1996). The yeast homologue of this Na+/H* antiporter Nhxl 
is located exclusively intracellularly (Nass and Rao, 1998) and so an involvement of the 
mammalian equivalent in glucose transport cannot be ruled out. Thus, an investigation 
into the possibility that GLUT4-vesicles might be endowed with a NHE pump was 
undertaken. Initially plasma membrane and low density microsomal fractions were 
analysed for NHE1 content by SDS-PAGE and Western blotting. Clear signals for 
NHE1 were detected in both the plasma membrane and LDM fractions. Indeed a slight 
decrease in NHE1 in the LDM fraction was observed in the insulin-stimulated sample, 
although no significant increase in immunoreactive NHE1 in the plasma membrane was 
detected (Figure 4.10A).
Since NHE1 was clearly detected in the low density microsomal fraction, we next tested 
whether NHE1 was directly associated with GLUT4 vesicles. To this end GLUT4 
vesicles were immunoprecipitated on acrylic beads coated with non-specific rabbit IgG 
(NS) or affinity purified rabbit GLUT4 antibodies (GLUT4). Vesicle associated 
proteins were solubilised in a detergent buffer (soluble). Bound GLUT4 was eluted by 
denaturing the GLUT4 antibodies by heating to 95°C for 5 min in SDS-sample buffer 
supplemented with 20 mM DTT (insoluble). Both the detergent soluble and insoluble 
fractions were resolved by SDS-PAGE and analysed by Western blotting with 
antibodies against GLUT4 and NHE1. Mouse and chicken antibodies were used for the 
Western blotting of GLUT4 and NHE1 respectively, to obviate interference by the 
heavy chain of the immmunoprecipitating polyclonal antibody. As illustrated, 
significant amounts of GLUT4 vesicles were found immunoadsorbed to the beads only 
when anti-GLUT4 antibodies were used, and not when non-specific rabbit IgG was 
employed (Figure 4.1 OB, top panel). Extensive characterisation of this system for 
immunoprecipitating GLUT4 vesicles has been performed and is detailed (Chapter 5, 
Sections 5.3.1, 5.3.2 and 5.3.5). The efficiency of this method of GLUT4 vesicle 
immunoadsorption is 67%.
The immunoprecipitated vesicles were tested for the presence of NHE 1. As illustrated 
in Figure 4.1 OB, lower panel, no NHE1 was detected on immunoprecipitated GLUT4 
vesicles, whereas a clear signal was obtained in the control total membrane standard 
resolved in lane 1. Thus immunoprecipitated GLUT4-organelles are devoid of NHE 1 
activity. The ostensible absence of the NHE1 exchanger from GLUT4 vesicles suggests 
that either (a) a separate compartment endowed with NHE pumps is essential for the
Figure 4.10 Localisation of the Sodium-Proton Pump NHE-1 in Rat Adipocytes. A. Basal and insulin treated adipocytes were homogenised and 
subfractionated by differential centrifugation as described in Methods 2.5.1 to produce the low density microsomes (LDM) and the plasma membrane (PM). 20 jig of each 
fraction was resolved by SDS-PAGE and analysed by Western blotting with a polyclonal antibody against NHE-1. B. GLUT4 vesicles were immunoadsorbed on acrylic beads 
coated with non-specific IgG (NS) or affinity purified anti-GLUT4 antibodies (GLUT4). Vesicle associated proteins were eluted in a detergent buffer (soluble). Proteins bound 
to the beads were released by heating at 95°C for 5 min (insoluble). Both the soluble and insoluble material was resolved by SDS-PAGE and analysed by Western blotting with 
antibodies against GLUT4 and NHE-1. A 50 p.g total membrane control (TM) was run in lane 1. The results shown are representative of 2 independent experiments.
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translocation and activation of glucose transporters, (b) that another NHE exchanger, 
possible NHE4, is active in these organelles or (c) that global effects on the cytoplasmic 
pH, perhaps involving perturbations of the insulin-signalling pathway are responsible 
for the inhibition of insulin-stimulated glucose transport.
4.2.6 The Effect of HOE-642 on the Distribution of Signalling Molecules at the 
Plasma Membrane
The insulin-inhibiting effects of HOE-642 may results from interference within steps of 
the insulin-signalling pathway or by mis-localisation of signalling molecules. Thus an 
investigation into whether the distribution of the insulin receptor was altered by 
treatment of adipocytes with HOE-642 was performed. Plasma membranes obtained 
from basal, insulin-stimulated and HOE-642/insulin-treated adipocytes were resolved 
by SDS-PAGE and analysed by Western blotting with an antibody against the a-subunit 
of the insulin receptor.
As demonstrated in Figure 4.11, top panel levels of insulin receptors present in the 
plasma membrane fractions were slightly decreased following insulin stimulation due to 
insulin-induced insulin receptor internalisation. This is in agreement with previous 
studies which have shown that approximately 10% of the insulin receptors at the plasma 
membrane are internalised following administration of insulin (Heller-Harrison et al., 
1995; Chinni and Shisheva, 1999). However treatment of cells with HOE-642 and 
insulin appeared to inhibit this insulin-induced receptor internalisation. Since the 
effects on insulin receptor internalisation induced by insulin are small, these 
experiments would need to be repeated many times in order to be confident that HOE- 
642 behaves in a manner similar to the unstimulated samples.
Since targeting of ‘non-functional5 GLUT4 to the cell periphery in HOE-642/insulin- 
treated cells was observed we next investigated whether other components of the 
insulin-signalling pathway were mis-targeted to the plasma membrane. Insulin receptor 
substrate-1 (IRS-1), PI 3-kinase and protein kinase B (PKB) which are localised 
primarily to the low density microsomes and the cytosol, were all detected in the plasma 
membrane fraction derived from basal adipocytes at low concentrations. The levels of 
IRS-1 and PKB at the plasma membrane decreased following insulin stimulation, 
however no change in the association of PI 3-kinase was observed. Plasma membrane
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Figure 4.11 The Effect of HOE-642 on the Distribution of Insulin Signalling 
Molecules at the Plasma Membrane. Adipocytes were prepared as described in Methods 
2.2.2. Following isolation adipocytes were treated with 20 nM insulin (I), with 20 jiM HOE-642 and 
20 nM insulin (IH) or were left untreated (B). The adipocytes were then homogenised and 
subfractionated as described in Methods 2.5.1 to produce the plasma membrane fraction (PM). 50 pg 
of plasma membrane from each condition (B, I and IH) were resolved by SDS-PAGE and analysed by 
Western blotting with antibodies against the insulin receptor a-subunit, the insulin receptor substrate-1, 
PI 3-kinase p85a-subunit and Protein Kinase B
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fractions derived from HOE-642/insulin-treated adipocytes displayed a distribution of 
signalling molecules similar to basal adipocytes, perhaps indicating that changes in 
cytosolic pH induced by HOE-642 perturb elements of the insulin-signalling pathway. 
Further experiments could examine whether the activity of signalling molecules (e.g. 
phosphorylation of tyrosine residues on the insulin receptor and IRS-1) are altered by 
the actions of HOE-642.
4.3 Studies with the Vacuolar ATPase Inhibitor Bafilomycin Ai
GLUT4 has been localised to a number of endosomal-tubulovesicular structures by 
immunoelectron microscopy (Slot et a l 1991a; Slot et a l 1991b). These and other 
biochemical data (Malide et al., 1997; Millar et a l, 1997) suggest that the interaction of 
GLUT4 with certain membrane compartments is responsible for the formation of a 
specialised GLUT4 population. One of the features of endosomal, and endosomal-like 
organelles including Golgi and lysosomes is their controlled pH. Although the exact 
mechanism by which endosomal pH regulates membrane trafficking has yet to be 
elucidated, it is well established that endosomal pH is required for the dissociation of 
ligands from their receptors and for the recycling of a number of membrane receptors 
back to the plasma membrane (Mellman, 1996). Recently an investigation into the role 
of pH in the function of endosomal and endosomal-like membranes in GLUT4 
trafficking was performed (Chinni and Shisheva, 1999). Using 3T3-L1 adipocytes these 
authors examined the distribution of GLUT4 following administration of the v-ATPase 
inhibitor, bafilomycin Ai. Incubation of 3T3-L1 adipocytes with this inhibitor resulted 
in an increase in GLUT4 at the plasma membrane, and thus it was proposed that 
bafilomycin Ai exhibits insulinomimetic effects (Chinni and Shisheva, 1999).
4.3.1 Changes in Intracellular pH Assessed with the Acidotrophic Dye Acridine 
Orange
To further examine the role of intra-organelle acidification in GLUT4 trafficking, 
changes in the intracellular pH of cardiomyocytes induced by treatment with 
bafilomycin Ai were analysed. To this end, isolated cardiomyocytes were either left 
untreated (basal), treated with 30 nM insulin for 30 min, treated with 100 nM 
bafilomycin Ai or treated with a combination of insulin and bafilomycin A}> before 
staining with acridine orange. As already documented (Section 4.1.1) in basal
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Figure 4.12 The Effect of Bafilomycin Ai on the Intracellular pH As Judged By 
Vital Fluorescence. Cardiomyocytes were prepared as described in Methods 2.2.3. The cells were 
either left untreated (A), treated with 30 nM insulin for 30 min (B), treated with 100 nM bafilomycin 
Ai (C) or treated with both 30 nM insulin and 100 nM bafilomycin A! (D). The cells were then 
incubated for 10 min with 5 |ug/ml acridine orange, then washed and mounted in Vectorshield. The 
cells were viewed using a Zeiss confocal scanning microscope (LSM510) with dual lasers set at 









cardiomyocytes the cytoplasm, nuclei and nucleoli exhibited green fluorescence while a 
number of large red/orange vesicular structures were observed dispersed throughout the 
cytoplasm, and clustered around the nuclei (Figure 4.12A). Upon administration of 
insulin a marked decrease in red/orange labelling was observed, while the cytoplasm 
and nuclei remained green (Figure 4.12B). These results are supported by earlier 
studies which indicate that insulin induces a rapid alkalinisation of the cytoplasm, 
detectable in < 2 min and sustained for up to 1 h (Klip et a l, 1986).
Incubation of cells with bafilomycin Ai effectively inhibited the acidification of the 
lysosomal/endosomal structures with only a small number of yellow organelles visible 
(Figure 4.12C). This is in good agreement with studies of the effect of bafilomycin Ai 
detected by acridine orange staining in A431 and BNL CL.2 cells (Yoshimori et a l, 
1991). Treatment of cardiomyocytes with insulin and bafilomycin also prevented the 
accumulation of acridine orange in endosomal/lysosomal compartments as expected 
(Figure 4.12D).
4.3.2 Inhibition of Insulin-Stimulated Glucose Uptake in Cardiac Myocytes by 
Bafilomycin Ai
In the study documenting the effects of bafilomycin Ai on GLUT4 trafficking in 3T3- 
L1 adipocytes (Chinni and Shisheva, 1999), a direct measurement of the effect of 
bafilomycin Ai on glucose transport was not performed. Thus we decided to test 
whether bafilomycin A\ altered the rate of 2-deoxy-D-glucose transport in 
cardiomyocytes. Low concentrations of bafilomycin Ai marginally increased the level 
of basal glucose transport. However in contrast to Chinni and Shisheva who saw an 
increase in GLUT4 at the cell surface upon increasing concentrations of bafilomycin Aj 
(Chinni and Shisheva, 1999), the rates of 2-deoxy-D-glucose transport did not increase, 
indeed a decrease back to the basal level was observed (Figure 4.13A). Furthermore, 
and again in contrast to the results obtained in 3T3-L1 adipocytes, the level of 
stimulation by bafilomycin Ai was small in comparison to the level of stimulation 
induced by insulin, {Figure 4.13A and B). Bafilomycin Ai increased 2-deoxy-D- 
glucose transport by 1.4-fold over basal levels, whereas insulin increased basal 2-deoxy- 
D-glucose transport by 5.9-fold. The absolute values for transport being 0.0084 ± 
0.0016 nmoles/min/mg of protein, 0.0119 ± 0.0027 nmoles/min/mg of protein and 
0.0494 ± 0.0054 nmoles/min/mg of protein for basal, bafilomycin Ai-treated and
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Figure 4.13 Inhibition of Insulin-Stimulated Glucose Uptake in Cardiac
Myocytes by Bafilomycin Al. Cardiomyocytes were prepared according to Methods 2.2.3. A. 
Cells were either left untreated, treated with 30 nM insulin or treated with various concentrations of 
bafilomycin The top panel compares the level of stimulation induced by bafilomycin A! with 
insulin. The lower panel is a titration curve of bafilomycin At without insulin. B. Cells were either 
left untreated (B), treated with 30 nM insulin (I) or treated with 20 nM insulin and 100 nM bafilomycin 
A! for 30 min at 37°C. In all cases 2-deoxy-D-[3H]-glucose uptake was measured as described in 
Methods 2.4.2. The results shown in B are representative of 3 separate experiments (paired, two tailed 
t-test with 95% confidence intervals).
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insulin-treated cardiomyocytes, respectively. Unexpectedly treatment of 
cardiomyocytes with insulin and bafilomycin Ai resulted in a decrease in 2-deoxy-D- 
glucose transport of approximately 60%, to 0.0215 ± 0.0036 nmoles/min/mg of protein, 
compared with the insulin sample.
4.3.3 The Effect of Bafilomycin Ai on Cell-Surface Levels of GLUT4 in 
Cardiomyocytes
To determine whether the effects of bafilomycin Ai on glucose transport are due to a 
loss of functional GLUT4 from the cell-surface, GLUT4 at the plasma membrane was 
photo-tagged with Bio-lc-ATB-BMPA. Thus following cell isolation, myocytes were 
either left untreated or treated with 30 nM insulin, with 100 nM bafilomycin or with a 
combination of both reagents (at the same concentrations), then photolabelled with 500 
pM Bio-lc-ATB-BMPA. The cells were washed, solubilised and precipitated on 
streptavidin beads. Following an overnight incubation the precipitated transporters 
were eluted and resolved by SDS-PAGE. Biotinylated transporters were analysed by 
Western blotting with antibodies against GLUT4.
Preliminary experiments indicated that both bafilomycin Ai and bafilomycin Ai in 
combination with insulin, reduce the number of glucose transporters present at the cell 
surface. Comparison of the inhibition induced by bafilomycin Ai with that induced by 
HOE-642 suggests that direct perturbation of organelle pH is more potent in inhibiting 
GLUT4 activity at the plasma membrane, than the global effects on the cytoplasmic pH 
induced by HOE-642 (Figure 4.14).
4.3.4 Distribution of the Insulin-Sensitive Glucose Transporter GLUT4 Revealed 
by Confocal Microscopy
To further analyse the distribution of GLUT4 following bafilomycin A\ treatment, 
cardiomyocytes were analysed by confocal microscopy. Thus following incubation 
with bafilomycin Ai, with insulin or a combination of both reagents, myocytes were 
fixed in 4% paraformaldehyde and permeabilised with 0.1% saponin. The cells were 
then probed with mouse monoclonal antibodies against GLUT4, washed and incubated 
with rhodamine-conjugated anti-mouse antibodies. The myocytes were washed again, 
then mounted and viewed in Vectorshield.
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Figure 4.14 The Effect of Bafilomycin Ai on the Cell Surface Levels of GLUT4 in 
Cardiomyocytes As Judged By Photolabelling. Cardiomyocytes were prepared as 
described in Methods 2.2.3. The cells were either left untreated (B), treated with 20 pM HOE-642 
(BH), treated with 30 nM insulin (I), treated with 20 pM HOE-642 and 30 nM insulin (IH), treated with 
100 nM bafilomycin Ai (Bf) or treated with both 100 nM bafilomycin Ai and 30 nM insulin. The cells 
were photolabelled with 500 pM Bio-lc-ATB-BMPA, washed and solubilised in a Thesit detergent 
buffer. Photo-tagged GLUTs were precipitated on streptavidin beads. The precipitates were analysed 



























As already shown, GLUT4 labelling in basal cardiac myocytes was intracellular and 
concentrated around the nuclei and along transverse striations {Figure 4.15A). Upon 
insulin stimulation a marked translocation of GLUT4 from the intracellular locus to the 
plasma membrane was observed {Figure 4.15B). Likewise and in agreement with the 
subfractionation data obtained in 3T3-L1 adipocytes (Chinni and Shisheva, 1999), 
bafilomycin Ai alone and in conjunction with insulin, caused the re-location of GLUT4 
to the cell periphery. These findings suggest that GLUT4 activity at the plasma 
membrane can be partially dissociated from the cell-surface content of GLUT4. Thus 
either the intrinsic activity of GLUT4 is subject to regulation i.e. by a conformational 
change allowing glucose (and glucose analogues) to bind, or GLUT4 exists in an 
occluded population of vesicles, close to but not completely associated with the plasma 
membrane. This latter suggestion is supported by the observation that following insulin 
stimulation in rat adipocytes GLUT4 enters the plasma membrane rapidly and then 
there is a slower transition to a caveolae-enriched subdomain of the plasma membrane 
where glucose transport takes place (Gustavsson et al., 1996).
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Figure 4.15 The Effect of Bafilomycin Aj on the Distribution of GLUT4 in 
Cardiomyocytes. Cardiomyocytes were prepared as described in Methods 2.2.3. The cells were 
either left untreated (A), treated with 30 nM insulin (B), treated with 100 nM bafilomycin Ai (C) or 
treated with 100 nM bafilomycin A! followed by 30 nM insulin for 30 min (D). The cells were fixed 
with paraformaldehyde, solubilised with saponin and probed with mouse antibodies against GLUT4. 
The cells were then washed and incubated with rhodamine-conjugated anti-mouse antibodies. The 
samples were viewed using a Zeiss laser scanning microscope (LSM510) with 543 nm lasers.
Figure 4.15 cont. The Effect of Bafilomycin Aj on the Distribution of GLUT4 
Cardio myocytes.
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Many organelles including clathrin-coated vesicles, endosomes, the Golgi apparatus, 
multivesicular bodies and secretoiy granules are acidified to varying degrees (Mellman 
et al., 1986). These elements of the endocytic and exocytic pathways contain various 
ion channels and proton pumps which precisely control inter-organelle acidification 
(Forgac, 1989). The functions served by pH have been the subject of intense 
investigation and several physiological roles have been established. These include 
receptor-ligand dissociation and receptor recycling (Mellman et a l, 1986).
Much of what is known about the functions of intracellular pH has been learned from 
classical studies employing weak bases (e.g. chloroquine, NH4CI) or ionophores (e.g. 
monesin) to dissipate pH gradients (Mellman et a l, 1986; Maxfield and Yamashiro, 
1991). Treatment of cells with these agents leads to concurrent endosome alkalinisation 
and decreased numbers of cell-surface receptors, however receptor internalisation is 
unaffected. Furthermore in the presence of these compounds a number of proteins are 
seen to accumulate in endosomes. These include the TfR (Stoorvogel et a l , 1987), 
TGN38 (Chapman and Munro, 1994) and the cation-independent mannose-6 -phosphate 
receptor, indicating that dissipation of the pH gradient has affected receptor 
extemalisation (Johnson et al., 1993). However in some cases transport continues, for 
example, neither weak bases nor monesin block Fc-receptor recycling (Mellman et al, 
1984). Moreover chloroquine inhibits insulin-induced translocation of GLUT4 to the 
cell surface independent of its effects on endosomal pH (Romanek et al., 1993). Thus 
much remains to be elucidated concerning the role of intracellular pH on protein 
trafficking.
Insulin plays an important role in Na+ metabolism, and as such has been implicated in a 
number of clinical conditions associated with Na+ imbalance. These include Na+ 
wasting in poorly controlled diabetes, natriuresis of starvation and increased Na+ 
reabsorption in hypertensive patients with type II diabetes (Arsenis et al., 1995). In 
addition insulin stimulates glucose transport activity and glycolysis and raises the 
intracellular pH by activating the Na+/H+ antiport in various cells including muscle and 
fat (Mukherjee and Mukheijee, 1981; Fidelman et al., 1982).
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Amiloride which inhibits glucose transport and glycolysis blocks NaVH* exchange 
(Fidelman et al., 1982; Klip et a l, 1986; Klip et a l , 1988) by acting as a competitive 
inhibitor (Holman et a l , unpublished observation). However the effects of amiloride 
are diverse and as such this study was undertaken to determine whether inhibition of 
Na+/H+ exchange activity alone would attenuate insulin-stimulated glucose transport. 
This was achieved using the selective NHE1 inhibitor HOE-642.
In the absence of HCO3', the Na+/H+ exchanger is the only mechanism for maintaining 
intracellular pH (pHi) and pHi recovery following an acid load (Aronson, 1985). Thus 
to isolate the Na+/H+ exchanger all experiments were performed in nominally HCO3' 
free buffer. Under these conditions, HOE-642 markedly inhibited insulin-stimulated 
glucose transport, and the ability of the exofacial photolabel Bio-lc-ATB-BMPA to 
detect functional GLUT4 at the cell surface. However using both subfractionation of 
adipocytes and by confocal microscopical analysis of GLUT4 in cardiomyocytes a 
substantial translocation of GLUT4 to the cell periphery could be demonstrated. The 
mechanism by which this occurs appears to involve a reversible occlusion or disruption 
of the exofacial sugar-binding site of the glucose transporter protein.
It is now well established that insulin stimulates glucose transport by inducing the 
translocation of GLUT4 from an intracellular storage compartment to the plasma 
membrane (Suzuki and Kono, 1980; Cushman and Wardzala, 1980). However the 
magnitude of GLUT4 translocation, as determined by Western blotting of GLUT4, or 
cytochalasin B binding to plasma membranes does not always fully account for the 
increase in glucose transport activity measured in intact cells (Simpson et al., 1983). 
The discrepancy between transporter number and activity is more marked when the 
actions of catecholamines such as isoprenaline (which inhibits Na+/Hf exchange) in 
conjunction with insulin are analysed (Kuroda et al., 1987). This initially led to the 
hypothesis that these catecholamines alter the intrinsic catalytic activity of glucose 
transporters in the plasma membrane (Kuroda et al., 1987). In addition, labelling cells 
with the cell impermeant bis-mannose photolabel ATB-[3H]-BMPA, has shown that like 
HOE-642, isoprenaline decreases the number of ‘active’ glucose transporters at the cell 
surface, while subfractionation data shows little change in the plasma membrane content 
of these glucose carriers (Vannucci et al., 1992). Taken together these data imply that 
isoprenaline induces an alteration but not a loss of glucose transporters in the plasma 
membrane of intact cells such that they can neither bind photolabel nor transport
163
glucose. One interpretation of these results is that neither isoprenaline nor HOE-642 
affect the stimulation of GLUT4 to the plasma membrane by insulin, but that they both 
prevent the full ‘activation’ of transporters by the formation of a pre-fusion competent 
population of vesicles (Vannucci et al, 1992). This model is consistent with the 
observation that isoprenaline alters the Vmax of glucose transporters without effecting 
the apparent Km for 3-0-methyl-D-glucose (Smith et al., 1984). Alternatively HOE-642 
and isoprenaline may induce a conformational change in the glucose transporter protein 
itself, such that it can no longer bind sugar.
The mechanism by which isoprenaline and HOE-642 induce the formation of the 
‘masked’ population of vesicles is unknown but may occur by a common inhibition of 
Na+/Hf exchange. Alternatively the potential involvement of heteromeric G-proteins in 
the isoprenaline-induced occluded state has been implicated from the actions of 
pertussis toxins and cholera on this system (Honnor et a l, 1992). However as yet no 
direct interaction between a G-protein and GLUT4 has been observed, and as such this 
system requires further study. Another possible explanation for the occluded state 
stems from the observation that isoprenaline can induce the activation of adenylyl 
cyclase and hence PKA. In turn PKA can phosphorylate the t-SNARE syntaxin 4 at the 
plasma membrane, thus blocking the interaction of syntaxin 4 and VAMP2 and 
therefore inhibiting the fusion of GLUT4 vesicles with the plasma membrane (Foster et 
a l, 1998).
Treatment of cardiomyocytes with low doses of isoproterenol leads to mild acidification 
of their cytosol. During this time, late endosomes show signs of fragmentation and 
microtubule-dependent movement towards the cell periphery, while the subcellular 
distribution of lysosomes is unchanged (Maijomaki et a l, 1994). Ultrastructural data 
reveal that these small vesicles are formed by the vesiculation of large perinuclear late 
endosomes and that treatment of cells with nocodazole, following acidification results 
in fewer vesicles at the periphery. Since a movement of GLUT4 to the cell surface 
following treatment of cells with HOE-642 was observed, it may be the case that 
inhibition of Na+/H+ exchange leads to fragmentation of endosomes and the passive 
movement of GLUT4 vesicles to the cell exterior. Since there must also be a block in 
fusion with the plasma membrane or in the priming of fusion, GLUT4 vesicles remain 
associated with microtubules in the cytoplasm. It would therefore be of interest to test 
whether treatment of cardiomyocytes with nocodazole following acidification, inhibits
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the movement of GLUT4 vesicles. Furthermore if inhibition of Na+/Hf exchange alone 
results in the fragmentation of endosomes one could speculate that treatment of basal 
cells with HOE-642 would lead to a similar translocation of vesicles to the cell 
periphery. This requires further experimentation, however it is interesting to note that 
basal myocytes treated with HOE-642 exhibit a slight increase in glucose transport 
activity, which may be a result of aberrant fusion of some of these endosomal fragments 
with the plasma membrane.
Kinesin has been shown to be responsible for centrifugal elongation of lysosomes along 
tubules (Hollenbeck and Swanson, 1990). From the data in this chapter it is not 
possible to conclude which proteins or factors are responsible for the movement of 
GLUT4 to the cell surface in the presence of HOE-642. GLUT4 tethers have been 
postulated including spectrin (Tsakiridis et a l, 1994) and aldolase (Kao et al., 1999), 
although the precise roles of these proteins in GLUT4 trafficking remain to be 
elucidated, and as yet no information regarding their control by changes in pH has been 
reported.
It is well documented that the regulation of intracellular pH in the myocardium is of 
particular importance for several physiological processes. Firstly a change in 
intracellular pH induces an alteration in contractility (Orchard and Kentish, 1990). 
Secondly activation of the Na+/H+ pump, one of the major regulators of intracellular pH 
after ischemia induced acidosis, plays a key role in the development of alterations 
related to reperfusion (Karmazyn and Moffat, 1998). The drug HOE-642 is known to 
possess cardioprotective properties during ischemia and reperfusion (Scholz et a l, 
1995). The protective effects of HOE-642 were originally assumed to be due to the 
prevention of intracellular sodium and calcium ion overload. However more recently 
the actions of HOE-642 have been attributed to its ability to prevent the recovery of 
intracellular pH from anoxic acidification during re-oxygenation (Russ et a l, 1996). 
Thus low intracellular pH during re-oxygenation appears to be beneficial and may be 
cardioprotective (Russ et al., 1996). In this study we have shown that HOE-642 
significantly inhibits insulin-stimulated glucose transport, thus the question arises as to 
how this can be reconciled with the apparent beneficial attributes of this drug during 
times of ischemia and reperfusion. If insulin-stimulated glucose transport were 
inhibited by HOE-642, would this not be detrimental to the ischemic heart? One 
explanation for this is that in addition to insulin, anoxia also stimulates glucose
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transport and GLUT4 translocation albeit by a different, PI 3-kinase independent 
mechanism (Yeh et al., 1995). Furthermore anoxia actually results in the acidification 
of the intracellular cytosol. Thus the signalling pathways to glucose transport by anoxia 
and insulin differ, in fact are opposite, in terms of their effects on cytosolic pH: insulin 
increasing the pH of the cytoplasm, while anoxia decreases it. The inhibition of insulin- 
stimulated glucose transport in cardiomyocytes by HOE-642 may therefore be 
compensated for in the anoxic/ischemic heart by the translocation of glucose 
transporters to the plasma membrane in response to an ischemia-stimulated pathway. 
This could be tested by photolabelling and glucose transport studies in the absence and 
presence of HOE-642 in the ischemic heart.
In this study acridine orange staining of non-ischemic cardiomyocytes treated with 
HOE-642 and insulin resulted in a yellow fluorescence distributed throughout the 
cytoplasm, and bright staining within vesicular structures. This yellow fluorescence 
may be caused by a decrease in pH following NHE1 inhibition, however at this time we 
cannot rule out that the unusually bright staining was due to an interaction between 
HOE-642 and the acridine orange stain. Acridine orange staining of cells treated with 
HOE-642 alone needs to be performed to address this issue.
Subcellular fractionation of adipocytes revealed that NHE1 could be detected in both 
the plasma membrane and the low density microsomes. However no NHE1 was 
detected on immunoprecipitated GLUT4 vesicles from freshly isolated adipocytes. This 
indicates that either a subset of GLUT4 vesicles containing NHE1 are regulated by the 
actions of HOE-642, that another compartment containing NHE1 is required for 
GLUT4 trafficking, that another HOE-642 sensitive NHE exchanger is present on 
GLUT4 vesicles, possibly NHE4, or that global cytosolic pH changes, due to plasma 
membrane localised NHE1, affect GLUT4 trafficking.
Treatment of 3T3-L1 cells with the v-ATPase inhibitor bafilomycin Ai has been 
reported to induce the translocation of GLUT4 to the cell surface (Chinni and Shisheva, 
1999). Unexpectedly we found that incubation of cardiomyocytes with bafilomycin Ai 
caused little stimulation of glucose transport and in the presence of insulin resulted in a 
substantial inhibition of glucose transport. Furthermore, preliminary photolabelling 
results indicate that like HOE-642, bafilomycin Ai causes a decrease in the number of 
functional transporters detected at the plasma membrane by the exofacial photolabel,
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Bio-lc-ATB-BMPA, while confocal analysis of bafilomycin Ai treated cells reveals a 
movement of GLUT4 vesicles to the cell periphery. Since these results are similar to 
those observed for HOE-642 inhibition of NHE1, it is interesting to speculate that there 
is a link between NHE1 and the v-ATPases. Indeed in early endosomes, regulation of 
the v-ATPase has been proposed to be due to the generation of a membrane potential by 
the Na+/K+ ATPase (Fuchs et al., 1989). In fat and muscle, insulin stimulation of the 
Na+/H+ pump increases the intracellular Na+ concentration and subsequently activates 
the Na+/K+ exchanger (Resh et al., 1980; Rosie et al., 1985). Therefore v-ATPases may 
be indirectly regulated by the actions of Na+/H+ pumps via Na+/K+ ATPases.
Studies of receptor recycling in numerous cell types have shown that bafilomycin Ai 
inhibits receptor extemalisation. For example, in CHO cell lines treated with 
bafilomycin Ai endosomal pH is increased and TfR recycling back to the plasma 
membrane is markedly reduced (Johnson et a l, 1993). More detailed analysis of TfR 
recycling in bafilomycin Aj treated cells has revealed that removal of transferrin in 
sorting endosomes and the accumulation of TfRs in recycling endosomes continues 
normally but that the rate of exit of TfRs from the recycling compartment to the plasma 
membrane is reduced by 50%. Bulk membrane flow is also reduced in bafilomycin A\ 
treated cells but not to the same extent as TfR recycling (Presley et a l, 1997).
The slowed recycling of TfRs when the pH is perturbed requires the presence of the 
cytoplasmic domain of the TfR containing the tyrosine based internalisation motif, 
YTRF, which is also critical for efficient uptake of the receptor via clathrin-coated pits 
(Collawn et al., 1990). A simple explanation for these results is that a block in 
intravesicular acidification leads to a receptor tail interaction involving the tyrosine- 
based internalisation motif, which does not normally occur. This mechanism is not 
mediated by any noticeable change in the localisation of the plasma membrane clathrin 
adaptor protein, AP2, (Johnson et a l, 1993) but may be due to the interaction of 
receptors with other adaptor proteins (API, AP3 or AP4), or by association with 
unidentified cytosolic adaptin-like proteins. Other studies also support the involvement 
of acidification in receptor tail recognition and controlled recycling via interactions with 
internalisation motifs (Basu et al., 1981). Since GLUT4 contains a number of 
trafficking motifs, in particular a phenylalanine based motif in its N-terminus and a di­
leucine sequence in its C-terminus, it would be interesting to examine the involvement 
of these internalisation signals in the regulation of GLUT4 trafficking by pH. This
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could be achieved by analysing the trafficking of GLUT1/GLUT4 chimeras or of 
GLUT4 mutants with point mutations in these amino acid motifs.
How might these receptor-protein associations be regulated by acidification? Several 
proteins have been shown to undergo pH-sensitive changes in conformation (Turkewitz 
et a l, 1988), so one explanation may be that endosome acidification induces an overall 
conformational change in the receptor which alters the association of its tail with 
cytosolic proteins. However since it has been shown that the position of the 
internalisation motif within a receptors cytoplasmic tail can be altered without changing 
its recycling kinetics (McGraw et al., 1991) and because endosomal alkalinisation can 
disrupt the extemalisation of a number of receptors and transporters, it seems more 
likely that the change in conformation induced by acidification is exhibited by the 
putative cytosolic protein. Thus a protein other than the recycling receptor may be 
required to transmit the necessary information concerning luminal pH. To this end, it is 
interesting to note that treatment of pancreatic acrinar cells with bafilomycin Ai inhibits 
the Mg.ATP induced distribution of ARF to the cytoplasmic face of the tams-Golgi 
network, where it is required for vesicle coating and budding (Zeuzem et a l 1992). An 
alternative explanation for the role of pH in protein trafficking is that changes in 
acidification allow receptors to aggregate. Thus when receptor tails containing 
internalisation motifs are present in high enough concentrations, aberrant interactions 
with cytosolic adaptin-like proteins may occur (Figure 4.16).
Previously it has been demonstrated that glucose transporters and vacuolar-type H* 
pumps do not coexist in the same membrane (Romanek et a l, 1993). However the 
efficiency of the immunoprecipitation procedure used to recover GLUT4 vesicles in this 
published study was only 52%. Thus approximately half of the GLUT4 vesicles were 
not isolated using this technique and it is feasible that this subset of vesicles contain v- 
ATPases. If GLUT4 vesicles do not contain ion channels or proton pumps then perhaps 
another sorting station regulated by pH is necessary for GLUT4 translocation. Indeed 
GLUT4 passes through a number of compartments in order to generate and maintain the 
GSVs and many of these are regulated by pH.
Use of weak bases and inhibitors such as bafilomycin Ai have inherent problems, since 
these reagents disrupt pH in all the acidified compartments of the cell. This leads to 
changes in organelle morphology. Furthermore in the case of bafilomycin Ai v-
Figure 4.16 The Role of pH in GLUT4 Vesicle Trafficking. Intracellular pH is modulated by a number of ion channels and proton pumps. Inhibition of v- 
ATPases by bafilomycin Ai and the sodium-proton exchanger (NHE-1) by HOE-642 reduces insulin-stimulated glucose transport due to the formation of an occluded 
population of GLUT4 vesicles at the plasma membrane. The occlusion of GLUT4 vesicles at the cell surface may be due to the inability of vesicles to dissociate from vesicle 






















ATPases in different organelles may be differentially inhibited, making interpretations 
of results difficult. Recently a new method for selective perturbation of pH within 
organelles has been described (Henkel et a l, 1999). This method uses the expression of 
the M2 protein of the influenza virus to alter intracellular pH. Since the M2 protein is 
an acid activated proton selective channel, it will disrupt the pH gradient across 
organelle membranes in which it is expressed. At low multiplicity of infection delivery 
of proteins from the TGN to the cell surface is disrupted, but there is no change in the 
rate of TfR internalisation. At higher multiplicity of infection M2 accumulates in both 
the TGN and the endosomes, and TfR trafficking is attenuated. Since the experiments 
presented here have indicated a role for pH in GLUT4 trafficking, perhaps this method 
could be used to dissect this role in more detail.
The results documented in this chapter show a partial dissociation of insulin-stimulated 
glucose transport and GLUT4 translocation. Studies of the overexpression of human 
GLUT1 in the skeletal muscle of transgenic mice have also shown that glucose transport 
and GLUT4 translocation can be separated (Hansen et al., 1998). In these studies basal 
glucose transport in human GLUT1 expressing transgenic mice is increased, however 
insulin-stimulated glucose transport is diminished. Photolabelling of glucose 
transporters in skeletal muscles from transgenic mice reveals that insulin can cause a 
redistribution of GLUT4 to the plasma membrane in line with control non-transgenic 
mice. These results are different from those presented here in that they show that non­
functional glucose transporters at the plasma membrane can be labelled by ATB- 
BMPA. However this study further supports the idea that dissection of GLUT4 
translocation and glucose transport activity, by whatever mechanism, is possible.
Early Western blotting and photolabelling studies have demonstrated that the 
appearance of GLUT1 and GLUT4 at the cell surface occurs prior to the stimulation of 
glucose transport in adipocytes (Clark et a l, 1991) and 3T3-L1 adipocytes (Yang et al.,
1992). The lag period between precipitation of transporters at the cell surface and the 
increase in carrier activity has been attributed to a population of glucose transporters in 
occluded precursor/fusion-incompetent states or bound to regulatory proteins which 
prevent the full exposure of the transporter to the extracellular environment. A recent 
study (Gustavsson et al., 1996), has shown that insulin-induced translocation of GLUT4 
to the plasma membrane fraction is followed by a slower transition of the transporter 
into a detergent resistant caveolae-rich region of the plasma membrane. The insulin-
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stimulated appearance of transporters in the caveolae-rich fraction occurs in parallel 
with enhanced glucose uptake by cells (Gustavsson et a l, 1996). Thus the actions of 
HOE-642 and bafilomycin Ai may be to prevent the transition of transporters from the 
plasma membrane into the cavaelae-rich domain, where they become activated.
The results presented here indicate that steps in the trafficking of GLUT4 are controlled 
by changes in pH. Perhaps the pH of a compartment aids its identification by 
specifying interactions between membrane transporters (e.g. GLUT4) and the cytosolic 
proteins which are required for efficient trafficking. These proteins may include 
clathrin, adaptins and members of the small GTPase families including Rabs and ARFs. 
The unique pH established within the lumen of consecutive compartments of the 
endocytic and exocytic pathways may therefore act as a ‘sensor’ for families of 
cytosolic proteins which direct transporters and receptors through the labyrinth of 
compartments to their target destinations. This sorting mechanism may be dependent 
on the strength of interactions of proteins with internalisation motifs in receptor tails, 
and these associations may be modulated by changes in pH.
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5.0 The Association of Adaptor Proteins and ARF with 
GLUT4 Vesicles
5.1 Subcellular Distribution of Adaptor Proteins in Subcellular 
Fractions of Rat Adipocytes
The aim of this study was to identify which, if any, of the known adaptor complexes are 
required for GLUT4 vesicles coating and budding {see Introduction, Section 1.6). In 
order to achieve this, it was first necessary to examine the distribution of adaptor 
proteins in subcellular fractions of rat adipose cells. Adipocytes were fractionated by 
differential centrifugation (Weber et a l , 1988) to produce four fractions: the plasma 
membrane (PM), the low density microsomes (LDM), the high density microsomes, 
(HDM), and the cytosol (CYT). The protein recovered in each of these fractions is 
shown in Figure 5.1 A, being approximately 300-400 jug per rat for both the PM and 
LDM fractions, 80 jug per rat for the HDM fraction and 1.3.mg per rat for the cytosol.
Aliquots of 20 jug from each of the subcellular fractions were resolved by SDS-PAGE 
and analysed by Western blotting with rabbit polyclonal antibodies raised against 
GLUT4, API, AP2 and AP3 {Figure 5. IB). As expected GLUT4 was predominantly 
localised to the LDM in untreated basal adipocyte fractions. Upon insulin stimulation 
GLUT4 translocates to the PM, with a concomitant decrease in the LDM fraction 
{Figure 5. IB). All of the adaptor complexes were detected in all of the subcellular 
fractions to varying extents {Figure 5. IB). However since an equal amount of protein 
from each fraction was loaded onto the gel but the recovery of the protein in each 
fraction varied, the Western blots were analysed by densitometry and normalised for 
protein recovery. The percentage of the total adaptor population in each fraction in 
basal adipocytes corrected for protein recovery is shown in Figure 5.1C. API which 
associates with the TGN, (Kirchhausen et a ly 1997) was recovered primarily in the 
LDM fraction (« 34%) and the cytosol (« 48%). AP2 pelleted with the plasma 
membrane fraction (« 47%) or remained in the cytosol (« 44%). The majority of the 
AP3 complex, which colocalises with markers of the endosomal compartment (Simpson 
et a l, 1997), was detected with the LDM protein (« 30%) and in the cytosol (« 54%).
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Figure 5.1 The Distribution of GLUT4 and Adaptor Proteins API, AP2 and AP3 
in Subcellular Fractions of Rat Adipocytes. Basal and insulin stimulated adipocytes were 
homogenised and subfractionated as described in Methods 2.5.1 to produce the plasma membrane (PM), 
the low density microsomes (LDM), the high density microsomes (HDM) and the cytosol (CYT). A. 
Table to show the total protein obtained in each fraction by the subfractionation procedure. Results are 
given as the mean ± s.e.m. B. 20 pg of protein from each fraction was analysed by SDS-PAGE and 
Western blotting for GLUT4, API, AP2 and AP3. C. Graph to show the percentage of each adaptor 
protein detected in each fraction from basal cells, corrected for protein recovery. The results shown are 
representative of 3 separate experiments for API and AP3, and 2 experiments for AP2.
A. Subcellular Fraction F irnuarujc o v e ry
rat)
Plasma Membrane (PM) 371.3 + 17.8
Low Density Microsomes (LDM) 390.3 ± 15.4
High Density Microsomes (HDM) 77.0 ± 2.5





























5.2 Characterisation of Post-HDM Supernatants on Gradients
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5.2.1 Sedimentation of GLUT4 Vesicles on Nycodenz Gradients
Efforts were initially focussed on two adaptor protein complexes, namely the TGN 
specific adaptor complex, API and the endosomal adaptor complex, AP3. EM studies 
show that GLUT4 is localised to both the TGN and to endosomal compartments (Slot et 
al., 1991a). Furthermore confocal microscopy has revealed partial co-localisation of 
GLUT4 with y-adaptin, a subunit of the API complex (Malide et al., 1997). In addition, 
a recent study of synthetic peptides has demonstrated a direct association of the p l- 
subunit of API with a C-terminal GLUT4 peptide (Rapoport et al., 1998). Our interest 
in the AP3 adaptor complex, stems from the observation that although it is important for 
vesicles budding it does not appear to associate with clathrin (Dell'Angelica et al.,
1997). Similarly the majority of GLUT4 vesicles are not found associated with clathrin 
(Malide et al., 1997). Finally both of these adaptor complexes are enriched in the LDM 
and the cytosol, both of which can be isolated together, and are collectively referred to 
as the post-HDM supernatant.
In order to further examine the distribution of API and AP3 with GLUM, the post- 
HDM supernatant from basal adipocytes was fractionated on a linear 9-27% Nycodenz 
gradient. Nycodenz was selected for the sedimentation of GLUT4 vesicles, since unlike 
sucrose, it forms an iso-osmotic gradient over the density required. This avoids 
subjecting vesicles to unnecessary osmotic stress and results in the recovery of intact 
structures. As Nycodenz gradient separation of intracellular membrane fractions from 
the post-HDM supernatants of rat adipose tissues had not been previously studied, the 
system was characterised by comparing the sedimentation of GLUM, with markers of 
the endosomal compartment (TfR) and of secretory vesicles (VAMP2) {Figure 5.2).
GLUM-containing fractions form a broad band in the centre of the gradient, peaking 
between fractions 29 and 35. Very little of the GLUM peak colocalised with the TfR 
which was localised to a low density region of the gradient. GLUM partially co- 
sedimented with VAMP2 on these gradients. However the VAMP2 peak was narrower 
than the GLUM peak, suggesting that the latter may be a mixture of membrane vesicles 
some of which contain VAMP2, and some of which do not. TGN-38, a marker of the
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Figure 5.2 Nycodenz Gradient Sedimentation of GLUT4 Vesicles. Plasma 
membranes and high density microsomes were removed from basal rat adipocyte homogenates 
(Methods 2.5. J). The remaining fraction (the post-HDM supernatant) was layered onto the top of a 9- 
27% Nycodenz gradient, which was centrifuged for 2.5 hrs at 63,000g. Fractions were collected from 
the bottom to the top of the gradient, and analysed by SDS-PAGE and Western blotting with antibodies 
against GLUT4, VAMP2 and TfRs. None of these proteins could be detected in fractions 1-19 and 
therefore only fractions 20-39 are shown. Densitometric analysis of the Western blotting data are 





Figure 5.3 The Effects of GTPyS on the Fractionation of GLUT4 vesicles and 
Adaptor Complexes on Nycodenz Gradients. Plasma membranes and high density 
microsomes were removed from basal rat adipocyte homogenates {Methods 2.5.1) and the remaining 
post-HDM supernatant was maintained without additions (-) or was treated with 600 pM GTPyS and an 
ATP regenerating system for 30 min at 37°C (+). The samples were returned to ice to arrest the 
coating reaction and then loaded onto a 9-27% Nycodenz gradient, which was centrifuged for 2.5 hrs at 
63,000g. Fractions were collected from the bottom to the top of the gradient, and analysed by SDS- 
PAGE and Western blotting with antibodies against GLUT4, the API y-subunit and the AP3 p3A- 
subunit. None of these proteins could be detected in fractions 1-19 and therefore only fractions 20-39 
are shown. Densitometric analysis of the Western blotting data from GTPyS treated ( • )  or untreated 
( • )  samples is shown in the right hand panels. The results shown are representative of 3 separate 
experiments. The distribution of GLUT4 on the gradient is compared with the VAMP2 and TfR 
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trans-Golgi network migrated to a region which partially overlapped with the peaks of 
both GLUT4 and the TfR (data not shown). Both API and AP3 partially co-localised 
with GLUT4 on Nycodenz gradients (Figure 5.3). API formed two peaks the first 
sedimenting at fractions 29-31, and the second, less dense peak distributing to fractions 
33-36. The latter peak co-localised with GLUT4. AP3 is predominantly localised to 
the top of the gradient, peaking at fraction 36.
API recruitment to purified Golgi membranes can be stimulated by incubation with 
GTPyS and inclusion of an ATP regenerating system (Traub et al., 1993; Zhu et al.,
1998). To investigate whether GTPyS can drive a coating reaction in which adaptor 
subunits associate with GLUT4 vesicles, the post-HDM supernatant from adipose cells 
was treated with GTPyS in the presence of an ATP regenerating system consisting of 
ImM ATP, 8 mM creatine phosphate and 31U/ml creatine phosphokinase type III (Diaz 
et al., 1989), for 30 min at 37°C before addition to the Nycodenz gradient. A high 
percentage of the GLUT4 reactivity was shifted to a denser region of the gradient 
following GTPyS treatment. Similarly there was an increase in API in the denser of its 
two peaks. Thus following incubation of the post-HDM supernatant with GTPyS in the 
presence of an ATP regenerating system, co-sedimentation of GLUT4 with API was 
markedly increased. In contrast to the clear alteration in API distribution on the 
Nycodenz gradient upon GTPyS treatment, little change in the sedimentation of AP3 
was observed (Figure 5.3).
5.2.2 Sedimentation of GLUT4 vesicles on Glycerol Gradients
Since at least two different adaptor protein complexes co-sediment with GLUT4 on 
Nycodenz gradients, attempts were made to confirm these results using a different 
gradient system and to analyse whether the adaptor associated pools could be further 
resolved. To this end, post-HDM supernatants from basal adipocytes were layered onto 
a stepwise 5-25% glycerol gradient containing a 50% sucrose cushion, and centrifuged 
in a swing-out rotor at 80, 000 g  for 16 h. One ml fractions were collected from the 
bottom to the top of the gradient and resolved by SDS-PAGE. The fractions were 
analysed by immunoblotting with a panel of antibodies against GLUT4, VAMP2, the 
TfR and Rab4. Under these conditions the GLUT4 vesicles were found to fractionate as 
two populations, the major pool located just above the sucrose cushion in a dense region
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Figure 5.4 Glycerol Gradient Sedimentation of GLUT4 Vesicles. Plasma membranes 
and high density microsomes were removed from basal rat adipocyte homogenates (Methods 2.5.1). 
The remaining fraction (the post-HDM supernatant) was layered onto the top of a 5-25% glycerol 
gradient with a 50% sucrose pad, which was centrifuged for 16 hrs at 80,000g. 1ml fractions were 
collected from the bottom to the top of the gradient, and analysed by SDS-PAGE and Western blotting 
with antibodies against GLUT4, VAMP2, TfRs and Rab4. Densitometric analysis of the Western 
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of the gradient and the minor pool in fractions 26-31 (Figure 5.4). VAMP2 co-localised 
with GLUT4 in fractions 5-10, as a single sharp peak. Immunoreactive TfRs were 
localised to fractions 17-25, and consisted of a peak with a small shoulder. Again 
GLUT4 and the TfRs did not co-migrate on this gradient, confirming a separation of the 
endosomal compartment containing TfRs and the specialised GLUT4 pool. Rab4, a 
marker of the cytosol, was localised to fractions 29-36, peaking at fraction 31.
Analysis of API and AP3 on glycerol gradients, showed that the majority of these 
complexes co-sediment with the minor pool of GLUT4 in fractions 26-31. Some of this 
‘low density’ peak must represent cytosolic adaptor proteins. AP3 but not API partially 
co-localised with the major GLUT4 pool in fractions 5-10. Following incubation of the 
post-HDM supernatant with GTPyS and an ATP regenerating system for 30 min at 
37°C, API could also be detected in fractions which co-sediment with the major 
GLUT4 pool, although there was little change in the association of AP3 with this pool. 
Following GTPyS treatment, the peak of GLUT4 in the dense region of the gradient 
became sharper and more concentrated. Thus partial dissociation of two populations of 
GLUT4 vesicles has been achieved: a high density AP3-associated GLUT4 vesicles 
population, and a low density GLUT4 vesicle population, which can be recruited to the 
major GLUT4 pool upon stimulation with GTPyS by association with API.
5.3 Characterisation of GLUT4 Vesicles
5.3.1 Components of the GLUT4 Vesicles
In order to examine whether adaptor subunits associate directly with GLUT4 vesicles, it 
was first necessary to assess our ability to immunoprecipitate GLUT4 vesicles from rat 
adipocytes. Adipocytes were therefore fractionated to produce the post-HDM 
supernatant containing the LDM and the cytosol. GLUT4 vesicles were 
immunoisolated from this fraction (in which they comprise approximately 3% of the 
total vesicle population (Zorzano et a l, 1989)), using acrylic beads derivatised with 
affinity purified antibodies directed against the C-terminal tail of GLUT4 at a 
concentration of 1 mg/ml. As a control, non-specific rabbit IgG was immobilised on the 
support at the same concentration. Following a 2 h incubation at 4°C with end-to-end 
rotation, the beads were washed and bound vesicular proteins were solubilised in 1% 
Thesit in HES buffer. GLUT4 was released from the beads following denaturation of
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Figure 5.5 The Effects of GTPyS on the Fractionation of GLUT4 vesicles and 
Adaptor Complexes on Glycerol Gradients. Post-HDM supernatants were maintained 
without additions (-) or were treated with 600 pM GTPyS and an ATP regenerating system for 30 min 
at 37°C (+). The samples were loaded onto a 5-25% glycerol gradient, which was centrifuged for 16 
hrs at 80,000g. Fractions were collected and analysed by Western blotting for GLUT4, the API y- 
subunit, the AP3 p3A-subunit and ARF. Densitometric analysis of the Western blotting data from 
GTPyS treated ( • )  or untreated ( • )  samples is shown in the right hand panels. The distribution of 


















- I --------- 1---------1--------- 1 I





6 12 18 24 30 360
A
1 ---------- 1---------- 1---------- 1---------- 1-----------1
6 12 18 24 30 36
Fraction Number
180
the antibodies by heating at 95°C for 5 min in electrophoresis sample buffer containing 
20 mM DTT. Both the detergent extract and the GLUT4 eluate were analysed by SDS- 
PAGE and Western blotting with appropriate antibodies (Figure 5.6A).
GLUT4 was detected using a mouse monoclonal antibody (clone 1F8), to avoid any 
possible cross-contamination of GLUT4 with IgG from the immunoisolation procedure, 
the heavy chains of which migrate by SDS-PAGE to roughly the same position as 
GLUT4. Use of the acrylic beads resulted in only a small amount of IgG release since 
anti-GLUT4 antibodies are covalently coupled to the beads via an uncharged N- 
alkylcarbamate linkage.
As expected there was a decrease (of approximately 50%) in the yield of GLUT4 
vesicles immunoadsorbed from post-HDM supernatants prepared from insulin- 
stimulated (I) cells compared with their basal unstimulated (B) counterparts (Figure 
5.6A). This results as a consequence of the insulin-induced translocation of GLUT4 
vesicles from the intracellular storage compartment to the cell surface and their 
subsequent fusion with the plasma membrane.
In order to test the integrity of the vesicles, the detergent solubilised material was 
immunoblotted with antibodies against VAMP2, a known component of GLUT4 
vesicles and against a-SNAP, an important cytosolic factor which binds to vesicles 
prior to their docking and fusion with target membranes. The presence of both proteins 
as markers for fusion competent vesicles has been previously demonstrated (Cain et a l , 
1992; Mastick and Falick, 1997), and both were detected in the detergent solubilised 
material indicating the presence of intact vesicles in the precipitates (Figure 5.6A). In 
addition, low levels of the t-SNARE, syntaxin 4 were also detected on GLUT4-specific 
immunoprecipitates (data not shown). This is presumably as a result of the interaction 
between syntaxin 4 and the GLUT4 v-SNARE, VAMP2. Indeed this has been 
previously demonstrated, (Kandror and Pilch, 1996).
To directly examine the association of adaptor complexes with isolated GLUT4 
vesicles, the solubilised material was immunoblotted with antibodies to the y- and c l-  
subunits of API, and to the p3A-subunit of AP3. Clear signals were obtained with 
GLUT4 vesicle samples isolated immediately at 0-4°C (Figure 5.6B) or in vesicles 
maintained at 37°C for 30 min before the immunoadsorption (Figure 5.8A). No
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Figure 5.6 Analysis of GLUT4 Vesicle Associated Proteins. GLUT4 vesicles were 
immunoadsorbed from the post-HDM supernatants of basal (B) and insulin-stimulated (I) cells using 
acrylic beads covalently coupled with either non-specific rabbit IgG (NS) or with affinity purified 
rabbit anti-GLUT4 antibodies (GLUT4). Vesicle associated proteins were eluted by solubilisation in 
1% Thesit in HES buffer and resolved by SDS-PAGE. A. Markers of intact GLUT4 vesicles were 
analysed by Western blotting with polyclonal antibodies against VAMP2 and a-SNAP and a 
monoclonal antibody against GLUT4 (clone 1F8). B. The association of adaptor complexes with 
GLUT4 vesicles was analysed by Western blotting with polyclonal antibodies against both the a l -  and 
y-subunits of API and the |i3A-subunit of AP3.
A. NS GLUT4





















association was found in material isolated from the non-specific control precipitation. 
Additional experiments showed that the majority of the adaptor protein subunits were 
eluted from the beads with Thesit (data not shown). Furthermore, adaptor association 
was resistant to a salt wash using HES buffer containing 100 mM KC1 {Figure 5.6B).
5.3.2 The Efficiency of the Acrylic Beads to Immunoprecipitate GLUT4 Vesicles
Following characterisation of GLUT4 vesicles immunoadsorbed on to acrylic beads, the 
efficiency of the immunoadsorption procedure was addressed. Thus after 
immunoprecipitation of the GLUT4 vesicles onto acrylic beads covalently coupled to 
either non-specific rabbit IgG or affinity purified rabbit anti-GLUT4 antibodies, the 
remaining supernatants were centrifuged at 541, 000 g  for 17 min. The resultant LDM 
pellets were solubilised in 1% Triton X-100 in PBS buffer for 20 min at 20°C, then 
assayed for protein content. Equal protein (20 pg) from the remaining LDM of both 
GLUT4- and IgG-coupled acrylic beads was resolved on a 10% minigel, transferred to a 
nitrocellulose membrane and compared by Western blotting and scanning densitometry 
with a standard curve of LDM protein (5-20 pg).
The amount of GLUT4 detected in the remaining LDM pellets of basal and insulin 
samples rotated with acrylic beads coated with non-specific IgG corresponded to 
approximately 17.2 and 16.3 pg of the LDM protein standard respectively. In the 
remaining LDM pellets of basal and insulin samples rotated with beads coated with 
anti-GLUT4 antibodies, the values were 6.7 and 5.6 pg respectively. Thus the 
efficiency of the acrylic beads to immunoprecipitate GLUT4 vesicles is approximately 
67% {Figure 5.7).
5.3.3 Quantification of Adaptor Proteins on GLUT4 Vesicles
In order to quantify the proportion of immunoadsorbed adaptors, a series of dilutions of 
the post-HDM supernatant {Figure 5.8B) were compared with the immunoadsorbed 
material {Figure 5.8A). These data indicated that GLUT4 vesicles isolated from basal 
cells and then maintained for 30 min at 37°C associate with 1.4% of the total API y- 
subunit and 0.9% of the total AP3 p3A subunit from post-HDM supernatants. When 
corrected for GLUT4 vesicle recovery these percentages increase to 2.1% and 1.3% for 
API and AP3 respectively. Since GLUT4 vesicle protein comprises only 3% of the
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F ig u re  5.7 A n a ly sis  o f  th e  R eco v e ry  o f  G L U T 4  V esic les by A c ry lic  B ead s. GLUT4 
vesicles were isolated by immunoprecipitation on acrylic beads coated with either non-specific rabbit 
IgG (NS) or with affinity purified rabbit anti-GLUT4 antibodies (GLUT4). Following 
immunoprecipitation of the vesicles the remaining supernatant was centrifuged at 541,000# for 17 min 
to pellet the remaining low density microsomes (rLDM). The rLDM membranes were solubilised in 
1% Triton X-100 and 20 pg aliquots were loaded onto a 10% gel with a standard curve of LDM protein. 
Western blotting was performed with a polyclonal antibody against GLUT4 and is shown in A. The 



















total microsomal protein present in this fraction (Zorzano et al., 1989), the levels of 
API and AP3 are highly significant, and suggest a role for these adaptor complexes in 
the regulation of GLUT4 vesicle sorting and trafficking.
AP2 is predominantly recruited to the plasma membrane, where it plays an important 
role in clathrin mediated endocytosis (Hirst and Robinson, 1998). Since GLUT4 is 
continually recycling between an intracellular locus and the cell surface (Satoh et al.,
1993), the association of GLUT4 with AP2 was analysed (Figure 5.8). In this case the 
Thesit solubilised material was examined by Western blotting using an antibody against 
the hinge region of the 100 kDa a-subunit of AP2 (Ball et al., 1995). Only minor 
amounts of AP2 on GLUT4 vesicles could be detected, comprising <0.2% of the total 
AP2 pool in the post-HDM supernatant. In order to assess this small signal, it was 
necessary to over-expose the detection film for the dilutions of the post-HDM 
supernatant (Figure 5.8).
5.3.4 The Effect of a Liposome Wash on the Association of Adaptor Proteins with 
GLUT4 vesicles.
To examine whether the association of adaptor proteins with GLUT4 vesicles was due 
to a lipid or protein interaction, the effect of a liposome wash on API and AP3 
recruitment was examined. A 6 mM liposome stock solution was prepared according to 
the method of Helms and colleagues (Helms et a l, 1993). Briefly, 9 mg egg lecithin 
was resuspended in 2 ml HES buffer and sonicated in 10 s bursts with 20 s rest periods 
until the solution was clear. Following immunoadsorption of the vesicles onto acrylic 
beads coupled to either non-specific rabbit IgG or affinity purified anti-GLUT4 
antibodies, the beads were washed in HES buffer. The beads were then incubated with 
1 mM phosphotidylcholine liposomes for 10 min at 4°C. The vesicles were washed 
again, and vesicle associated proteins were solubilised in a detergent buffer. The 
proteins were analysed by SDS-PAGE and Western blotting with antibodies against 
GLUT4, the y-subunit of API and the p3A-subunit of AP3, (Figure 5.9). No change in 
the levels of immunoadsorbed GLUT4 vesicles were detected, nor was there any 
significant decrease in the levels of API or AP3 recruitment to the GLUT4 populated 
membranes. This suggests that the interaction between GLUT4 and the adaptor proteins 
is specific. Furthermore fewer API adaptors were recovered on GLUT4 vesicles 
isolated in the presence of a buffer in which HEPES was replaced by Tris (data not
Figure 5.8 Quantification of the Amount of each Adaptor Complex Associated with GLUT4 Vesicles. GLUT4 vesicles were immunoadsorbed from 
post-HDM supernatants of basal (B) and insulin stimulated (I) rat adipocytes using acrylic beads covalently coupled to either non-specific IgG (NS) or affinity purified rabbit 
anti-GLUT4 antibodies (GLUT4). Densitometric scanning was used to compare the vesicle associated material (left panel) with the levels of adaptor subunits found in the post- 
HDM supernatant (right panels). The results shown are representative of 4 independent experiments.
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Figure 5.9 The Effect of a Liposome Wash on the Association of Adaptor Proteins with GLUT4 Vesicles. Plasma membranes and high density 
microsomes were removed from basal (B) and insulin treated (I) homogenates by centrifugation to give post-HDM supernatants. GLUT4 vesicles were immunoadsorbed from 
these post-HDM supernatants by acrylic beads covalently coupled to either non-specific rabbit IgG (NS) or affinity purified rabbit anti-GLUT4 antibodies (GLUT4). The 
adsorbed vesicles were then incubated with 1 mM phosphatidylcholine liposomes for 10 min at 4°C. Vesicle associated proteins were eluted and resolved by SDS-PAGE and 
Western blotting with antibodies to GLUT4, the y-subunit of API and the p.3 A-subunit of AP3. The results shown are representative of 2 separate experiments.
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shown), consistent with the known effects of Tris on the binding of adaptors to their 
target membranes (Dittie et al., 1996; Zhu et al., 1998).
5.3.5 GTPyS Treatment Increases the Association of API with GLUT4 Vesicles
Recruitment of adaptor proteins to the TGN has been reconstituted in vitro, and is 
stimulated by GTPyS and this stimulation is enhanced by ATP (Traub et al., 1993; West 
et a l , 1997; Zhu et al., 1998). To examine the possibility of GTPyS enhanced in vitro 
recruitment of adaptor proteins onto GLUT4 vesicles, vesicles were immuno-isolated 
from post-HDM supernatants of basal and insulin-stimulated cells that had either been 
treated with 100 pM or 600 pM GTPyS in the absence or presence of an A1P 
regenerating system. Control samples were left untreated (Figure 5.10A). Following 
incubation of all of the samples at 37°C for 30 min to stimulate adaptor recruitment, the 
preparations were returned to ice for 5 min to arrest the coating reaction. The vesicles 
were subsequently immunoadsorbed onto acrylamide beads coupled to affinity purified 
anti-GLUT4 antibodies and bound vesicle proteins were eluted and analysed by SDS- 
PAGE and Western blotting.
Immunoblotting for API was performed using antibodies against the y-, p i- and c l  
subunits. The recruitment of all of the subunits of API was enhanced by incubation of 
the post-HDM supernatants with GTPyS, and further stimulated by the addition of an 
ATP regenerating system in conjunction with the GTPyS. The association of the y- 
subunit of API with GLUT4 vesicles was increased » 4-fold following the GTPyS and 
ATP regeneration incubation (Figure 5.10B) suggesting that there is a requirement for 
both a GTP binding protein (possibly a GTPase) and an ATPase in API recruitment. 
There was no significant difference in the fold-change of GTPyS driven recruitment of 
adaptors onto GLUT4 vesicles prepared from basal compared with insulin-treated 
adipose cells. The lower levels of adaptor recruitment onto the vesicles prepared from 
insulin-treated cells reflected the lower levels of GLUT4 vesicles present (Figure 5.10A 
top panel). In contrast to the GTPyS enhanced recruitment of API, no significant 
change in the association of AP2 or AP3 with GLUT4 vesicles was observed (Figure 
5.10B).
Figure 5.10 The Effects of GTPyS and an ATP Regenerating System on the Recruitment of Adaptor Complexes onto GLUT4 Vesicles in a 
Cell-Free System. Post-HDM supernatants of basal (B) and insulin stimulated (I) adipose cells were either left untreated (no additions) or treated with 100 pM or 600 |aM 
GTPyS in the absence or presence of an ATP regenerating system (rATP). GLUT4 vesicles were then immunoadsorbed on acrylic beads coated with affinity purified anti- 
GLUT4 antibodies. Vesicle associated proteins were eluted and resolved by SDS-PAGE. Western blotting was performed with antibodies against GLUT4 and the y- p i- and 
c l -subunits of API and the p.3A-subunit of AP3.
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Figure 5.11 The Association of GLUT4 Vesicles with the Insulin Receptor and TGN38. Post-HDM supernatants of basal (B) and insulin stimulated (I) 
adipose cells were either left untreated (no additions) or treated with 100 pM or 600 pM GTPyS in the absence or presence of an ATP regenerating system (rATP). GLUT4 
vesicles were then immunoadsorbed on acrylic beads coated with affinity purified anti-GLUT4 antibodies. Vesicle associated proteins were eluted and resolved by SDS-PAGE. 
Western blotting was performed with antibodies against the insulin receptor a-subunit, a marker of the plasma membrane and against TGN38, a marker of the trans-Golgi 



















Control experiments confirmed previous studies characterising the GLUT4 vesicle 
population immunoadsorbed by acrylic beads derivatised with anti-GLUT4 antibodies. 
These studies showed that neither the insulin receptor, a marker of the plasma 
membrane, nor TGN38, a marker of the trans-Golgi network, are associated with 
immunoprecipitated GLUT4 (Kandror and Pilch, 1998). Indeed a distinction between 
the TGN compartment and the GLUT4 compartment has been further demonstrated by 
morphological studies in 3T3-L1 adipocytes, in which these two proteins were 
compared (Martin et a l, 1994). Furthermore the levels of association of the insulin 
receptor and TGN38 with GLUT4 vesicles does not increase when these vesicles are 
prepared from GTPyS treated samples {Figure 5.11). This indicates that little non­
specific interaction of proteins or membranes with the GLUT4 vesicles occurs, even in 
the presence of GTPyS.
5.4 The Involvement of ARF in Adaptor Association with GLUT4 
Vesicles
5.4.1 The Effect of GTPyS on the Sedimentation of ARF on Nycodenz and 
Glycerol Gradients
The recruitment of API onto membranes is known to be dependent on the small G- 
protein ARF1. ARFs are members of the Ras family of GTPases. They have been 
implicated in API recruitment since relocation of API from the cytosol to the TGN 
membrane is preceded by ARF. Since a GTPyS-enhanced recruitment of API onto 
GLUT4 vesicles was observed, we next examined whether ARF could be recruited to 
GLUT4 vesicles under similar conditions. Post-HDM supernatants derived from basal 
adipocytes, treated with 600 pM GTPyS and an ATP regenerating system or left 
untreated were centrifuged on Nycodenz gradients at 63, 000 g  for 2.5 h. Fractions 
were collected as already described and analysed by SDS-PAGE. The resulting 
nitrocellulose membranes were probed using a monoclonal antibody to ARF (clone 
1D9). This antibody is known to cross-react with ARFs 1, 3, 5 and 6 but has lower 
affinity for ARF4. ARF was localised to the top of the gradient in the untreated post- 
HDM supernatant sample, peaking at fractions 37-38. None of the ARF fractionated 
from the untreated post-HDM supernatant co-localised with GLUT4 from the same 
sample {Figure 5.12A). Treatment of the sample with GTPyS and an ATP regenerating
Figure 5.12 The Effect of GTPyS on the Sedimentation of ARF on Nycodenz and Glycerol Gradients. Post-HDM supernatants from basal cells were 
left untreated ( • )  or treated with 600 |iM GTPyS and an ATP regenerating system at 37°C for 30 min (•). The supernatants were then returned to ice to arrest the reaction 
before loading onto either 9-27% Nycodenz gradients (A) or 5-25% glycerol gradients with 50% sucrose cushions (B). The gradients were centrifuged at 63,000# for 2.5 hrs or 
80,000# for 16 hrs respectively. One ml fractions were collected and analysed by SDS-PAGE and Western blotting with a monoclonal pan antibodv to ARF. Densitometric 
analysis of the Western blotting data is shown in the right hand panels. The positions of the GLUT4 peaks on these gradients are indicated by the bars above the graphs. 
Neither ARF nor GLUT4 were detected in fractions 1-19 on the Nycodenz gradient and therefore only fractions 20-39 are shown.
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system resulted in a marked shift in immunoreactive ARF to a denser region of the 
gradient. In this region of the gradient ARF partially co-localised with GLUT4 (Figure 
5.12A).
These results were confirmed using glycerol gradients. In this case ARF from untreated 
or GTPyS-treated post-HDM supernatants was fractionated on 5-25% glycerol gradients 
with a 50% sucrose cushion. The gradients were centrifuged at 80, 000 g for 16 h and 
fractions were collected as already described (»Section 5.5.2). The distribution of ARF 
on the gradient was analysed by SDS-PAGE and Western blotting. In the untreated 
post-HDM supernatants, ARF migrated at the top of the gradient, in a region that co­
localised with Rab4 (Section 5.2.2) and presumably represented the cytosol. Treatment 
of the post-HDM supernatant with GTPyS and an ATP regeneration system for 30 min 
at 37°C, resulted in a shift in ARF immunoreactivity, such that a small peak of ARF 
was observed in fractions 4-8. This high density ARF peak completely co-localised 
with the major pool of GLUT4 (Figure 5.12B).
5.4.2 The Association of ARF with GLUT4 Vesicles
To test for a direct interaction of GLUT4 vesicles with ARF, vesicles were 
immunoprecipitated on acrylic beads coupled to either non-specific rabbit IgG or 
affinity purified anti-GLUT4 antibodies, and were resolved by SDS-PAGE and Western 
blotting. In contrast to the association of API with freshly isolated GLUT4 vesicles, 
significant levels of ARF could not be detected on GLUT4 vesicles in the absence of 
GTPyS. However in vitro recruitment of ARF to GLUT4 vesicles could be driven by 
GTPyS and an ATP regenerating system, with concentrations as low as 100 pM GTPyS 
inducing substantial association {Figure 5.13A). In these experiments a small amount 
of non-specific interaction of ARF with the immunoadsorbed precipitates was detected 
and could not be eliminated by an additional pre-clearing step or by washing with 
liposomes {Figure 5.13B). The latter procedure has been reported to reduce the non­
specific ARF-binding effects (Helms et a l, 1993). However, the levels of association 
of ARF detected using the specific GLUT4 acrylic beads were always considerably 
higher than the non-specific control.
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The amounts of ARF recruited reflected the amounts of GLUT4 vesicles recovered from 
basal and insulin-treated samples. Quantitative comparison with the post-HDM 
supernatant samples revealed that in the presence of GTPyS and an ATP regeneration 
system, « 1.5% of the total ARF available was associated with the GLUT4 vesicles. 
This value takes into account the non-specific association of ARF with the control 
beads, which has been subtracted. Since the efficiency of the acrylic beads to 
immunoadsorb GLUT4 vesicles was 67%, the total amount of ARF associated with 
these vesicles was determined to be » 2.2% {Figure 5.13B).
5.4.3 The Effect of the ATP Regeneration System on API and ARF Recruitment
Since both GTPyS alone and GTPyS in conjunction with an ATP regeneration system 
stimulated recruitment of both API and ARF to GLUT4 vesicles, we next tested 
whether the ATP regeneration system alone was sufficient to stimulate coat recruitment. 
Post-HDM supernatants derived from basal adipocytes were either left untreated, treated 
with the ATP regeneration system, treated with 600 pM GTPyS or treated with both 600 
pM GTPyS and the ATP regenerating system for 30 min at 37°C. The post-HDM 
supernatants were then returned to ice to arrest the coating reaction, before 
immunoadsorption on aciylic beads. Following a 2 h incubation the 
immunoprecipitated vesicles were washed and solubilised in a detergent buffer. Vesicle 
associated proteins were analysed by SDS-PAGE and Western blotting with antibodies 
against GLUT4, the y-subunit of API and ARF. GLUT4 was clearly detected in 
samples precipitated with acrylic beads covalently coupled to anti-GLUT4 antibodies, 
with little immunoreactivity in the control samples {Figure 5.14). API was not detected 
in control samples, but was detected in all the precipitates derived from the GLUT4- 
specific acrylic beads. As expected API was associated with vesicles derived from 
untreated post-HDM supernatants and to a higher level on vesicles immunoadsorbed 
from post-HDM supernatants treated with GTPyS in the absence or presence of an ATP 
regenerating system. A small increase in the association of API with GLUT4 vesicles 
was observed in samples treated with the ATP regenerating system alone, but this 
probably reflects the slight increase in GLUT4 vesicles immunoprecipitated from this 
sample. Likewise, the association of ARF with GLUT4 vesicles was only significantly 
enhanced in samples treated with GTPyS, with little ARF detected on vesicles
Figure 5.13 The Association of ARF with GLUT4 Vesicles. GLUT4 vesicles were immunoadsorbed from post-HDM supernatants of basal (B) and insulin 
treated (I) adipocytes which had been treated with 100 pM or 600 pM GTPyS and/or an ATP regenerating system (rATP) using acrylic beads covalently coupled to either non­
specific rabbit IgG (NS) or affinity purified polyclonal rabbit anti-GLUT4 antibodies (GLUT4). Vesicle associated proteins were eluted by solubilisation in 1% Thesit in HES 
buffer and resolved by SDS-PAGE. A. Western blotting with antibodies against ARF. B. A standard curve of post-HDM supernatant was constructed and densitometric 
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Figure 5.14 The Effect of an ATP Regenerating system on API and ARF Recruitment to GLUT4 Vesicles. Post-HDM supernatants from basal 
adipocytes were either left untreated (B), treated with an ATP regenerating system (BA), treated with 600 pM GTPyS (BG) or with a combination of both reagents at the same 
concentrations (BAG). GLUT4 vesicles were immunoadsorbed from the post-HDM supernatants onto acrylic beads coupled to either non-specific IgG (NS) or affinity purified 
anti-GLUT4 antibodies (GLUT4). Vesicle associated proteins were solubilised in 1% Thesit in HES buffer and resolved by SDS-PAGE. Proteins were characterised by 
Western blotting with antibodies against GLUT4, the y-subunit of API and against a panel of ARE proteins.
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immunoadsorbed from a post-HDM supernatant treated with the ATP regeneration 
system alone.
5.4.4 Temperature Dependence of API and ARF Recruitment
The in vitro recruitment of API in the presence of GTPyS was found to be temperature 
dependent. In the absence of GTPyS only a small change in amounts of API associated 
with GLUT4 vesicles was observed when the coating reaction temperature was 
increased from 4°C to 37°C. However when the recruitment of API was stimulated by 
the inclusion of GTPyS, the reaction was very temperature dependent (Figure 5.15A). 
API could be detected on vesicles isolated at 4°C. This association was increased 
markedly by incubating the reaction at 20°C, with maximal recruitment observed at 
37°C. The recruitment of API to GLUT4 vesicles observed at 37°C was approximately 
5-fold greater than that observed at 4°C (Figure 5.15A, lower panel). In addition the 
temperature dependent in vitro recruitment of ARF paralleled the API association, 
increasing 3-fold over the same temperature range (Figure 5.15B).
5.4.5 The Inhibition of API and ARF Recruitment to GLUT4 Vesicles by 
Brefeldin A
Budding of vesicles from their donor membranes must be accurately organised so that 
the basic structure of the membrane compartments is not disturbed. The association of 
API with membranes is finely controlled, being stimulated by GTPyS and inhibited by 
the fungal heterocyclic lactone, brefeldin A. Brefeldin A inhibits API re-location by 
blocking GDP.GTP exchange by ARF-GEFs. This prevents ARF association with 
membranes (Robinson and Kreis, 1992; Wong and Brodsky, 1992; Liang and Komfeld,
1997). Thus the effect of brefeldin A on API and ARF recruitment to GLUT4 vesicles 
was examined. Post-HDM supernatants were either left untreated, pre-treated with 100 
jug/ml brefeldin A for 10 min at 37°C, followed by incubation with GTPyS and an ATP 
regenerating system, or treated with GTPyS and an ATP regenerating system alone. All 
samples were incubated for a total of 45 min at 37°C. The post-HDM supernatants 
were returned to ice to arrest the coating reaction and GLUT4 vesicles were 
immunoprecipitated on acrylic beads as already described (Section 5.3.1). Vesicular 
proteins were analysed by SDS-PAGE and Western blotting.
Figure 5.15 The Effects of GTPyS and Tem perature on the Recruitment of API and ARF onto GLUT4 Vesicles in a Cell-Free System.
Post-HDM supernatants from basal adipose cells were treated with 600 pM GTPyS for 30 min at either 4, 20 or 37°C. GLUT4 vesicles were then immunoadsorbed on acrylic 
beads coated with either non-specific rabbit IgG (NS) or polyclonal GLUT4 antibodies (GLUT4). Vesicle associated proteins were eluted and examined by SDS-PAGE and 
Western blotting with polyclonal antibodies against the y-subunit of API and monoclonal pan antibodies against ARF. The lower panels are densitometric analyses of the 






Figure 5.16. The effect of Brefeldin A on the GTPyS driven recruitment of API and ARF onto GLUT4 vesicles. Post-HDM supernatants of basal (B) 
and insulin treated (I) adipose cells were either left untreated (No Additions), treated with GTPyS and an ATP regenerating system for 30 min at 37°C (GTPyS + rATP) or pre-treated 
with 100 (ig/ml Brefeldin A for 10 min at 37°C, followed by treatment with GTPyS and an ATP regenerating system for 30 min at the same temperature (BFA/GTPyS + rATP). 
GLUT4 vesicles were then immunoadsorbed on acrylic beads coupled to affinity purified anti-GLUT4 antibodies. Vesicle associated proteins were analysed by SDS-PAGE and 
Western blotting with a monoclonal antibody to GLUT4 (clone 1F8), a polyclonal antibody to the y-subunit of API and a monoclonal pan antibody against ARF. The results shown 
are representative of 2 experiments.
A. No GTPyS + BFA/GTPyS + 
Additions rATP rATP
B.
















A significant reduction in API recruitment (« 60%) to GLUT4 vesicles was observed in 
the sample pre-treated with brefeldin A before stimulation with GTPyS and an ATP 
regenerating system. The film shown in Figure 5.16A was only exposed long enough to 
quantitate this difference, however API was also observed in the sample derived from 
the untreated adipocyte post-HDM supernatant, to a level 10% of the GTPyS/ATP 
stimulated control sample (Figure 5.16B).
The association of ARF with GLUT4 vesicles was also shown to decrease following the 
brefeldin A incubation, however ARF was not completely dissociated from the 
membranes. A number of explanations for this observation can be surmised. Firstly the 
incubation with brefeldin A may not have been sufficiently long to induce a total loss of 
ARF from the membrane. Secondly the concentration of brefeldin A may not have been 
stringent enough. To our knowledge no prior study has analysed the effects of brefeldin 
A on ARF and API recruitment to membranes in a cell-free system. However in 
permeabilised cells a substantially higher concentration of brefeldin A is required to 
completely inhibit ARF association with TGN membranes, compared with 
immunofluorescence studies in intact cells (Wong and Brodsky, 1992). One further, 
although remote, explanation is that another ARF isoform is associated with GLUT4 
vesicles. Since the monoclonal antibody used in this study detects ARFs 1, 3, 5 and 6, 
this alternative ARF may be ARF6, a brefeldin A-insensitive isoform.
5.4.6 The Effect of Neomycin on Glucose Transport
Phospholipase D (PLD) hydrolyses phospholipids into phosphatidic acid and their 
respective polar head groups. PLD activity is stimulated by ARF and its activity is 
required for the formation of certain vesicle populations. Recently it was reported that 
inhibition of PLD activity using Neomycin, prevents the recruitment of AP2 on to the 
plasma membrane and the endosomes but has little effect on API (West et al., 1997). 
However, treatment of cells with ethanol, which diverts the action of PLD from the 
production of phosphatidic acid to the production of phosphatidylethanol, prevents the 
formation of coated vesicles at the Golgi membrane, even in the presence of ARF 
(Ktistakis et al., 1996). Thus there appears to be some controversy over the exact role 
of PLD in adaptor recruitment, and how it is regulated.
Figure 5.17. The effect of the phospholipase D inhibitor neomycin on glucose transport in ra t adipocytes. Rat adipocytes were isolated as described in 
Methods 2.2.2. The cells were pre-treated with the appropriate concentration of neomycin for 30 min at 37°C. During this time the samples were kept in the dark. Following 
neomycin treatments cells were either left in the basal condition or stimulated for 30 min at 37°C with 20 nM insulin. The uptake of 14C-3-0-methyl-D-glucose was perfomred as 
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C - Basal + 1.0mM Neomycin
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F - Insulin + 1.0mM Neomycin
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Since GLUT4 vesicles were shown to associate with specific adaptor protein 
complexes, we decided to test whether inhibition of PLD activity had any effect on 
glucose transport. Rat adipocytes were therefore incubated for 30 min at 37°C with 0.1 
mM or 1.0 mM Neomycin, or were left untreated. Glucose transport was increase 40- 
fold in insulin-stimulated adipocytes compared with unstimulated basal controls {Figure 
5.17). However inhibition of PLD activity by Neomycin did not significantly effect 
glucose transport in either basal or insulin-stimulated rat adipocytes.
5.4.7 Detection of Adaptor Proteins on GLUT4 Vesicles from Other Insulin- 
Sensitive Tissues
Since the association of adaptor proteins and ARF with GLUT4 vesicles derived from 
rat adipocytes was clearly established, we next attempted to analyse whether the same 
adaptor proteins were recruited to GLUT4 vesicles derived from other insulin-sensitive 
tissues. To this end adaptor protein antibodies were tested on fractions isolated from 
cardiomyocytes, and compared with adipocyte LDM controls. Myocytes were 
homogenised, and centrifuged at 541, 000 g for 30 min at 4°C to produce a cytosolic 
fraction and a total membrane fraction. The total membrane fraction was resuspended 
in 3 ml HES buffer and re-pelleted at the same speed. Samples of adipocyte LDM and 
cardiomyocyte total membrane and cytosolic fractions were compared by SDS-PAGE 
and Western blotting with antibodies against API, AP3 and ARF {Figure 5.18A). Clear 
signals were obtained for all three antibodies in the cardiomyocyte fractions.
Next, GLUT4 vesicles were prepared from the post-HDM supernatants of 
cardiomyocytes isolated consecutively from two hearts. The myocytes were 
homogenised and the plasma membrane and high density microsomes were removed by 
centrifugation. The post-HDM supernatant was treated with GTPyS and an ATP 
regenerating system, before the vesicles were immunoprecipitated on acrylic beads 
covalently coupled to either non-specific rabbit IgG (NS) or affinity purified anti- 
GLUT4 antibodies (GLUT4). Vesicle associated proteins were analysed by SDS-PAGE 
and Western blotting. A small number of GLUT4 vesicles could be detected in the 
GLUT4-specific precipitates, with fewer vesicles isolated from the insulin treated 
sample, as expected. However significant levels of API y-subunit could not be detected 
{Figure 5.18B). In addition no association between GLUT4 vesicles and AP3 or ARF 
was determined (data not shown). Since GLUT4 vesicles comprise only a small
Figure 5.18 The Association of Adaptor Complexes with GLUT4 Vesicles Prepared from Cardiomyocytes. A Total membranes and cytosol 
prepared by centrifuging cardiomyocyte homogenates at 541,000g for 30 min, were compared with low density microsomes prepared from rat adipocytes {Methods 2.5.1) for 
API, AP3 and ARP content. 20 pig of protein from each fraction were resolved by SDS-PAGE and Western blotting. B. GLUT4 vesicles were prepared from post-HDM 
supernatants of untreated (B) and insulin stimulated (I) cardiomyocytes. The vesicles were immunoadsorbed onto acrylic beads coated with non-specific IgG (NS) or affinity 
purified anti-GLUT4 antibodies (GLUT4). Vesicle associated proteins were analysed by SDS-PAGE and Western blotting. A total membrane protein standard (50 pig) was run 
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percentage of the post-HDM supernatant protein, it is possible that insufficient vesicles 
were obtained from two hearts.
5.5 The Effect of Insulin on GLUT4 and Adaptor Proteins
5.5.1 Insulin-induced Redistribution of GLUT4 on Nycodenz Gradients
Recent research suggests that GLUT4 vesicles are spherical, homogeneous particles 
with a sedimentation co-efficient of 120 S in sucrose. Upon insulin stimulation the co­
sedimentation co-efficient of the vesicles in sucrose increases by 20 S  and consequently 
the buoyant density decreases (Kandror and Pilch, 1998). To examine whether this is 
the case when vesicles are isolated on other gradients, post-HDM supernatants were 
prepared from untreated (B) and insulin-stimulated (I) adipocytes, then layered on to the 
top of linear 9-27% Nycodenz gradients and centrifuged at 63, 000 g  for 2.5 h. 
Fractions were collected from the bottom to the top of the gradient and analysed by 
SDS-PAGE and Western blotting.
As already shown GLUT4 vesicles from the basal adipocyte post-HDM supernatant 
fractionate as a broad band on Nycodenz gradients {Section 5.2.1). Treatment of 
adipocytes with insulin reduced the concentration of GLUT4 vesicles recovered on the 
Nycodenz gradient {Figure 5.19\ although the characteristic broad distribution was 
retained. The reduction in vesicles is primarily due to the exocytosis of GLUT4 from 
the intracellular specialised compartment (contained within the post-HDM supernatant) 
and fusion with the plasma membrane. In addition and although the distribution of 
GLUT4 on gradients varied slightly between experiments, treatment of cells with 
insulin before the isolation of vesicles, consistently resulted in a shift of 
immunoreactive GLUT4 by 1-2 fractions to a less dense region of Nycodenz. These 
results are in agreement with the shift of GLUT4 vesicles derived from insulin treated 
adipocytes observed on sucrose gradients (Kandror and Pilch, 1998).
5.5.2 Insulin-induced Redistribution of API
The action of insulin on adaptor proteins is of interest since it has been shown that PIP3 
negatively regulates the interaction between adaptor proteins and membrane receptors 
which contain di-leucine targeting sequences within their cytoplasmic tails (Rapoport et
Figure 5.19 The Effect of Insulin on the Distribution of GLUT4 on Nycodenz Gradients. Plasma membrane and high density microsomes were 
removed by centrifugation of basal (B) ( • )  and insulin treated (I) ( • )  rat adipocyte homogenates. The remaining supernatants (the post-HDM supernatants) were layered on to 
the top of 9-27% Nycodenz gradients and centrifuged for 2.5 hrs at 63,000g. One ml fractions were collected from the bottom (most dense) to the top (least dense) of the tube. 
Fractions were analysed by SDS-PAGE and Western blotting with affinity purified polyclonal rabbit anti-GLUT4 antibodies. Densitometric analysis of the Western blot is 



















a l, 1998). Furthermore the association of a C-terminal peptide and the (31-subunit of 
API is reduced in the presence of PIP3 (Rapoport et a l, 1998). Thus the association of 
API with subcellular fractions derived from rat adipose cells in the absence and 
presence of insulin was examined in more detail (Figure 5.20A). Insulin caused a 
reproducible decrease in the level of association of API with both the plasma membrane 
and the low density microsomes. The decrease in API recruitment at the plasma 
membrane was smaller and although consistent, did not reach significance (paired, one 
tailed t-test, with 95% confidence interval). This is presumably because the API 
adaptor is TGN-specific, and is probably adhering non-specifically to the plasma 
membrane. However the decrease in API at the LDM was significant, with a p-value 
<0.01.
Since insulin appeared to reduce the level of association of API with the LDM fraction, 
possibly due to the activation of PI 3-kinase and the generation of PIP3, we next 
analysed whether incubation of GLUT4 vesicles with an insulin cytosol could reduce 
adaptor association. GLUT4 vesicles from basal post-HDM supernatants were 
immunoadsorbed onto acrylic beads covalently coupled to non-specific rabbit IgG or 
rabbit polyclonal anti-GLUT4 antibodies. The vesicles were washed in HES buffer, 
then incubated in the presence of cytosol derived from either basal or insulin-stimulated 
adipocytes. Vesicle associated proteins were eluted in a detergent buffer and analysed 
by SDS-PAGE and Western blotting. The results are shown in Figure 5.20B. 
Incubation of basal GLUT4 vesicles in the presence of a basal or insulin cytosol had 
little effect on the levels of immunoreactive GLUT4 detected. A decrease in the API 
signal was detected which may be due to negative modulation by PIP3, however no 
change in the level of AP3 association with GLUT4 vesicles was observed.
5.5.3 The Effect of Wortmannin on the Association of API with GLUT4 Vesicles
Wortmannin is a PI 3-kinase inhibitor. Treatment of mammalian cells with wortmannin 
results in a massive change in terms of general membrane morphology, indicated by 
tubulation and vacuolation of the endosomal compartment and by swelling of lysosomes 
(Shpetner et a l, 1996). These wortmannin-induced morphological changes demonstrate 
the importance of PI 3-kinases in maintaining the integrity of intracellular 
compartments. However PI 3-kinases also play a fundamental role in both the
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Figure 5.20 The Effect of Insulin on Adaptor Protein Complexes. A. Analysis o f the 
effect of insulin on the distribution of API in the plasma membrane (PM) and low density microsomes 
(LDM). Basal (B) and insulin treated (I) adipocytes were fractionated by centrifugation as described in 
Methods 2.5.1. 20 pg of the plasma membrane and low density microsomal fractions were resolved by 
SDS-PAGE and Western blotting with an antibody against the y-subunit of API. The results were 
analysed by densitometry, shown in the graph below. Significance differences following insulin 
treatment are given by the indicated p values (paired t-test, one tailed). B. The effect of an insulin 
treated cytosol on API recruitment to GLUT4 vesicles. GLUT4 vesicles were adsorbed from basal 
post-HDM supernatants using acrylic beads coated with either non-specific rabbit IgG (NS) or with 
affinity purified anti-GLUT4 antibodies (GLUT4). Following immunoadsorption of the vesicles, the 
beads were washed in HES buffer and then incubated at 37°C with cytosol derived from either basal or 
insulin treated adipocytes for 15 min. Following this incubation, the beads were washed and the vesicle 
associated proteins were eluted and analysed by SDS-PAGE and Western blotting.
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exocytosis and endocytosis of GLUT4 (Malide and Cushman, 1997). Thus in order to 
establish whether any of these effects are potentiated by changes in adaptor association 
we analysed coat recruitment to GLUT4 vesicles from wortmannin treated adipocytes. 
Adipocytes were therefore treated with insulin, with insulin and wortmannin or left 
untreated. Post-HDM supernatants were prepared, stimulated by GTPyS and an ATP 
regenerating system and vesicles were immunoadsorbed on acrylic beads as already 
described (Section 5.3A), Vesicle associated API was analysed by SDS-PAGE and 
Western blotting. API was found in all the precipitates isolated on GLUT4-specific 
acrylic beads. Fewer adaptors were detected on vesicles isolated from the insulin 
treated sample, consistent with the stimulation of GLUT4 vesicles to the plasma 
membrane. Treatment of cells with wortmannin and insulin together resulted in a level 
of API association which was intermediate between the basal- and insulin-level of 
association {Figure 5.21).
5.6 How do the GLUT4 Vesicles Associate with Adaptor Proteins?
5.6.1 Immunoprecipitation of GLUT4 Vesicles using an N-terminal Antibody
Adaptor proteins have been shown to bind to membrane receptors and transporters via 
their tyrosine or di-leucine motifs (Kirchhausen et al., 1997). Furthermore a C-terminal 
peptide of GLUT4 containing a di-leucine motif has been shown to specifically interact 
with the pi-subunit of API (Rapoport et al., 1998). Thus if GLUT4 vesicles are 
immunoadsorbed onto acrylic beads derivatised with an antibody against this very 
region, how do the adaptor proteins associate with the vesicles? Initially attempts to 
answer this question centred on the use of an antibody directed against the N-terminal 
of GLUT4. If vesicles could be isolated with this GLUT4 antibody which was directed 
against a region of the transporter distant from the di-leucine motif would an enhanced 
association of adaptors be observed? In these experiments Staphylococcus aureus 
Cowan I cells (Staph cells) were coupled with antibodies raised against the C-terminal of 
GLUT4, the N-terminal of GLUT4 or a combination of both. Staph cells were used as 
acrylic beads can not be incubated with azide in which the N-terminal antibody was 
stored.
Post-HDM supernatants derived from basal adipocytes were either left untreated or treated 
with GTPyS plus an ATP regenerating system for 30 min at 37°C. The samples were
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Figure 5.21 The Effect of Wortmannin on the Association of Adaptor Complexes 
with GLUT4 Vesicles. GLUT4 vesicles were prepared from post-HDM supernatants derived 
from unstimulated, basal adipocytes (B), insulin stimulated adipocytes (I) and adipocytes treated with 
both insulin and wortmannin (1 pM) (IW). Post-HDM supernatants were then incubated with 600pM 
GTPyS before isolation of vesicles on acrylic beads coated with either non-specific rabbit IgG (NS) or 
affinity purified anti-GLUT4 antibodies (GLUT4). Vesicle associated proteins were eluted in a 
detergent buffer and analysed by SDS-PAGE and Western blotting with antibodies against the y- 
subunit of API. Bound GLUT4 was released by denaturation of the anti-GLUT4 antibodies and 












returned to ice before an initial preclearing incubation with Staph cells coupled to non­
specific rabbit IgG. Supernatants were then transferred to Staph cells bound with non­
specific rabbit IgG or rabbit anti-GLUT4 serum (C-, N-, or a combination of both) and 
rotated for 2 h at 4°C. Staph cells were subsequently washed once in HES buffer and 
twice in HES buffer containing 100 mM KC1. Vesicular proteins were solubilised and 
bound GLUT4 protein was eluted by heating pellets to 95°C in sample buffer. The 
resulting samples were analysed by SDS-PAGE and Western blotting with monoclonal 
antibodies against GLUT4 (clone 1F8) and ARF and a polyclonal antibody against the 
y-subunit of API. The levels of GLUT4 vesicles immunoprecipitated by the different 
GLUT4 antibodies varied, being greatest for the post-HDM supernatant 
immunoadsorbed with a combination of N- and C-terminal directed antibodies. The 
efficiency of the N-terminal GLUT4 antibody was particularly poor, but was increased 
by incubation with GTPyS and an ATP regenerating system. This may imply that a 
protein is associated with the N-terminus of GLUT4 blocking the interaction of the N- 
terminal antibody with this region {Figure 5.22A). The actions of a GTPase, an ATPase 
or a combination of both may release this protein block. The levels of API found in the 
sample immunoprecipitated on Staph cells bound with N-terminal GLUT4 antibodies 
were lower than that found in samples immunoadsorbed on Staph cells coupled to the 
C-terminal GLUT4 antibody. However this presumably reflects the ability of these 
antibodies to efficiently immunoprecipitate GLUT4 vesicles. Indeed considering the 
lower efficiency of the N-terminal antibody to immunoprecipitate GLUT4 vesicles, the 
association of API is relatively high, and may be greater than the levels of API bound 
to an equivalent population of GLUT4 vesicles immunoadsorbed by the C-terminal 
GLUT4 antibody.
5.6.2 Detection of GLUT4 in the Thesit-Soluble Eluate
Another approach to analyse the importance of the C-terminus of GLUT4 in adaptor 
recruitment was to analyse whether any of the GLUT4 in the immunoprecipitated 
vesicles was freely soluble and therefore available for association with adaptor subunits. 
Thus both the Thesit-soluble material and the protein eluted by heating the acrylic beads 
(Thesit-insoluble) was analysed by SDS-PAGE and Western blotting with a GLUT4 
antibody. Approximately half of the total GLUT4 was recovered in the soluble 
material, and half was covalently bound to the beads. This implies that there may be
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Figure 5.22 How do GLUT4 Vesicles Associate with the Adaptor Complexes? A
GLUT4 vesicles were isolated from post-HDM supernatants prepared from basal adipose cells. The 
post-HDM supernatants were either treated with 600 pM GTPyS or left untreated before the 
immunoadsorption of the vesicles on Staphylococcus aureus cells coated either with antibodies against 
the C-terminus of GLUT4 (C-GT4), or antibodies against the N-terminus of GLUT4 (N-GT4), or a 50:50 
mixture of both antibodies (C/N-GT4). Vesicle associated proteins were eluted and resolved by SDS- 
PAGE and Western blotting. B. GLUT4 vesicles from basal (B) and insulin stimulated (I) adipocytes 
were isolated on acrylic beads covalently coupled to either non-specific rabbit IgG (NS) or affinity purified 
polyclonal rabbit anti-GLUT4 antibodies (GLUT4). Vesicle associated proteins were eluted in a Thesit 
detergent buffer (soluble). Covalently bound GLUT4 was released by denaturing the anti-GLUT4 
antibodies (insoluble). Both the soluble and insoluble material was resolved by SDS-PAGE and Western 
blotting with monoclonal antibodies against GLUT4 (clone 1F8). The results presented are representative 
of 3 separate experiments.
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sufficient GLUT4 protein available in the vesicles to interact via its cytoplasmic C- 
terminal tail with adaptor complexes in the Golgi membrane (Figure 5.22B).
5.6.3 Crosslinking Adaptor Proteins and GLUT4
In an attempt to show a direct interaction of GLUT4 with the API adaptor complex, 
chemical cross-linking studies were performed. Post-HDM supernatants from basal 
adipocytes were either left untreated or treated with the chemical cross-linkers 
designated ‘ABABA’ and ‘s-ABABA-s’ (the structures of which are shown in Figure 
5.23A). Post-HDM supernatants from basal and insulin treated adipocytes were either 
left untreated or incubated with one of the cross-linking reagents at a concentration of 1 
mM, in the presence of 1 mM WSC (l-(3-Dimethylaminopropyl)-3-Ethylcarboimide 
Hydrochloride) and 1 mM HAT (1-Hydroxylbenzothiazole) for 1 h at room 
temperature. The reaction was quenched by the addition of 20 mM Tris-HCl pH 7.4. 
20 jug of protein from each condition was analysed on a 7% resolving gel with 4% 
stacking gel (Figure 5.23B). GLUT4, API and AP3 could all be cross-linked using 
these reagents and formed high molecular weight complexes that did not migrate into 
the gel. GLUT4 vesicles from cross-linked post-HDM supernatants were 
immunoprecipitated on acrylic beads covalently coupled to affinity purified GLUT4 
antibodies. Cross-linked complexes were cleaved by the addition of 5 mM sodium 
periodate for 30 min at room temperature. Oxidised proteins were reduced by 
incubation with 20 mM sodium borohydride for 5 min, then analysed by SDS-PAGE 
and Western blotting. Neither GLUT4 nor API could be detected in the periodate- 
cleaved material, the blots being particularly dark (data not shown).
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Figure 5.23 The Use of Chemical Cross-linkers to Identify Proteins in Close 
Proximity to GLUT4 and the Adaptor Complexes. Post-HDM supernatants from basal 
(B) and insulin stimulated (I) adipocytes were either left untreated (no linker) or cross-linked with 
‘ababa’ or ‘s-ababa-s’, (the structures of which are shown in A). 20 pg of protein from each condition 
were resolved on a 7% SDS-PAGE gel with a 4% stacker and Western blotted with rabbit polyclonal 
antibodies against GLUT4 and subunits of the API and AP3 adaptor complexes, shown in B.
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Knowledge of the intracellular itinerary of GLUT4 is fundamental to our understanding 
of how insulin stimulates a massive increase in GLUT4 levels at the plasma 
membranes. Trafficking of GLUT4 through the labyrinth of intracellular compartments 
appears to be important for the generation and maintenance of a GLUT4 reservoir 
(Holman et a l , 1994). Insulin acts upon this reservoir recruiting GLUT4 to the plasma 
membrane and increasing the levels of the transporter at the cell surface by 10-20 fold. 
Kinetic analyses using photolabel-tagged GLUT4 have shown that insulin acts primarily 
on the exocytic limb of the recycling pathway, with little or no effect on the rate of 
GLUT4 endocytosis (Satoh et al., 1993; Yang and Holman, 1993; Yang et al., 1996). 
As well as GLUT4, insulin also causes the translocation of a number of other proteins to 
the plasma membrane, including GLUT1 (Holman et al., 1990; Calderhead et al., 1990) 
and the TfR (Tanner and Lienhard, 1987). However the stimulatory effect on these 
proteins is small in comparison with the response of GLUT4. These observations 
strongly imply that GLUT4 resides in a specialised compartment, which is acted upon 
by insulin in a unique and selective manner. The discriminatory interaction of GLUT4 
with proteins along its recycling pathway may underlie the mechanism for its 
specialised sorting and sequestration.
GLUT4 contains targeting signals present at both its N- and C-termini. This trafficking 
information includes a ‘tyrosine-like’ motif and a di-leucine sequence, which are ideal 
candidates to interact with adaptor complexes (Piper et a l, 1993; Verhey and Bimbaum, 
1993; Melvin et a l, 1999). Substantial evidence suggests that both these motifs are 
important for the intracellular sequestration of GLUT4 from the plasma membrane, and 
for subsequent intracellular trafficking (Corvera et a l, 1994; Araki et a l, 1996; Garippa 
et a l, 1996). Thus it is likely that GLUT4 interacts with both the plasma membrane 
adaptor AP2, and other intracellular-specific adaptors including the endosomal adaptor 
complex, AP3 and the TGN-directed adaptor complex, API.
In this study an immunoprecipitation technique was employed to address whether there 
is any direct association of adaptor proteins with GLUT4 vesicles. Using this procedure 
approximately 67% of the total GLUT4 population could be absorbed onto acrylic 
beads derivatised with a C-terminal antibody against GLUT4. This immunoadsorption 
efficiency is lower than that reported by Kandror and Pilch (Kandror and Pilch, 1994), 
who recovered 70-80% of the GLUT4 vesicles in the LDM fraction using beads coupled
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to monoclonal GLUT4 antibodies (clone 1F8). This difference can be explained in part 
by the different methods employed; in our study the post-HDM supernatant was rotated 
for 2 h at 4°C with the acrylic beads compared with an overnight incubation used by 
Kandror and Pilch (Kandror and Pilch, 1994). This shorter incubation was initially used 
in an attempt to prevent weakly bound proteins from dissociating during the rotation 
step. Furthermore in our study the post-HDM supernatant was used rather than the 
LDM fraction. The cytosol contained within the post-HDM supernatant may include 
proteins, which interfere with the immunoadsorption procedure, decreasing the 
association of GLUT4 vesicles with the beads. Finally in our study, an antibody against 
the C-terminal tail of GLUT4 was used, whereas in the published work an antibody 
directed against a longer stretch of amino acids in the C-terminus was employed. It is 
therefore possible that this latter antibody is more efficient at immunoprecipitating 
GLUT4 vesicles. Indeed the efficiency of GLUT4 antibodies coupled to various inert 
supports to immunoprecipitate vesicles has been used to reveal distinct populations of 
GLUT4 vesicles in cardiomyocytes (Fischer et a l , 1997).
This work has clearly demonstrated an association of the y- p i- and ol-subunits of API 
with GLUT4 vesicles from freshly isolated rat adipose cells. These data are consistent 
with electron micrographs showing that the y-subunit of API co-localises with GLUT4 
vesicles derived from 3T3-L1 adipocytes (Marsh et a l , 1998). Furthermore the 
association of API with GLUT4 observed by microscopy is increased when serine 488 
in the C-terminal phosphorylation site is substituted for alanine. Thus phosphorylation 
may play a role in targeting and sorting of GLUT4 through its interaction with API. In 
addition to the microscopy data, a recent study has shown a direct interaction between a 
C-terminal peptide of GLUT4 containing the di-leucine motif and the phosphorylation 
site, and the pi-subunit of API (Rapoport et al., 1998) and this interaction was 
modulated by PIP3 . Data shown here reveals that the interaction of API with low 
density microsomes is decreased in adipocytes treated with insulin. Furthermore, 
GLUT4 vesicles derived from adipocytes treated with insulin and the PI 3-kinase 
inhibitor, wortmannin, are associated with higher levels of API, than those derived from 
adipocytes treated with insulin alone. Thus it could be hypothesised that in the insulin- 
stimulated state when PIP3 is generated by the action of PI 3-kinase, adaptor proteins 
may be released from GLUT4 vesicles and redistributed to the cytosol. This in turn 
may allow vesicle fusion with target membranes. The role of PIP3 could therefore be to 
evoke uncoating.
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Specific kinases present on clathrin coated vesicles regulate adaptor proteins using 
phosphorylation as a molecular switch (Wilde and Brodsky, 1996). Thus 
phosphorylation disrupts the interaction of adaptor proteins with clathrin, and results in 
their dissociation from the membrane. How these kinases are regulated remains to be 
determined. However it is interesting to speculate that binding of PIP3 to adaptor 
subunits results in a conformational or allosteric change, which facilitates 
phosphorylation on specific residues. Future work could therefore focus on whether 
adaptor proteins isolated from insulin cell lysates are hyperphosphorylated compared 
with basal controls.
As well as the high levels of API association, AP3 was also detected at an appreciable 
concentration on GLUT4 vesicles. In contrast to this, only a minor amount of AP2 was 
isolated. This data therefore suggests that the steady-state localisation and intracellular 
sequestration of GLUT4 are more likely to be dependent on API and AP3, than on AP2. 
However, only the post-HDM supernatant was examined in these experiments, and as 
such it is not possible to evaluate the extent of association of AP2 with GLUT4 during 
its sorting and trafficking at the plasma membrane. Indeed vesicles budding at the cell 
surface are considerably larger than those budding from intracellular structures, which 
may facilitate their ability to pellet with the plasma membrane fraction. Thus the 
association of AP2 with GLUT4 vesicles needs to be further examined, perhaps by 
attempting to immunoprecipitate vesicles from the plasma membrane fraction itself.
Since GTPyS can stimulate API recruitment to the TGN, a number of experiments were 
performed to examine the effects of GTPyS on recruitment of adaptors to isolated 
GLUT4 vesicles. Importantly, we have shown for the first time that, in a cell free 
system, API can be recruited to isolated GLUT4 vesicles. The extent to which API can 
be recruited to GLUT4 vesicles is large, and is enhanced by the addition of an ATP 
regenerating system, and by incubation at physiological temperature. Furthermore the 
recruitment of API to GLUT4 vesicles can be partially blocked by brefeldin A. This 
implies that an ARF protein is involved in the coating process.
Unlike API, ARF could not detected on GLUT4 vesicles from freshly isolated 
adipocytes, but could be effectively recruited by incubation with GTPyS, with 
maximum recruitment observed in the presence of an ATP regenerating system. This 
data implies that an activated ARF is not required to maintain cellular API on vesicles
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once the adaptor complex has been recruited. This idea is supported by recent 
experiments showing that only a small amount of ARF is present in the purified 
clathrin-coats of vesicles, and that ARF is instead necessary for priming of the vesicle 
coating process (Zhu et a l , 1998).
As in the case of API, treatment of the post-HDM supernatant with brefeldin A resulted 
in a marked loss of ARF from GLUT4 vesicles. However incubation of adipocytes with 
brefeldin A has no effect on the insulin-stimulated glucose transport and only decreases 
basal transport moderately (Bao et a l , 1995). In addition treatment of cultured skeletal 
myotubes with brefeldin A causes the fusion of endosomal-TfR with GLUT4- 
containing compartments (Section 1.3.3), (Ralston and Ploug, 1996). These results 
suggest that the steady-state recycling of GLUT4 (responsible for maintaining the 
intracellular location of the transporter) may include a membrane budding step that is 
brefeldin A-sensitive. Furthermore inhibition of PLD, a downstream effector of ARF, 
has no effect on insulin-stimulated glucose transport, again suggesting that it is the 
intracellular trafficking and not the insulin stimulated exocytosis of GLUT4 that 
contains an ARF-associated step.
In contrast to the recruitment of API, GTPyS did not stimulate the association of AP3 
with GLUT4 vesicles. This unexpected observation may occur because under the 
experimental conditions used here, API is preferentially recruited to GLUT4 vesicles 
and competes with the binding of AP3. Therefore these data do not exclude the 
possibility that at some sites within the cell, delimited by membranes and where API 
availability is restricted, recruitment of AP3 may be dependent on ARF. Indeed at least 
one study has suggested that ARF1 is capable of inducing the re-location of AP3 from 
the cytosol to the endosomal membranes (Ooi et a l, 1998).
The separation of the bulk of GLUT4 from TfR on both Nycodenz and glycerol 
gradients suggests a specialised compartment exists which is distinct from the recycling 
system. However these results contradict the findings of Kandror and Pilch, who 
suggest that up to 60% of GLUT4 co-localises with TfR on sucrose gradients (Kandror 
and Pilch, 1998). While we are unable to reconcile this difference, our results are in 
agreement with a number of other studies. Firstly examination of cultured skeletal 
myotubes by immunogold electron microscopy shows GLUT4 in structures which are 
close to but distinct from compartments containing TfRs (Ralston and Ploug, 1996).
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Secondly glycerol gradients of PC 12 cells transfected with GLUT4, show that the vast 
majority of the TfRs migrate in fractions which are distal from the major GLUT4 pool 
(Herman et a l , 1994). Finally ablation of the endosomal system using internalised 
transferrin-HRP and diamino benzidine chemistry results in a total loss of TfR but only 
a 40% reduction in the levels of GLUT4 (Livingstone et al., 1996).
GLUT4 co-localises with API and AP3 on both of the gradients used in this study. 
Furthermore, the association of API and GLUT4 is increased by GTPyS which is 
presumably as a result of a vesicle budding or coating reaction. API and AP3 adaptors 
may therefore act as ‘filters’ in the GLUT4 trafficking pathway, providing the 
divergence from the normal endosome-recycling system that is necessary for the 
generation of a compartment that can respond so markedly to insulin. Thus GLUT4 in 
the endosomal compartment may be in equilibrium with a TGN recycling system 
(Melvin etal., 1999).
Since little co-localisation of GLUT4 with the TGN-specific marker TGN38 is 
observed, large-scale localisation of GLUT4 within this compartment is unlikely 
(Martin et a l, 1994). However GLUT4 has been shown to traffic though this 
compartment in atrial cardiomyocytes (Slot et a l, 1997), and EM studies have localised 
a sizeable proportion of GLUT4 to this region of the cell (Slot et a l, 1991a). Thus it is 
interesting to speculate that GLUT4 buds from here to form fusion competent vesicles, 
which constitute the specialised GLUT4 pool. These vesicles may resemble a 
compartment similar to the TGN-derived pre-secretory compartment (Dittie et a l, 1997; 
Tooze, 1998). This pre-secretory compartment may act as a sorting station at which 
several proteins may be retrieved back to the TGN or to the endosomal system, resulting 
in the concentration of proteins such as GLUT4 and vpl65. The association of API 
with GLUT4 vesicles may therefore be part of a mechanism for iterative enrichment of 
GLUT4 and removal of molecules such as the mannose-6-phosphate receptor that are 
required elsewhere (Mauxion et al, 1996; Tooze, 1998; Klumperman et a l, 1998). In 
addition it is possible that AP3 acts in an analogous iterative retrieval process that 
generates GLUT4 enriched vesicles but re-directs associated proteins to other parts of 
the endosomal system. A general hypothetical scheme for these processes is shown in 
Figure 5.24.
Figure 5.24 The Role of Adaptor Proteins and Internalisation Signals in GLUT4 Trafficking. GLUT4 is internalised from the cell surface, presumably 
by the interaction of its FQQI and LL motifs with the plasma membrane adaptor complex AP2. GLUT4 vesicles then traffic via the recycling endosomes, where TfRs are 
removed and recycled back to the plasma membrane, to the tram-Golgi network (TGN). The movement of GLUT4 vesicles between the endosomes and the TGN may be 
mediated by an interaction between AP3 and the FQQI motif of GLUT4. From the TGN, GLUT4 buds to create the GSVs and proteins such as the mannose-6-phosphate 
receptor are retrieved by the interaction of API with these vesicles. (In this diagram GLUT4 is shown in red, the TfRs in blue, the mannose-6-phosphate receptors in green and 










How GLUT4 vesicles specifically interact with adaptor proteins remains to be clarified. 
Studies presented here suggest that there may be sufficient GLUT4 freely available in 
vesicles (i.e. not bound to antibodies) to interact with adaptor proteins via their C- 
terminal targeting sequences. This is supported by the finding that a C-terminal peptide 
interacts with the pi-subunit of API (Rapoport et a l , 1998). However equally plausible 
is an interaction via the ‘tyrosine-like’ domain in the N-terminal region of GLUT4. 
This could be investigated using mutants of GLUT4 in which these two targeting 
domains are disrupted to analyse whether there are any changes in the levels of adaptor 
proteins immunoprecipitated with GLUT4 vesicles. A problem with this type of study 
is that the mutant proteins may not traffic faithfully, and may therefore aggregate in 
compartments where their association with adaptor proteins would increase, not as a 
consequence of a change in the interaction of adaptor proteins with the GLUT4 
targeting sequence per se, but as a consequence of aberrant localisation.
Furthermore a number of other proteins found in varying quantities on GLUT4 vesicles 
may be responsible for the association of these vesicles with adaptor proteins. These 
proteins include the mannose-6-phosphate receptor which has been shown to interact 
directly with API at the level of the Golgi apparatus (Le Borgne et al., 1993; 
Klumperman et a l , 1998), and vpl65 which contains two di-leucine motifs (Keller et 
a l , 1995).
In summary, the in vitro demonstration of a GTPyS-stimulated increase in API 
association with GLUT4 vesicles, and an increase in the density of these vesicles on 
sedimentation gradients, is an important methodological advance. It allows the link 
between signalling and small G-protein-dependent steps involved in GLUT4 vesicle 
processing to be studied in a cell-free system.
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6.0 Conclusions
The aims of this study were to establish a protocol for the isolation of insulin responsive 
cardiomyocytes and to investigate the roles of intracellular pH and adaptor protein 
complexes in GLUT4 trafficking. The isolation of myocytes using a modified 
procedure has resulted in the preparation of cells with a relatively low level of basal 
transport, particularly when inosine is added to the preparation. The reason for 
requiring the addition of inosine during the isolation procedure is unclear at present but 
would suggest that an alternative energy source is necessary. Inosine is not a 
particularly efficient metabolite, in that for every inosine molecule absorbed only one 
molecule of ATP is generated. This suggests that only a small drop in ATP levels 
occurs in the myocytes during their preparation. Further work is required to determine 
why the levels of ATP decline during the myocyte isolation and if additional steps can 
be undertaken to avoid this loss of cellular ATP.
Intracellular pH has been shown to be important for the recycling of a number of 
proteins including the TfR (Johnson et al., 1993; Presley et a l , 1997), TGN38 
(Chapman and Munro, 1994) and the cation-independent mannose-6-phosphate receptor 
(Johnson et a l , 1993). Results presented in this thesis show that the maintenance of 
intracellular pH is also important for the faithful targeting and translocation of GLUT4 
in cardiomyocytes and adipocytes. The mechanism by which pH controls targeting is 
unknown. However some evidence suggests that changes in pH may regulate the 
interaction of adaptor or adaptin-like proteins with receptor tails carrying internalisation 
sequences (Johnson et a l , 1993). Characterisation of the occluded population of 
GLUT4 vesicles is therefore required. For example if the internalisation motifs in 
GLUT4 are disrupted can HOE-642 still induce the formation of fusion-incompetent 
vesicles? What is the mechanism or ‘block’ in fusion at the plasma membrane?
Confocal analysis has shown that GLUT4 partially co-localises with the y-subunit of the 
adaptor complex API (Malide et a l , 1997). Furthermore a direct interaction between 
the |31-subunit of API and a C-terminal peptide of GLUT4 containing the di-leucine 
internalisation motif has been demonstrated (Rapoport et a l , 1998). In addition work 
described in this thesis has indicated that GLUT4 vesicles are coated with both API and 
AP3 complexes. Thus, the role of pH and GLUT4-specific adaptor proteins needs to be 
investigated with respect to vesicle trafficking. For example, how does the treatment of
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adipocytes with HOE-642 or bafilomycin Ai affect the interactions between GLUT4 
vesicles and the adaptor proteins API and AP3? It is conceivable that the block in 
fusion of GLUT4 vesicles with the plasma membrane and therefore the formation of the 
‘occluded’ vesicles in HOE-642-treated cell is due to a failure of adaptor proteins to 
dissociate from the vesicles. Since changes in pH may lead to aggregation of receptor 
tails or result in the failure to cytosolic adaptor-like proteins to transmit information, 
which may be important for uncoating, GLUT4 vesicles may remain bound to their 
adaptor proteins. The converse is also true, in that a change in pH could induce a 
conformational or allosteric change, which does not normally occur, and that this 
change ‘lock’s the adaptors onto the GLUT4 vesicles.
Recently a number of coiled coil proteins, for example p230 (also known as Golgin- 
245) and Giantin, which may act as vesicle tethers, have been shown to contain the 
‘granin’ consensus sequence E(N/S)LX(A/D)X(D/E)XEL (Erlich et al., 1996). In 
chromatogranin A, a short sequence at the C-terminus containing the granin motif has 
been shown to be responsible for pH regulated oligomerisation (Yoo and Lewis, 1993) 
and for pH-dependent association of chromatogranin A with integral membrane proteins 
of secretory vesicles (Yoo, 1994). The role of the granin motif in vesicle tethering 
proteins such as giantin is unknown but its presence is suggestive of a role in vesicle 
sorting or trafficking in response to changes in pH. Thus tethering proteins important 
for the biogenesis of GLUT4 vesicles need to be isolated and their role with respect to 
pH regulation needs to be investigated.
Future studies could also focus on the identification of cytosolic interactors for 
GLUT4/AP1-coated vesicles. Similar studies of M6PR vesicles coated with API have 
shown that TIP47 is responsible for recognising M6PR tails at the endosome and that 
this interaction leads to the recycling of M6PRs to the biosynthetic pathway (Diaz and 
Pfeffer, 1998). Furthermore a novel protein, PACS-1, localises both M6PRs and Furin 
to the TGN by interacting with their phosphorylated cytoplasmic tails (Wan et al.,
1998). Indeed the interaction of PACS-1 with receptor tails is regulated by successive 
rounds of phosphorylation and dephosphorylation (Molloy et al., 1998). Thus it would 
be interesting to analyse whether these proteins or similar proteins play a role in API 
mediated GLUT4 vesicle trafficking.
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